UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________

Form 10-K

(Mark One)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934.

For the fiscal year ended December 31, 2023

For the fiscal year ended December 31, 2016

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the transition period from ____ to _____

For the transition period from ___ to _____

Commission file number: 1-16525

CVD EQUIPMENT CORPORATION

(Exact name of registrant as specified in its charter)

New York

11-2621692

(State or Other Jurisdiction of

(I.R.S. Employer Identification No.)

Incorporation or Organization)

355 South Technology Drive

Central Islip, New York 11722

(Address including zip code of registrant’s Principal Executive Offices)I.R.S. Employer

Identification No.)

355 South Technology DriveCentral Islip, New York11722

(Address including zip code of registrant’s Principal Executive Offices)

(631)981-7081

(Registrant’s Telephone Number, Including Area Code)

Securities registered underpursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)Name of each exchange on which registered

Common Stock, Par value $0.01

CVVNASDAQ Capital Market

Securities registered underpursuant to Section 12(g) of the Act:
None

None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data file required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months/(ormonths (or for such shorter period that the registrant was required to submit and post such files).Yes ☑. Yes No ☐

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  ☐   

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” and emerging growth company in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer Smaller reporting company Emerging Growth Company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter: $44,511,547$48,002,094 at June 30, 20162023.

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date: 6,363,6906,824,511 shares of Common Stock, $0.01 par value at March 15, 2017.25, 2024.

DOCUMENTS INCORPORATED BY REFERENCE: None.None.

 

PART I

INFORMATION CONCERNING FORWARD-LOOKING STATEMENTS

Except for historical information contained herein, this Annual Report on Form 10-K contains forward–looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. These statements involve known and unknown risks and uncertainties that may cause our actual results or outcomes to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on various factors and are derived utilizing numerous important assumptions and other important factors that could cause actual results to differ materially from those in the forward-looking statements. Important assumptions and other factors that could cause actual results to differ materially from those in the forward-looking statements, include, but are not limited to: competition in our existing and potential future product lines of business; our ability to obtain financing on acceptable terms if and when needed; uncertainty as to our future profitability, uncertainty as to the future profitability of acquired businesses or product lines, uncertainty as to any future expansion of the Company.

competition in our existing and potential future product lines of business, including our PVT150 / PVT 200 systems;
our ability to attract and retain key personnel and employees;
our ability to obtain financing on acceptable terms if and when needed;
uncertainty as to our ability to develop new products for the high power electronics market including our plan to commercialize and market a PVT200 to grow silicon carbide crystals for 200 mm wafers;
uncertainty as to our future growth and profitability; and
uncertainty as to our ability to adequately obtain raw materials and on commercially reasonable terms.

Other factors and assumptions not identified above were also involved in the derivation of these forward-looking statements and the failure of such assumptions to be realized as well as other factors may also cause actual results to differ materially from those projected. We assume no obligation to update these forward-looking statements to reflect actual results, changes in assumptions, or changes in other factors affecting such forward-looking statements. Past performance is no guaranty of future results.

Item 1.DescriptionYou should not place undue reliance on any forward-looking statements, which speak only as of Business.the dates they are made. When used with this Report, the words “believes”, “anticipates”, “expects”, “estimates”, “plans”, “intends”, “will” and similar expressions are intended to identify forward-looking statements.

2

Item 1.Description of Business.

Definitions

The use of the words “CVD,” “we,” “us”“us,” or “our”“our,” refers to CVD Equipment Corporation, a New York corporation incorporated on October 13, 1982, and its wholly owned subsidiaries, CVD Materials Corporation (including its wholly owned subsidiarysubsidiaries, and CVD MesoScribe Technologies Corporation and Tantaline CVD Holding ApS, collectively “CVD Materials”), and FAE Holdings 411519R LLC except where the context otherwise requires.

Overview

CVD has served the advanced materials markets with chemical vapor deposition, physical vapor transport and thermal process equipment for over 40 years. We are headquartered in Central Islip, New York with one other location in Saugerties, New York.

We design, develop, and manufacture a broad range of chemical vapor deposition, gas control and other state-of-the-art equipment and process solutions used to develop and manufacture materials and coatings for researchthe compound semiconductor, semiconductor, aerospace, battery energy storage markets as well as advanced industrial applications, and industrial applications. This equipment is used byresearch.

We conduct our customers to research, design,business through three reportable operating segments: i) CVD Equipment that supplies chemical vapor deposition, physical vapor transport and manufacture these materials or coatings for aerospace engine components, medical implants, semiconductors, solar cells, smart glass, carbon nanotubes, nanowires, LEDs, MEMSthermal process equipment; ii) SDC that designs and other applications. Throughmanufactures ultra-high purity gas and chemical delivery control systems; and iii) CVD Materials that provide products related to advanced materials and coatings.

Developments

On May 26, 2023, we sold our Application Laboratory, we provide material coatings, process development supportTantaline subsidiary located in Nordborg, Denmark in exchange for a nominal amount at closing and process startup assistance withan earn-out provision based on any net income that Tantaline may earn during the five-year period ending December 31, 2027. The decision to sell Tantaline was based on our ongoing strategy to focus on enabling tomorrow’s technologiesTM.the equipment business consisting of the CVD Equipment and SDC segments and reduce its focus on the non-core CVD Materials business.

On August 8, 2023, we entered into an agreement with a third party to sell certain assets and license certain propriety information of MesoScribe. We will continue to fulfill remaining orders for MesoScribe products through the end of 2024 at which time we plan to cease the remaining operations of MesoScribe and dispose of any remaining equipment.

The decisions to sell our Tantaline subsidiary and wind down the operations of MesoScribe were based on our ongoing strategy to focus on the equipment business consisting of the CVD Equipment and SDC segments.

3

Key Company Strengths

Based on more than 3440 years of equipment experience, we use our engineering, manufacturing andcapabilities in process development, engineering, and vertical manufacturing to transform newemerging applications into leading-edgemainstream manufacturing solutions. This enables university, research and industrial scientists at the cutting edge of technology to develop next generation aerospace, medical, solar, nano, LEDs, semiconductors and other electronic components. We develop, manufacture and provide equipment for research and production based on our proprietary designs.

We have built a significant library of design expertise, know-how and innovative solutions to assist our customers in developing these intricate processes and to accelerate their production and commercialization. This library of equipment design solutions, along with our vertically integrated manufacturing and systems integration facilities, allows us to provide superiorapplication-specific design, process, and manufacturing solutions to our customers on a cost effective basis.customers.

Our strategy is to target opportunities in the research and development and production equipment market, with a focus on higher-growth applications such as aerospace, medical, solar, smart glass, carbon nanotubes, nanowires, graphene, MEMS and LEDs. To expand our penetration into these growth markets, we have developed a line of proprietary standard products and custom systems. Historically, we manufactured products on a custom, one-at-a-time basis to meet an individual customer’s specific research requirements. Our new proprietary systems leverage the technological expertise that we have developed through designing these custom systems onto a standardized basic core. This core is easily adapted through a broad array of available add-on options to meet the diverse product and budgetary requirements of the research community. By manufacturing the basic core of these systems in higher volumes, we are able to reduce both the cost and delivery time for our systems. These systems, which we market and sell under the EasyTube® product line, are sold to researchers at universities, research laboratories, and startup companies in the United States and throughout the world.

Sales of our proprietary standard, custom systems and process solutions have been driven by our installed customer base, which includes several Fortune 500 companies. The strong performance and success of our products has historically driven repeat orders from existing customers, as well as business from new customers. However, with our proprietary solutions and expanded focus on “accelerating the commercialization of tomorrow’s technologies”TM we have been developing a new customer base in addition to growing with our existing customers. We have generally gained new customers through word of mouth, limited print advertising and trade show attendance. We are now also gaining new customers by their awareness of our company in the marketplace with results from our Application Laboratory, partnerships with startup companies, increased participation in trade shows and expanded internet advertising.

The core competencies we have developed in equipment and software design, as well as in systems manufacturing and process solutions,development are used to engineer our finished products and to accelerate the commercialization path of our customer base. Our proprietary-real-time,proprietary real-time software allows for rapid configuration, and provides our customers with powerfulenabling tools to understand, optimize and repeatedly control their processes. Our vertically integrated structure allows us to control the manufacturing process, from bringing raw metal and components into our manufacturing facilities to shipping out finished products. These factors significantly reduce cost, improve quality, and reduce the time it takes from customer order tobetween customers’ orders and the shipment of our products. Our Application Laboratory allows selected customers the option to testbring their process tools into our Application Laboratorylaboratory and to work togethercollaboratively with our scientists and engineers to optimize process performance.

To expand our presence into our major target markets, we are developing a line of proprietary standard use products to complement our customized legacy systems. Historically, we manufactured products for research and development on an application-specific basis to meet an individual customer’s specific research and production requirements. Our proprietary systems leverage the technological expertise that we have developed through designing these custom systems into a broader standardized product line. The standard product line can be configured from a wide range of available options to meet diverse product and budgetary requirements. Manufacturing these standardized systems in higher volumes may provide us the flexibility to reduce both the cost and delivery time of our systems. These systems, which we market and sell under the CVD, FirstNano and EasyTube® product names, are sold to commercial companies, universities and research laboratories in the United States and throughout the world.

Sales of our proprietary standard systems, custom systems and process solutions have been driven by our installed customer base, which includes Fortune 500 companies. The performance and success of our products has historically driven repeat orders from existing customers as well as generated business from new customers. Furthermore, with our proprietary solutions and expanded focus on “enabling tomorrow’s technologiesTM we have been developing a new customer base in addition to growing with our existing customers.

Key Growth Strategies

Our core strategy is to focus on growth market applications in end markets related to the “electrification of everything,” aerospace and industrial applications. The phrase “electrification of everything” refers to the shift from fossil fuels to the use of electricity to power devices, buildings, electric vehicles (“EVs”), and many other applications. With respect to aerospace, our systems are being used by our customers to produce ceramic matrix composite materials (“CMCs”) that will be used in next generation gas turbine jet engines with the objective of reducing jet fuel consumption and contributing to the decarbonization of that industry.

4

Business DevelopmentsOur current strategy yielded multisystem orders of PVT150 equipment that was delivered to one company that manufactures silicon carbide wafers.

On December 16, 2016,In February 2024, we purchased certain assets formerly owned by Tantaline A/Sreceived an order from an additional customer for our new PVT200 system used to grow silicon carbide crystals for the manufacture of Nordborg, Denmark (“Tantaline A/S”)200 mm wafers. This represents our second customer for our PVT equipment. This customer plans to evaluate our equipment for potential additional purchases of PVT equipment. We have also received orders from OneD Battery Materials in 2023, a company that is engaged in providing battery nanomaterials.

Both technologies are essential for the support of the EV market. These systems should provide us with standard product offering to continue to support the EV focused market as well as energy storage, power conversion and power transmission. We plan to expand our product offerings in the power electronics market to build off the introduction of the PVT150 and PVT200 systems. We are also evaluating our ability to provide other equipment used in the manufacturing process of silicon carbide wafers.

During 2022, we also received an order from an aerospace company for a production chemical vapor infiltration (CVI) system that will be used to manufacture CMCs for gas turbine jet engines. In 2023, we received an order from the same aerospace company for an additional three CVI systems.

In February 2024, we received a multisystem order from an industrial customer for approximately $10 million that will be used for depositing a silicon carbide protective coating on OEM components.

We have generally gained new customers through our industry reputation, as well as limited print advertising and trade show attendance. We have increased the number of trade shows and industry conferences in 2023. In addition, we added to our sales and marketing team in 2022 and expanded our sales team in early 2023.

Major Target Markets

Our major target markets are high power electronics, EV battery materials / energy storage and aerospace, defense and industrial applications – all of which have the objective of improving energy efficiency.

High Power Electronics

Demand for silicon carbide wafers to support high power electronics for energy storage and transmission/charging resulted in a multi-system order from a US-based, silicon carbide wafer manufacturer. Through December 31, 2023, we have received and delivered orders for 30 of our PVT150 physical vapor transport systems from one customer, which uses our systems to grow silicon carbide crystals that are made into 150 mm silicon carbide wafers for use in power electronics. In late 2023, we launched our PVT200 system designed to manufacture silicon carbide crystals for 200 mm wafer and received our first order from a second customer. We plan to expand our marketing and future product development for the PVT product line as well as expand our product offerings to manufacturers of silicon carbide wafers.

5

EV Battery Materials / Energy Storage

We have experienced increased interest and demand for nanotechnology materials including carbon nanotubes (CNTs), graphene and silicon nanowires (Si-NWs) to support the development and manufacturing for battery materials used in electric vehicles. We received two system orders in 2021 to deposit coatings onto powders used in silicon-graphite anodes, including a production system and a second for research and material development. We received additional system orders from this customer in 2023 that were completed during 2023.

Aerospace & Defense

CVD is a leading manufacturer of CVI and tow-coating systems to manufacture CMCs for aerospace gas turbine jet engine applications. Our customers include two of the leaders in aerospace gas turbine engines.

We continue to engage customers in the aerospace market regarding CMCs. During 2022, we received an order for a production CVI system valued at approximately $3.7 million. We received an additional order for three CVI systems during 2023 from the same customer. These systems will be used to manufacture CMCs for aerospace gas turbine jet engines.

We believe our future growth will be derived from production applications in our major target markets. Our legacy product line continues to provide advanced equipment and subsystems to enable development of emerging technology and research applications.

Our major targeted markets are further described as follows (the term “legacy product” refers to products and systems within our product offerings that we have produced in our history):

Major Target Markets:Description and Growth Drivers:CVD Equipment Products and Services:

High Power Electronics

The shift to electrification has the objectives of reducing emissions and reducing dependency on fossil fuels. This has driven the demand for electric vehicle and associated high power electronics used in charging and motor power conversion.

Production Applications:

- PVT150 SiC crystal growth system launched in 2022.

- PVT200 SiC crystal growth system launched in 2023.

- HVPE400: polycrystalline GaN (legacy product).

EV Battery Materials / Energy Storage

The shift to electrification also requires improvements in energy storage, specifically with the use of novel anode materials.

Production Applications:

- PowderCoat-1100 production system launched in 2021 grows Si nanowires on carbon nanoparticles.

- Carbon-150: Single substrate system for CNT growth. Versatile substrate format, on wafer or foil.

- Carbon-300: Multiple substrate batch tube system for CNT growth. Versatile substrate format, on wafer or foil.

R&D Applications:

- ET-3000: Versatile CNT growth system for research and development.

Aerospace, Defense and Industrial

Next generation gas turbine jet engines are incorporating CMC material for the hot section or exhaust of the engine to improve fuel efficiency.

Silicon carbide coating is use as a protective barrier in many OEM components used in LED and other applications.

Production and R&D Applications:

- Fiber tow coat system. Mass production system for multi-layer coating for CMCs.

- Silicon bond coat environmental barrier depositing system. Deposits Si on machined gas turbine jet engine CMC components and other OEM components.

- Chemical Vapor Deposition/ Chemical Vapor Infiltration production coating system for multi-layer CMC coatings on SiC fiber preforms.

6

Other MarketsCVD Equipment Products:

- Universal liquid and gas storage cabinets, management, and delivery systems (SDC segment).

- Production MOCVD Super Conducting Tape system.

- ET-3000: MOCVD for compound semiconductor R&D.

- ET-3000 for graphene.

- ET-6000: Multi-Tube Chemical Vapor Deposition Tube furnace (metals, oxides and nitrides).

- PowderCoat-300 for powder material R&D (including battery anode).

- TMD: cluster tool for advanced material development.

Our wholly owned subsidiary, CVD Materials. Formed in 2007, as a spin off from The Danfoss Group, Tantaline A/S established itself as a leader inMaterials Corporation, includes our MesoScribe product lines. Our MesoScribe product line supports the commercialization of tantalum treated parts for corrosion resistance.aerospace and defense markets with novel robust direct write instrumentation. We have now established in Denmark a new and wholly owned CVD subsidiary operating under the name Tantaline CVD ApS (“Tantaline”).

This asset acquisition was a significant step in our strategic plan to leverage our equipment know-how and proven abilitywind down the operations of MesoScribe in 2024 after satisfaction of customer purchase orders.

Bookings

During 2023, bookings of new orders from customers was approximately $25.8 million, representing a decrease of approximately 22.1% compared to scale up deposition processes into offering high value added materials, products and services. This innovative tantalum chemical vapor technology, called Tantaline® treatment, is used2022 bookings of $33.1 million. The decline in bookings was related to create a tantalum surface alloy on parts including valves, fittings, autoclaves, process chambers, flow reactors, fasteners, mixers, flowmeters, and medical devices,$8.8 million of orders of PVT150 systems that were received in 2022 as well as other parts that are pronecompared to corrosionno such orders in harsh environments. These parts are used across a broad range of industries including chemical processing, oil & gas, mining, pharmaceutical, and medical. In hot corrosive acidic environments (>150°C) such as sulfuric, nitric, and hydrochloric acids, Tantaline® treated parts outperform most high priced specialty alloys nearly at the level of more expensive solid tantalum parts. Tantaline® treatment therefore provides solid tantalum like superior corrosion resistance at a lower part cost. We believe that the acquisition of these assets will further CVD’s corrosion resistant technology and applications base and provide access to new markets and applications. Additionally, sales and manufacturing operations in Denmark expand our geographic footprint.2023.

OperatingSegmentsUnits

In 2016, we conducted our operations through two divisions: (1) CVD/First Nano, and (2) Stainless Design Concepts (“SDC”). Each division operates with divisional management supported by product development, sales and administration which are managed at the corporate level.

With the acquisition of certain assets formerly owned by Tantaline A/S, we set up Tantaline, a wholly owned subsidiary of CVD Materials where we operate a facility in Denmark. There was minimal activity in 2016 and is included in CVD/First Nano.

 

CVD/First NanoCVD Equipment - supplies state-of-the-art chemical vapor deposition and thermal process equipment targeting growth production markets as well as systems for use in research and development. This includes systems marketed under the research, developmentFirstNano product brand. Utilizing our over 40 years of expertise in the design and manufacturingmanufacture of chemical vapor deposition and thermal process equipment, we provide material processing capability and control at a competitive cost of ownership.

The targeted growth production markets include high power electronics (both silicon carbide (SiC) and gallium nitride (GaN)), aerospace advanced materials primarily for gas turbine jet engines, and medical components,nanomaterials used in batteries. The product group also consists of legacy products serving the production and R&D applications such as semiconductors, LEDs, carbon nanotubes, nanowires, solar cells and a number of other industrial & research applications. We utilize

7

Our developments and opportunities for the carbon composite business come from achievements in our expertise inApplications Laboratory. The Applications Laboratory, along with the designsales and manufacture of chemical vapor deposition systemsmarketing team continue to workexplore carbon-based products and applications that can be made from our CNT, infiltrated carbon/CVI and carbon nano fiber technology (CNF). Some applications include CNT and infiltrated carbon/CVI based battery material and CNF capacitors for 5G technology.

To support new emerging applications, we provide equipment to and collaborate with laboratory scientists to bring state-of-the-art processes from the research laboratory into production, as well as to provide production equipment andproduction. CVD Equipment group provides process solutions based on our designs. CVD/First Nano also operatesdevelopment value through our Application Laboratory where our personnel interact effectivelydirectly with the scientists and engineers of our customer base. CVD/First Nanobase to develop solutions to tomorrow’s challenges today. CVD Equipment segment operates out offrom our main135,000 sq. ft. facility in Central Islip, New York.


SSDC DC- designs and manufactures ultra-high purity gas and chemical delivery control systems for state-of-the-art semiconductor fabrication processes, aerospace, solar cells, LEDs, carbon nanotubes, nanowires, and a number of industrial applications. Our SDC products are sold on either a stand-alone basis or together withand are also integrated into certain CVD equipment. This internal supply of chemical and gas delivery systems and components provide a competitive advantage for our CVD/First Nano systems.CVD Equipment group over its competition. SDC operates out offrom a 22,000 square foot facility fitted with Class 10 and Class 100a clean room manufacturing space located in Saugerties, New York.

Principal Products

Chemical Vapor DepositionCVD Materials - A process which passes a gaseous compound over a target material surface that is heatedconsist of MesoScribe’s direct write printed electronics business. MesoScribe provides MesoPlasma™ printing services and products (heaters, antennas, and sensors) to such a degree that the compound decomposes and deposits a desired layer onto substrate material. The process is accomplished by combining appropriate gases in a reaction chamber, of the kind produced by the Company, at elevated temperatures (typically 150-1,800° Celsius). Our chemical vapor deposition systems are complete and include all necessary instrumentation, subsystems and components and include state-of-the-art process control software. We provide both standard and specifically engineered products for particular customer applications. Some of the standard systems we offer are for silicon, silicon-germanium, silicon dioxide, silicon nitride, polysilicon, liquid phase epitaxial, metalorganic chemical vapor deposition, carbon nanotubes, graphene nanowires, solar cell research and solar material quality control.

Chemical Vapor Deposition Systems - Used in a variety of models for laboratory research and production. All models are offered with total system automation, a microprocessor control system by which the user can measure, predict and regulate gas flow, temperature, pressure and chemical reaction rates, thus controlling the process in order to enhance the quality of the materials produced. Our standard microprocessor control system is extremely versatile and capable of supporting the complete product line and most custom system requirements. These chemical vapor deposition systems are typically priced between $80,000 and $1,500,000, but can go significantly higher.

Rapid Thermal Processing (“RTP”) - Used to heat semiconductor materials to elevated temperatures of up to 1,000° Celsius at rapid rates of up to 200° Celsius per second. Our RTP systems are offered for implant activation, oxidation, silicide formation and many other processes. We offer systems that can operate both at atmospheric or reduced pressures. Our RTP systems are priced up to $600,000.

Annealing and Diffusion Furnaces - Used for diffusion, oxidation, implant anneal, solder reflow, solar cell manufacturingaerospace, satellite, power generation, defense, and other processes. The systemsmarkets requiring high performance. MesoScribe operations are normally operatedlocated at atmospheric and/or reduced pressureour main facility in Central Islip, New York.

On August 8, 2023, we entered into an agreement with gaseous atmospheres relateda third party to the process. An optional featuresell certain assets and license certain proprietary information of the system allows for the heating elementMesoScribe. We will continue to be moved away from the process chamber allowing the wafers to rapidly cool or be heated in a controlled environment. Our cascade temperature control system enables more precise control of the wafers. The systems are equipped with an automatic process controller, permitting automatic process sequencing and monitoring with safety alarm provisions. Our annealing and diffusion furnace systems are priced up to $900,000.

Ultra-high Purity Gas and Liquid Control Systems - Our standard and custom designed gas and liquid control systems, which encompass gas cylinder storage cabinets, custom gas and chemical delivery systems, gas and liquid valve manifold boxes and gas isolation boxes, provide safe storage and handling of pressurized gases and chemicals. Our system design allows for automatic or manual control from both a local and remote location. A customer order often includes multiple systems and can total up to $1,000,000.


Quartz-ware - We provide standard and custom fabricated quartz-ware used in our equipment and other customer tools. We also provide repair and replacement of existing quartz-ware.

Markets and Marketing

Due to the highly technical nature of our products, we believe it is essential to contact customers directly through our sales personnel and through a network of domestic and international independent sales representatives and distributors specializing in the type of equipment we sell. Our primary marketing activities include direct sales contacts, participation in trade shows and our internet websites. We are also focusing our efforts on being in the top listings on many search engines in order to increase the number of “hits” to our websites.

Customers

We are continuing to work on expanding our product offerings. Many of these products are used in research and in production applications. We sell our products primarily to electronic component manufacturers, institutions involved in electronic component research (such as universities, government and industrial laboratories) and to industries such as aerospace that require specialized coatings. We have both a domestic and international customer base with hundreds of installed systems.

Given the complexity of some of the systems we sell, revenue from a single customer in any one year can exceed 10.0% of our total sales. In fiscal years 2016 and 2015 one customer represented 45.3% and 49.6% of our annual revenues respectively. Another customer represented 13.7% of our annual revenues for 2015. The loss of current key customers, if not replaced by others, may have a material adverse effect on our business and financial condition.

For the twelve months ended December 31, 2016, approximately 11.9% of our revenues were generated by sales to customers outside the U.S., compared to 9.0% for the twelve months ended December 31, 2015.

Warranties

Warranties on our equipment can range up to twenty-four months from shipment and we pass along any warranties from original manufacturers of components used in our products. We provide service and support for our installed base of equipment with in-house field service personnel. Warranty costs, including those incurred in fiscal years 2016 and 2015, have been historically insignificant and expensed as incurred.


Competition

We are subject to intense competition. We are aware of other competitors that offer a substantial number of products and services comparable to ours. Many of our competitors (including customers who may elect to manufacture systems for internal use) have financial, marketing and other resources greater than ours. To date, we believe that each of our two operating divisions has been able to compete favorably in markets that include these competitors, primarily on the basis of know-how, technical performance, quality, delivery and price and aftermarket support.

CVD/First Nano competes primarily with in-house design and engineering personnel at research and university laboratories with the capacity to design and build their own equipment internally. Due to budgetary and funding constraints, many of these customers are extremely price sensitive. We believe that our systems are among the most advanced available for the targeted market space.

SDC’s gas management and chemical delivery control systems are among the most advanced available. We further believe that SDC is differentiated from our competitors through our intimate understanding of how the systems in which our products are incorporated are actually used in field applications. We have gained this understanding as a result of having designed and built complex process gas systems for CVD/First Nano as well as for a number of the world’s leading semiconductor, solar manufacturers, research laboratories and universities.

Sources of Supply

Many of the components used in producing our products are purchased from unrelated suppliers. We have OEM status with our suppliers but we are not obligated to purchase a pre-determined quantity. We are not dependent on a principal or major supplier and alternate suppliers are available. Subject to lead times, the components and raw materials we use in manufacturing our products are readily obtainable.

We have a fully-equipped machine shop that we use to fabricate most of our metal components in-house, including the most complex designed parts of our equipment. Our investment in CNC machines for our machine shop has increased our efficiencies while significantly reducing costs in production. Similarly, our quartz fabrication capability is sufficient to meet our quartz-ware needs.

Materials procured from the outside and/or manufactured internally undergo a rigorous quality control process to ensure that the parts meet or exceed our requirements and those of our customers. Upon final assembly, all equipment undergoes a final series of complete testing to ensure maximum product performance.


Backlog

As of December 31, 2016, our order backlog was approximately $27.8 million compared to approximately $6.1 million at December 31, 2015, an increase of $21.7 million, or 355.7%. We received approximately $42.6 million infulfill remaining orders for MesoScribe products through the twelve months ended December 31, 2016 comparedend of 2024 at which time we plan to $24.0 million in orders forcease the twelve months ended December 31, 2015, an increaseremaining operations of $18.6 million or 77.5%. The CVD/First Nano division received orders totaling $39.9 millionMesoScribe and the SDC division received $2.7 million. The December 31, 2016 backlog consistsdispose of $23.3 million or 84% from one customer as a result of multiple orders that are still in process. The increase in backlog is related to an increase in orders, as we focus on new opportunities with new and existing customers. The timing for completion of the backlog varies depending on the product mix and can be as long as two years. Included in the backlog are all accepted purchase orders with the exception of those that are included in our percentage-of-completion. Order backlog is usually a reasonable management tool to indicate expected revenues and projected profits, however, it does notprovide an assurance of future achievement or profits as order cancellations or delays are possible.any remaining equipment.

Intellectual Property

Our success is dependent, in part onupon the development and protection of our proprietary technology and other proprietary rights. We have historically protectedand continue to protect our proprietary information and intellectual property such as design specifications, blueprints, technical processes, and employee know-how through the use of patents and non-disclosure agreements. In addition, wherethe area of patents, we deem appropriate, webelieve there is value in having protected intellectual property and will continue to file for patent and trademark protection of our proprietary technology and intellectual property that we believe has the potential to be incorporated into our products and can be sold to multiple customers. We also maintain and/or assert rights in certain trademarks relating to certain of our products and product lines and claim copyright protection for certain proprietary software and documentation.

8

While patent, copyright and trademark protections for our intellectual property are important to different degrees for our various products and solutions, we believe our future success in highly dynamic markets is most dependent upon the technical competence and creative skills of our personnel and our ability to accelerate the commercialization of next generation intellectual properties. We attempt to protect our trade secrets and other proprietary information through non-disclosure agreements with our customers, suppliers, employees and consultants and other security measures.

Research and Development

We develop new products based on market analysis or by customer request. The university research community is at the forefront of nanotechnologytechnology included in our product development includes mechanical hardware, software and controls systems and overall configuration. We have conducted research and we are focused on providing state-of-the-artdevelopment over the last 40 years and have a wealth of technology from which systems to this market that will help bridge the gap between pioneering research and marketable products. Our Application Laboratory, togethersolutions can be derived from and productized. Together with a number of leading universities and startup companies with whom we partner from time to time, conducts cutting-edgewe conduct research on SiC growth, the growth and infiltration of carbon nanotubes, graphene and nanowires as well as on selected solar cellaerospace manufacturing processes and smart glass coating processes. The results of this research could have far reaching implications concerning the use and manufacture of carbon nanotubes, graphene and nanowires, solar cell and glass coatings for many markets. Our intention is that together with these leadingcustomers and universities, and start-up companies, we will leverage our collective expertise in this field, which we believe will allow us to capitalize on commercial opportunities in the future. This relationship has thus far produced leading edge results,

Products and Technology

Chemical Vapor Deposition/Infiltration – Chemical vapor deposition is a method of coating or growing material through a chemical recombination at elevated temperatures onto or within pores of a substrate material. A single or collection of gases or vapor introduced on to the surface or into pores of a substrate material that is heated to such a degree that the gases decompose and deposits a desired layer onto and or into a substrate material. Chemical vapor infiltration (CVI) is a variant of a chemical vapor deposition process that is performed at low pressures to allow for coating the internal surfaces of a porous material. Using heat and low pressure, precursor vapors penetrate the pores/fiber of the material and deposit to form a conformal coating on the internal surfaces. Both processes are accomplished by combining appropriate gases in a reaction chamber, of the kind we manufacture, at elevated temperatures (typically 500° to 2,500° Celsius). Our chemical vapor deposition and CVI systems are complete and include all necessary heating techniques, precise control instrumentation, gas delivery and abatement subsystems and components and include state-of-the-art proprietary process control software. We provide both standard and emerging applications specified products. Some of the standard systems we offer are for SiC, GaN, Aluminum Nitride (AlN), CMCs, silicon (Si), CNT, graphene, silicon nanowires. The systems are sold under the CVD and FirstNano product brands.

Physical Vapor Transport (PVT) – While the PVT150 was officially launched for production in 2022, we have sold PVT systems in prior years and have pioneered both resistive heating and more effectively inductively heated PVT systems. The PVT150 system was specifically designed to address the SiC crystal growth market for 150 mm substrates or wafers. Designed to provide enhanced process parameter control it allows existing and future customers the ability to tightly control and monitor the crystal growth process for 150mm substrates. A 200 mm version called the PVT200 was developed during 2023 and the first order was received in February 2024. The crystal growth technique utilized a high temperature furnace to vaporize from seed granular material of SiC and further deposit out in an ordered crystal structure onto substrate wafer. The process takes days to over a week to complete and yield a SiC crystal ready for further processing into wafers.

9

Rapid Thermal Processing (RTP) – Used to heat semiconductor materials to elevated temperatures of up to 1,200° Celsius at rapid rates of up to 200° Celsius per second. Our RTP systems are offered for implant activation, oxidation, silicide formation and many other processes. We offer systems that can operate both at atmospheric and reduced pressures.

Annealing, Diffusion and Low-Pressure Chemical Vapor Deposition (LPCVD) Furnaces – These furnaces are used for dislocation removal in crystals, dopant diffusion, oxidation, for SiC, Si, SiOx and other applications. The systems are normally operated at atmospheric and/or reduced pressure with gaseous atmospheres related to the process. An optional feature of the system allows for the heating element to be moved away from the process chamber allowing the wafers to rapidly cool or be heated in a controlled environment. Our temperature control system enables more precise control of the wafers. The systems are equipped with an automatic process controller, permitting automatic process sequencing and monitoring with safety alarm provisions.

Ultra-High Purity Gas and Liquid Control Systems – Our standard and custom designed gas and liquid control systems, which encompass gas cylinder storage cabinets, custom gas and chemical delivery systems, gas and liquid valve manifold boxes and gas isolation boxes, provide safe storage and handling of pressurized gases and chemicals. Our system design allows for automatic or manual control from both a local and remote location. These subsystems and components are provided to the general market as well as support the CVD Equipment segment.

Quartzware – The majority of our process equipment solutions, utilize quartz components which we partially manufacturer internally. In addition, the equipment typically requires routine maintenance, consumable and spare parts. One such spare part and consumable which is core to our technology offering is quartz hardware. We provide standard and custom fabricated quartzware used in our equipment and to a lesser extent for other customer tools.

MesoPlasma™ Direct Write Printing – A materials deposition process that provides robust direct write high-definition instrumentation, fine feature patterns, and coatings onto conformal components. The technique involves powder material that is injected into a thermal plasma where it is rapidly heated and deposited onto the substrate or component. The versatility of the process enables a wide range of materials to be deposited including whatceramic dielectrics, nickel-based sensor alloys, metallic conductors, precious metals, and protective coatings. Products include temperature sensors, heaters, antennas and patterns per customer specifications.

Markets and Marketing

We serve multiple emerging and mature global markets including compound semiconductor high power electronics, aerospace, defense, battery energy storage, silicon and other microelectronic and micromechanical devices, semiconductor, universities, and research centers. Due to the highly technical nature of our products, we believe it is essential to engage with customers directly through our sales personnel, our network of domestic and international independent sales representatives, and distributors specializing in the type of equipment, products, and services that we sell. Our primary marketing activities include direct sales engagement, participation in trade associations and trade shows and our internet websites. We expanded our marketing activities in 2023 through attendance at key tradeshows and online marketing.

10

Customers

Our systems and products are used in both production applications and advanced materials research. We market and sell primarily to companies that are the tallest carbon nanotube arrays yet developed.engaged in producing compound semiconductor wafers, aerospace gas turbine jet engine component material, defense, battery energy storage, silicon and other microelectronic and micromechanical devices, semiconductor, universities and research centers. We have both a domestic and international customer base.

Given the complexity and magnitude of the systems we sell, revenue from a single customer in any one year can exceed 10% of our total sales. During the year ended December 31, 2023, three customers represented 14.3%, 13.5% and 10.9% of our revenues, while in 2022 one customer represented 29.2% of our revenues. While we believe that our relationships with these customers are generally positive, the loss of a large customer would have to be replaced by others, and our inability to do so could have a material adverse effect on our business and financial condition.

For the year ended December 31, 2023, approximately $4.1 million or 17% of our revenues were generated by sales to customers outside the U.S., compared to approximately $4.4 million or 17% for the year ended December 31, 2022.

Competition

We can experience intense direct competition from both domestic and international competitors in all our product segments. Our CVD Equipment product lines including FirstNano, target multiple markets and both production and research customers. Competition is substantial in both the production applications and research. In 2016,production application, competition comes from larger companies offering enhanced services. In research applications, the competition comes from small companies that compete with us mostly on price. We are aware of other competitors that offer a substantial number of products and services comparable to ours. Many of our competitors (including customers who may elect to manufacture systems for internal use) have financial, marketing and other resources greater than our own. To date, we incurredbelieve that each of our product and service segments has been able to compete favorably in markets that include these competitors, primarily based on know-how, technical performance, quality, delivery, price and aftermarket support. We continue to focus on products, which serve markets that are growing and where we have a technical and commercially competitive advantage.

CVD Equipment competes with companies located in Asia, Europe, and the US in both the production and research market. In the production and research markets, some of our potential customers built their own equipment. Additionally, there are large established companies who compete with us and pose a competitive risk in the market. Due to budgetary and funding constraints, many customers are price sensitive. We believe that our systems are among the most advanced available for the targeted market and coupled with our vertical integration in engineering and manufacturing, we believe that we can compete effectively.

11

SDC’s gas management and chemical delivery control systems are among the most advanced available. We further believe that SDC is differentiated from our competitors through our deep understanding of how the systems in which our products are incorporated are used in field applications. We have gained this understanding as a result of having designed and built complex process gas systems for our CVD Equipment group as well as for a number of the world’s leading semiconductor, aerospace, medical, solar manufacturers, research laboratories and universities.

CVD Materials consists of our MesoScribe subsidiary. There is no viable direct competitor for the MesoScribe services. There are technology competitors in the direct write applications and other additive manufacturing technologies competing for the same contracts and business opportunity.

Sources of Supply

Many of the components used in producing our products are purchased from unrelated suppliers. We have OEM status with our suppliers, but we are not obligated to purchase a pre-determined quantity. We are not dependent on a principal or major supplier and alternate suppliers are available. Historically, subject to lead times, the components and raw materials we used in manufacturing our products were readily obtainable.

We maintain a fully equipped machine shop that we use to fabricate a significant portion of our metal components in-house, including the most intricately designed parts of our equipment. We expanded our machine shop in 2022 to allow us to expand our ability to fabricate parts. Our quartz fabrication capability is currently sufficient to meet our quartzware needs. We believe our vertical manufacturing integration is a competitive advantage.

Materials procured from suppliers and/or manufactured internally undergo a rigorous quality control process to ensure that the parts meet or exceed our requirements and those of our customers. Upon final assembly, all equipment undergoes a final series of complete testing to ensure maximum product performance.

Backlog

As of December 31, 2023, our backlog was approximately $2.4$18.4 million, compared to $17.8 million as of December 31, 2022, an increase of $0.6 million. Our backlog at December 31, 2023 consists of approximately $16.3 million remaining performance obligations for contracts in researchprogress and development expensesthe balance of approximately $2.1 million represents orders received from customers. We continue to work at diversifying our customer base away from any one customer as we focus on new opportunities with new and existing customers within our existing marketplaces and in new applications. The timing for completion of backlog varies depending on the product mix and can be as long as two years or as short as 30-60 days.

12

There can be no assurance that our backlog will result in actual revenue in any particular period, or at all, or that any contract included in backlog will be profitable. The actual amount and timing of any revenue is subject to various contingencies, many of which $434,000 was independentare beyond our control, such as cancellations and delays. As a result of external customerthese contingencies, we may adjust our backlog if we determine that such orders comparedare no longer firm. In addition to 2015, whenadjustments from these types of contingencies, variations in backlog from time to time are attributable, in part, to changes in sales mix, the timing of contract proposals, the timing of contract awards, delivery schedules on specific contracts. As a result, we incurred $1.8 millionbelieve our backlog and orders, at any point in time, are not necessarily indicative of research and development expenses, $605,000 of which was independent of external customer orders.the total sales anticipated for any future period.


Government RegulationRegulations

We are subject to a variety of federal, state and local government regulations, such as environmental, labor and export control.control regulations. We believe that we have obtained all necessary permits to operate our business and that we are in material compliance with all laws and regulations applicable to us. These regulations are subject to change and the effect of these changes could materially impact our business in certain technology areas and regions.

Utilizing our in-house safety team, engineering expertise and consultants as required, we continue to monitor and comply with applicable Environmental Health and Safety regulations at our facilities as well as the installation of equipment at our customer facilities.

With respect to our sales to customers located in China or elsewhere outside the United States, products which (i) are manufactured in the United States, (ii) incorporate controlled U.S. origin parts, technology, or software, or (iii) are based on U.S. technology, are subject to the U.S. Export Administration Regulations (“EAR”). We are not aware of any government regulations or requirements necessary forcontinue to monitor, review, and maintain ongoing compliance with the sale ofEAR with respect to our products, other than certain approvals or permits which may be required for us to export certain of our products to certain foreign countries.sales.

InsuranceProduct Liability

Our products are used in our customers’ manufacturing processes, which in some cases contain explosive, flammable, corrosive, and toxic gases. There are potential exposures to personal injury as well as property damage, particularly if operated without regard to the design limits of the systems and components. Additionally, the end products of some of our customers are used in areas such as aerospace and high techhigh-tech devices where safety is of great concern. Management reviews its insurance coverage on an annual basis or more frequently, if appropriate, and we believe we have the types and amounts of insurance coverage that are sufficient for our business.

EmployeesHuman Capital

AtWe consider our employees a vital asset to our business and strive to ensure we foster a work environment of respect, communication, objective orientation, and personal life balance. We believe this results in a higher level of employee satisfaction and hence improved performance and employment longevity. On December 31, 2016,2023, we had 173 employees, with all but one being full time personnel.128 employees. We had 95 people70 employees in manufacturing, 3230 in engineering (including research and development and efforts related to product improvement) 7, 5 in field service, 109 in sales and marketing and 2914 in general management, maintenance and administration.administration, compared to 136 employees as of December 31, 2022. None of our employees were subject to a collective bargaining agreement.

13

The implementation of our business strategy depends on our ability to hire, train, and retain qualified and diverse professionals, and we must emphasize employee development and training in order to do so. We are committed to identifying and developing the talents of our next generation of managers and intend to establish a strong succession-planning program for our critical positions, including internships for technical and engineering resources from local universities. Moreover, a key strategic focus of our management team is to foster and maintain a strong and healthy culture, where collaboration to achieve results and focus on the success of our customers and shareholders is paramount.

Employee Safety

The health and safety of our employees and partners is our highest priority, and this is consistent with our operating philosophy. We maintain strong environmental, health and safety protocols that focus on implementing policies and training programs, as well as performing self-audits to ensure our colleagues and partners leave the workplace safely on a daily basis.

Employee Compensation

Management continues to review our employee compensation programs to better align the compensation of our employees with our objectives, performance, and personal performance, and to provide the proper short-term and long-term incentives to attract, retain and motivate them to achieve superior results. We believe we must offer wages that are competitive and consistent with employee positions, skill levels, experience, and knowledge, and in order to do so we may work with a nationally recognized outside compensation and benefits consulting firm to independently evaluate the effectiveness of our executive and non-executive compensation and benefit programs and to provide benchmarking against our peers within our industry.

Equal Opportunity

We are committed to building and sustaining a culture of equal opportunity that encourages all of our employees to reach their full potential. Our CVD team, like the technologies we enable, is a rich combination of diverse individuals coming together to make a material difference for our people, our customers, and the world. As a company that enables tomorrow’s technologies, we recognize that a diverse employee population makes CVD a stronger, more innovative, and a more engaging place to work. We are always striving to attract talented individuals from a diverse candidate pool.

Available Information

Our website address is www.cvdequipment.com and the contents of our website, including our investor relations website, is not incorporated by reference into this filing or any other report we file with or furnish to the SEC. We have no duty to update or revise any forward-looking statements in this Annual Report on Form 10-K or in other reports filed with the SEC, whether as a result of new information, future events or otherwise, unless we are required to do so by law. The SEC maintains a website (www.sec.gov) that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC.

14

Item 1A.Risk Factors

Item 1A.     Risk Factors

In addition to the other information set forth in this Annual Report on Form 10-K, our shareholders should carefully consider the risk factors described below. The risks set forth below may not be the only risk factors relating to the company.Company. Any of these factors, many of which are beyond our control, could materially adversely affect our business, financial condition, operating results, cash flow and stock price.

Risk categories:

Risks related to sales and product development
Risks related to manufacturing and supply chain
Risks related to cybersecurity, intellectual property and regulatory compliance
Risks related to financial and accounting matters
Risks related to product liability
Risks related to our stock
General risk factors

Risks related to sales and product development

Historically, we have maintained a highly concentrated customer base so that changes in ordering patterns, delays or order cancellations could have a material adverse effect on our business and results of operations.

During 2023, three customers represented 14.3%, 13.5% and 10.9% of our total revenues. The loss of a major customer would have to be replaced by others, and our inability to do so may have a material adverse effect on our business and financial condition. We expect that contracts or orders from a relatively limited number of customers will, at times, continue to account for a substantial portion of our business. The mix and type of customers, and sales to any single customer, may vary significantly from quarter to quarter and from year to year. If any major customer did not place orders, or if they substantially reduced, delayed, or cancelled orders, we may not be able to replace the business in a timely manner or at all, which can and has had a material adverse effect on our results of operations and financial condition.

Our lengthy and variable sales cycle makes it difficult to predict our financial results.

The marketing, sale and manufacture of our products, often requires a lengthy sales cycle ranging from several months to over one year before we can complete production and delivery. The lengthy sales cycle makes forecasting the volume and timing of sales difficult and raises additional risks that customers may cancel or decide not to enter into contracts. The length of the sales cycle depends on the size and complexity of the project, the customer’s in-depth evaluation of our products, and, in some cases, the protracted nature of a bidding process.

15

Because a significant portion of our operating expenses are fixed, we have and may continue to incur substantial expense before we earn associated revenue. If customer cancellations occur, they could result in the loss of anticipated sales without allowing us sufficient time to reduce our operating expenses.

If any of our customers cancel or fail to accept a large system order, our financial position and results of operations could be materially and adversely affected.

Our backlog includes orders for customized systems including our chemical vapor deposition equipment and furnaces which are built to client specifications. These customized systems can have prices up to several million dollars, depending on the configuration, specific options included and any specific requirements of the customer. Because our orders are subject to cancellation or delay by the customer, our backlog at any point in time is not necessarily representative of actual sales for succeeding periods, nor does our backlog provide any assurance of achievement of revenues or that we will realize a profit from completing these orders. Our financial position and results of operations could be materially and adversely affected should any large system order be cancelled prior to shipment, or not be accepted by the customer due to alleged non-conformity with product specifications or otherwise. Likewise, a significant change in the liquidity or financial position of any of our customers that purchase large systems, could have a material impact on the collectability of our accounts receivable and our future operating results. Our backlog does not provide any assurance that we will realize a profit from those orders or indicate in which period revenue will be recognized.

If demand declines for chemical vapor deposition,deposition/infiltration, physical vapor transport, gas control and related equipment, or for carbon nanotube and nanowire deposition systems, our financial position and results of operations could be materially adversely affected.


Our products are utilized to develop and manufacture materials and coatings for industrial and research applications that are used in numerous markets including but not limited to power electronics, battery materials, aerospace, medical, solar, nano and advanced electronic components. A significant part of our growth strategy involves continued expansion of the sales of our products for industrial as well as research and development purposes by companies, universities, and government-funded research laboratories. The availability of funds for these purposes may be subject to budgetary and political restrictions, as well as cost-cutting measures by manufacturers in the markets in which we operate.

If the availability of funds or the demand for capital equipment in the markets in which we operate declines, the demand for our products would also decline and our financial position and results of operations could be harmed.

16

We face risks associated with selling our products to a highly concentrated customer base.

In fiscal 2016, approximately 53.5% of our net sales was accounted for by 2 customers. We expect that contracts or orders from a relatively limited number of customers will continue to account for a substantial portion of our business. The mix and type of customers, and sales to any single customer, may vary significantly from quarter to quarter and from year to year. If any of our significant customers do not place orders, or they substantially reduce, delay or cancel orders, we may not be able to replace the business in a timely manner or at all, which could have a material adverse effect on our results of operations and financial condition. Major customers may also seek, and on occasion receive, pricing, payment, intellectual property-related, or other commercial terms that are less favorable to us.

 

The conditions of the markets in which we operate are volatile. The demand for our products and the profitability of our products can change significantly from period to periodas a result because of numerousfactors.

 

The industries in which we operate are characterized by ongoing changes,factors, including:

 

the availability of funds for research and development;

global and regional economic conditions;

developments and conditions including in Europe and Asia;

governmental budgetary and political constraints;

changes in the capacity utilization and production volume for research and industrial applications in the markets in which we operate;

the profitability and capital resources of manufacturers in the markets in which we operate;

changes in technology;
the availability of funds for research and

development; and
the effects of supply chain disruptions.

changes in technology.

For these and other reasons, our results of operations for past periods may not necessarily be indicative of future operating results.

VolatileOur business might be adversely affected by our dependence on foreign business.

Because a material portion of our revenues are traditionally derived from international customers, our operating results could be negatively affected by a decline in the economies of any of the countries or regions in which we do business. Each region can exhibit unique characteristics, which can cause capital equipment investment patterns to vary significantly from period to period. Periodic local or international economic downturns, trade balance issues and cyclical demandpolitical instability, as well as fluctuations in interest and currency exchange rates, could negatively affect our business and results of operations.

The majority of our sales to date have been primarily priced in U.S. dollars. While our business has not been materially affected in the past by currency fluctuations, there is a risk that it may be materially adversely affected in the future. Such risks include possible losses due to both currency exchange rate fluctuations and from possible social and political instability.

Our reputation and operating performance may be negatively affected if our products are not timely delivered.

We provide complex products that often require substantial lead-time for design, ordering parts and materials, and for assembly and installation. The time required to design, order parts and materials and to manufacture, assemble and install our products, may make it difficult for usin turn lead to accurately budgetdelays or shortages in the availability of some products. If a product is delayed or is the subject of shortage because of problems with our expense levels,ability to design, manufacture or assemble the product on a timely basis, obtain necessary materials and components, or if a product or software otherwise fails to meet performance criteria, we may lose revenue opportunities entirely, or experience delays in revenue recognition associated with a product or service. In addition, we may incur higher operating expenses during the period required to correct the problem.

17

We may not be able to keep pace with the rapid change in the technology we use in our products.

We believe that our continued success in the markets in which are basedwe operate depends, in part, on our projections of future revenues.

Demand for our equipmentability to continually improve existing technologies and related consumableto develop and manufacture new products may be volatile asand product enhancements on a result of sudden changes in supplytimely and demand, and other factors in the manufacturing process. Our orders tend to be more volatile than our revenue, as any change in demand is reflected immediately in orders booked, which are net of cancellations, while revenue, tends to be recognized over multiple quarters as a result of procurement and production lead times, and the deferral of certain revenue under our revenue recognition policies. The fiscal period in which we are able to recognize revenue is also at times subject to the length of time that our customers require to evaluate the performance of our equipment. This could cause our quarterly operating results to fluctuate.


When cyclical fluctuations result in lower than expected revenue levels, operating results may be adversely affected and cost reduction measures may be necessary in for us to remain competitive and financially sound. During a down cycle, wecost-effective basis. We must be able to make timely adjustments to our costintroduce these products and expense structure to correspond toproduct enhancements into the prevailing market conditions. In addition, during periods of rapid growth, we must be able to increase manufacturing capacity and the number of our personnel to meet customer demand, which may require additional liquidity. We can provide no assurance, that these objectives can be met in a timely manner, in response to changes withincustomer’s demands for higher-performance research and assembly equipment, customized to address rapid technological advances in capital equipment designs.

Technological innovations are inherently complex and require long development cycles and appropriate professional staffing. Our future business success depends on our ability to develop and introduce new products, or new uses for existing products, that successfully address changing customer needs. Our success also depends on our ability to achieve market acceptance of our new products. To maintain our success in the industry cycles in whichmarketplace, we operate.may have to substantially increase our expenditures on research and development. If we faildo not develop and introduce new products, technologies or uses for existing products in a timely manner and continually find ways to respondreduce the cost of developing and producing them in response to these cyclical change,changing market conditions or customer requirements, our business could be seriously harmed.

We do not have long-term volume production contracts with our customers, and we do not control the timing or volume of orders placed by our customers. Whether and to what extent our customers place orders for any specific products, and the mix and quantities of products included in those orders are factors beyond our control. Insufficient orders would result in under-utilization of our manufacturing facilities and infrastructure, and will negatively affect our financial position and results of operations.

We face significant competition, and we are relatively small in size and have fewer resources in comparison with many of our competitors.

We face significant competition throughout the world, which may increase as certain markets in which we operate continue to evolve. Some of our competitors have greater financial, engineering, manufacturing and marketing resources than us to develop new products and to support customers worldwide. Our future performance depends, in part, upon our ability to continue to compete successfully worldwide. Some of our competitors are diversified companies that have substantially greater financial resources and more extensive research, engineering, manufacturing, marketing and customer service and support capabilities than we can provide. We face competition from companies whose strategy is to provide a broad array of products, some of which compete with the products and services that we offer, as well as companies, universities and research laboratories that have the capacity to design and build their own equipment internally. These competitors may bundle their products and services in a manner that may discourage customers from purchasing our products. In addition, we face competition from smaller emerging processing equipment companies, whose strategy is to provide a portion of the products and services that we offer at often lower prices than ours, using innovative technology to sell products into specialized markets. Loss of competitive position could impair our prices, customer orders, revenue, gross margin, and market share, any of which would negatively affect our financial position and results of operations. Our failure to compete successfully with these other companies would seriously harm our business. There is a risk that larger, better financed competitors will develop and market more advanced products than those we currently offer, or that competitors with greater financial resources may decrease prices, thereby putting us under financial pressure.

18

The health and environmental effects of nanotechnology are unknown, and this uncertainty could adversely affect the expansion of our business.

The health and environmental effects of nanotechnology are unknown. There is no scientific agreement on the health effects of nanomaterials in general and carbon nanotubes, in particular, but some scientists believe that in some cases, nanomaterials may be hazardous to an individual’s health or to the environment. The science of nanotechnology is based on arranging atoms in such a way as to modify or build materials not made in nature; therefore, the effects are unknown. Future research into the effects of nanomaterials in general, and carbon nanotubes in particular, on health and environmental issues, may have an adverse effect on products incorporating nanotechnology. Since part of our growth strategy is based on sales of research equipment for the production of carbon nanotubes and the sale of such materials, the determination that these materials are harmful could adversely affect the expansion of our business.

We may experience increasing price pressure.

 

Our historical business strategy for many of

Risks related to manufacturing and our products has focused on product performance and customer service rather than on price. As a result of budgetary constraints, many of our customers are extremely price sensitive when purchasing of capital equipment. If we are unable to obtain prices that allow us to continue to compete on the basis of product performance and customer service, our profit margins will be reduced.supply chain

We may not be able to keep pace with the rapid change in the technology we use in our products.

 

We believe that our continued success in the markets in which we operate depends, in part, on our ability to continually improve existing technologies and to develop and manufacture new products and product enhancements on a timely and cost-effective basis. We must be able to introduce these products and product enhancements into the market in a timely manner, in response to customer’s demands for higher-performance research and assembly equipment, customized to address rapid technological advances in capital equipment designs.

Technological innovations are inherently complex, and require long development cycles and appropriate professional staffing. Our future business success depends on our ability to develop and introduce new products, or new uses for existing products, that successfully address changing customer needs. Our success also depends on our ability to achieve market acceptance of our new products. In order to maintain our success in the marketplace, we may have to substantially increase our expenditures on research and development. If we do not develop and introduce new products, technologies or uses for existing products in a timely manner and continually find ways to reduce the cost of developing and producing them in response to changing market conditions or customer requirements, our business could be seriously harmed.

Manufacturing interruptions or delays could affect our ability to meet customer demand and lead to higher costs, while the failure to estimate customer demand accurately could result in excess or obsolete inventory.


Our business depends on timely supply of equipment, services and related products that meet the rapidly changing technical and volume requirements of our customers. Some key parts to our products are subject to long lead-times and/or obtainable only from a single supplier or limited group of suppliers. Cyclical industry conditions and the volatility of demand for manufacturing equipment increase capital, technical, operational and other risks for us and for companies throughout our supply chain. Further, these conditions may cause some suppliers to scale back operations, exit businesses, merge with other companies, or file for bankruptcy protection and possibly cease operations. We have also experienced and continue to experience significant disruptions in our supply chain, resulting in delays and higher costs to procure certain components and materials that we utilize in our business.

We may also experience significant interruptions of our manufacturing operations, delays in our ability to deliver products or services, increased costs or customer order cancellations as a result of:

The failure or inability of suppliers to timely deliver sufficient quantities of quality parts on a cost-effective basis;

Volatility in the availability and cost of materials, including rare earth elements;

Difficulties or delays in obtaining required import or export approvals;

Information technology or infrastructure failures; and

Natural disasters or other events beyond our control (such as earthquakes, floods or storms, regional economic downturns, pandemics, social unrest, political instability, terrorism, or acts of war).

If a supplier fails to meet our requirements concerning quality, cost, socially-responsible business practices, or other performance factors, we may transfer our business to alternative sources, which could entail manufacturing delays, additional costs, or other difficulties. In addition, if we need to rapidly increase our business and manufacturing capacity to meet increases in demand or expedited shipment schedules, this may exacerbate any interruptions in our manufacturing operations and supply chain and the associated effect on our working capital.

We are presently experiencing supply chain delays and cost increases that may adversely affect our business.

Geopolitical developments across Europe and Asia have and may continue to restrict our ability to procure raw materials and components such as nickel and integrated circuits. Since 2021, we have experienced increased costs on certain components as well as delays in supply chain delivery, which may also impact our ability to recognize revenue and reduce our gross profit margins, as well as extend our manufacturing lead times and reduce our manufacturing efficiencies. We have begun placing orders with more lead time to help mitigate the manufacturing delays, as well as assessing other suppliers or components to attempt to mitigate the potential cost impacts. In addition, we are utilizing our in-house flexible manufacturing to attempt to further mitigate both potential schedule delivery delays and material cost increase, as well as increasing sales prices. While we have taken actions to mitigate the potential negative impacts to our revenue and profitability, there can be no assurance of the ultimate impact and the length of time that the supply chain factors may impact our revenues and profitability.

19

If any ofInflation has and may continue to adversely affect our customers cancel or fail to accept a large system order, ourbusiness, financial positioncondition, and results of operations.

Recent global inflation has adversely affected our costs, including the cost of materials, production, and labor. As such, we have had to implement measures to mitigate the negative impacts of inflation on our costs. As the selling prices in our customer contracts are fixed, any increase in the cost of materials, labor and other costs as we manufacture any system would negatively impact our gross margins and results of operations. Longstanding or increased periods of inflation could perpetuate these material adverse effects on our business, financial condition and results of operations.

If our critical suppliers fail to deliver enough quality materials and components in a timely and cost-effective manner, it could negatively affect our business.

We use numerous unrelated suppliers of materials and components. Due to geopolitical developments across Europe and Asia, we are experiencing reduced availability of raw materials and components. In turn, any reduction in the availability of these materials and components may reduce our ability to obtain sufficient amounts in a cost-effective manner. We generally do not have guaranteed supply arrangements with our suppliers. Because of the variability and uniqueness of our customer’s orders, we try to avoid maintaining an extensive inventory of materials and components for manufacturing. While we are not dependent on any principal or major supplier for most of our material and component needs, switching to an alternative supplier may take significant amounts of time and added expense, which could result in a disruption of our operations and adversely affect our business. It is not always practical or even possible to ensure that component parts are available from multiple suppliers; accordingly, we procure some key parts from a single supplier or a limited group of suppliers. At certain times, increases in demand for capital equipment can result in longer lead-times for many important system components, which may cause delays in meeting shipments to our customers. The delay in the shipment of even a few systems could cause significant variations in our quarterly revenue, operating results and the market value of our common stock.

Our manufacturing facilities are in Central Islip, New York and Saugerties, New York could be materiallyaffected due to multiple weather risks, including risks to our Central Islip facility from hurricanes and similar phenomena.

Our manufacturing facilities are located in Central Islip, New York and Saugerties, New York could be affected by multiple weather risks, most notably hurricanes for our Central Islip facility which is located on Long Island, New York. Although we carry property and casualty insurance and business interruption insurance, future possible disruptions of operations or damage to property, plant and equipment due to hurricanes or other weather risks could result in impaired production and affect our ability to meet our commitments to our customers and impair important business relationships, the loss of which could adversely affected.affect our operations and profitability. We do, however, maintain a backup power source at our Central Islip facility, are working to establish deeper redundancies between our New York facilities to help mitigate this risk.

20

Our backlog, largely consists of orders for customized systems including our chemical vapor deposition equipmentRisks related to cybersecurity, intellectual property and annealing and diffusion furnaces which are built to client specifications. These customized systems can have prices that range from $100,000 to several million dollars, depending on the configuration, specific options included and any special requirements of the customer.  Because our ordersregulatory compliance

If we are subject to cancellation or delay by the customer,cyberattacks, we could incur substantial costs and, if such attacks are successful, we could incur significant liabilities, reputational harm, and disruption to our backlog at any particular point in time is not necessarily representative of actual sales for succeeding periods, nor doesoperations.

We manage, store, and transmit proprietary information and sensitive data relating to our backlog provide any assurance of achievement of revenues or that we will realize a profit from completing these orders.  Since revenues on long-term contracts are recognized by the percentage-of-completion method, if a contract is canceled, weoperations. We may havebe subject to reverse revenue at such time. Our financial position and results of operations could be materially and adversely affected should any large system order be cancelled prior to shipment, or not be accepted by the customer due to alleged non-conformity with product specifications or otherwise. Likewise, a significant change in the liquidity or financial position of any of our customers that purchase large systems, could have a material impact on the collectability of our accounts receivable and our future operating results.  Our backlog does not provide any assurance that we will realize a profit from those orders, or indicate in which period revenue will be recognized.


Our success is highly dependent on the technical, sales, marketing and managerial contributions of key individuals, including Leonard A. Rosenbaum, Chairmanbreaches of the Board of Directors, Chief Executive Officerinformation technology systems we use for these purposes. Experienced computer programmers and President, and we may be unable to retain these individuals or recruit others.

We depend on our senior executives, including Leonard A. Rosenbaum, our Chairman of the Board of Directors, Chief Executive Officer and President, and certain key managers as well as, engineering, research and development, sales, marketing and manufacturing personnel, who are critical to our business. We do not have long-term employment agreements with our key employees. We presently have a key person life insurance policies on the life of Leonard A. Rosenbaum, for a total insured amount of $5 million, which may not be sufficient to cover our loss of Mr. Rosenbaum’s services. Furthermore, larger competitorshackers may be able to offer more generous compensation packagespenetrate our network security and misappropriate and/or compromise our confidential information (and or third-party confidential information), create system disruptions, or cause shutdowns. Computer programmers and hackers also may be able to develop and deploy viruses, worms, and other malicious software programs that attack our executivessystems or our products, or that otherwise exploit any security vulnerabilities.

While we have an active security training program for all employees during the year, utilize intrusion prevention and key employees,detection systems, as well as hardware firewall and therefore we risk losing key personnelvirus security, the costs to those competitors. If we were to loseaddress the services of any of our key personnel, our engineering, product development, manufacturingforegoing security problems and sales effortssecurity vulnerabilities before or after a cyber-incident could be slowed. We may also incur increased operating expenses, and be required to divert the attention of our senior executives to search for their replacements. The integration of any new personnel could disrupt our ongoing operations.

Wesignificant. Our remediation efforts may not be able to hiresuccessful and could result in interruptions, delays, or retain the numbercessation of qualified personnel, particularly engineering personnel, required forservice, and loss of existing or potential customers, impeding our business, which would harm the development and sales, manufacturing, distribution, or other critical functions. In addition, breaches of our productssecurity measures and limitthe unapproved dissemination of proprietary information or sensitive data about us, our ability to grow.

Competition incustomer, or other third parties, could expose us, our industry for senior management, technical, sales, marketing andcustomers, or other key personnel is intense. If we are unable to retain our existing personnel, or attract and train additional qualified personnel, our growth may be limited duethird parties to a lackrisk of capacity to develop and market our products.

In particular, we have, from time to time, experienced difficulty in hiring and retaining skilled engineers with appropriate qualifications to support our growth strategy. Our success depends on our ability to identify, hire, train and retain qualified engineering personnel with experience in equipment design. Specifically, we need to continue to attract and retain mechanical, electrical, software and field service engineers to work with our direct sales force to technically qualify and perform on new sales opportunities and orders, and to demonstrate our products.

The substantial lead-time required for ordering parts and materials may lead to inventory problems.

The lead-time for ordering parts and materials for someloss or misuse of our products can be several months. As a result, we must order some components based on forecasted demand. If demand for our products lags significantly behind our forecasts, we may order more components than we require, which wouldthis information, result in cash flow problems as well as excesslitigation and potential liability for us, damage our reputation, or obsolete inventory.otherwise harm our business.


Acquisitions can result in an increase in our operating costs, divert management’s attention away from other operational matters and expose us to other associated risks.

In December 2016, we purchased certain assets formally owned by Tantaline A/S, which we incorporated into a facility in Denmark which is operated by our subsidiary, Tnataline CVD ApS. We continually evaluate potential acquisitions of businesses and technologies, and we consider targeted acquisitions that expand our core competencies to be an important part of our future growth strategy.  In the past, we have made acquisitions of other businesses with synergistic products, services and technologies, and plan to continue to do so in the future.  Acquisitions involve numerous risks, which include but are not limited to:

difficulties and increased costs in connection with the integration of the personnel, operations, technologies, services and products of the acquired companies into our existing facilities and operations;

diversion of management’s attention from other operational matters;

failure to commercialize the acquired technology;

the potential loss of key employees of the acquired companies

lack of synergy, or inability to realize expected synergies, resulting from the acquisitions;

the risk that the issuance of our common stock, if any, in an acquisition or merger could be dilutive to our shareholders;

the inability to obtain and protect intellectual property rights in key technologies;

the acquired assets becoming impaired as a result of technological advancements or worse-than-expected performance of the acquired assets.

Our financial position and results of operations may be materially harmed if we are unable to recoup our investment in research and development.

The rapid change in technology in our industry requires that we continue to make substantial investments in research and development and selective acquisitions of technologies and products, in order to enhance the performance and functionality of our product line, to keep pace with competitive products and to satisfy customer demands for improved performance, features and functionality.  These efforts include those related to the development of technology for the commercialization of carbon nanotubes. There can be no assurance that revenue from future products or enhancements will be sufficient to recover the development costs associated with such products, enhancements, or acquisitions, or that we will be able to secure the financial resources necessary to fund future research and development or acquisitions. Research and development costs are typically incurred before we confirm the technical feasibility and commercial viability of a product, and not all development activities result in commercially viable products. In addition, we cannot ensure that products or enhancements will receive market acceptance, or that we will be able to sell these products at prices that are favorable to us. Our business could be seriously harmed if we are unable to sell our products at favorable prices, or if our products are not accepted by the markets in which we operate.

21

We have made investments in our proprietary technologies.If third parties violate our proprietary rights, or accuse us of infringing upon their proprietary rights, such events could result in a loss of value of some of our intellectual property or costly litigation.

Our success is dependent in part on our technologies and our other proprietary rights.  We believe that while patents can be useful and may be utilized by us in the future, they are not always necessary or feasibleattempt to protect our intellectual property. The processcertain of seeking patent protection is lengthy and expensive, and we cannot be certain that applications will actually result in issued patents or that issued patents will be of sufficient scope or strength to provide meaningful protection or commercial advantage to us.  In addition to patent protection, we have also historically protected our proprietary information and intellectual property such as design specifications, blueprints, technical processes and employee know-how, by limiting access to this confidential information and trade secrets and through the use of non-disclosure agreements. Other companies and individuals, including our larger competitors, may develop technologies that are similar or superior to our technology, or design around the intellectual property that we own or license.  Our failure to adequately protect our intellectual property could result in the reduction or extinguishment of our rights by obtaining patent and trademark protection where we believe it is appropriate to such intellectual property. We also assert rights to certain trademarks relating to certain of our products and product lines. We have not filed trademark applications to protect such marks with any governmental agency, including, but not limited to the U.S. Patent and Trademark Office. We claim copyright protection for certain proprietary software and documentation, but we have not filed any copyright applications with the U.S. Copyright Office in connection with those works.  As a result, we can give no assurance that our trademarks and copyrights will be upheld or successfully deter infringement by third parties. 

do so. While patent, copyright and trademark protection for our intellectual property may be important, we believe our future success in highly dynamic markets is most dependent upon the technical competence and creative skills of our personnel. We may also attempt to protect our trade secrets and other proprietary information through confidentiality agreements with our customers, suppliers, employees, and consultants, and through other internal security measures. However, these employees, consultants and third parties may breach these agreements, and we may not have adequate remedies for wrongdoing. In addition, the laws of certain territories in which we sell our products may not protect our intellectual property rights to the same extent as do the laws of the United States.

Occasionally, we may receive communications from other parties asserting the existence of patent rights or other intellectual property rights that they believe cover certain of our products, processes, technologies, or information. In addition, it is possible we could have a dispute with a customer concerning the use of intellectual property utilized in their equipment. If such cases arise, we will evaluate our position and consider the available alternatives, which may include seeking licenses to use the technology in question on commercially reasonable terms, developing new alternative technology or defending our position. Nevertheless, we cannot ensure that we will be able to obtain licenses, or, if we are able to obtain licenses, thatwhich related terms will be acceptable, or that litigation or other administrative proceedings will not occur. Defending our intellectual property rights through litigation could be very costly. If we are not able to negotiate the necessary licenses on commercially reasonable terms or successfully defend our position, our ability to utilize such intellectual property could substantially inhibit our access to certain markets and our ability to compete in these markets which could have a material adverse effect on our financial position and results of operations could be materially and adversely affected.operations.


Our reputation and operating performanceWe may be negatively affected ifunable to obtain required export licenses for the sale of our products are not timely delivered.products.

 

We provide complexWhether with respect to sales to customers located in China or otherwise, products that often require substantial lead-time for design, ordering parts and materials, and for assembly and installation. The time required to design, order parts and materials and to manufacture, assemble and install our products, may in turn lead to delays or shortageswhich (i) are manufactured in the availability of some products. If a product is delayed or is the subject of shortage because of problems with our ability to design, manufacture or assemble the product on a timely basis, or if a productUnited States, (ii) incorporate controlled U.S. origin parts, technology, or software, otherwise failsor (iii) are based on U.S. technology, are subject to meet performance criteria, wethe U.S. Export Administration Regulations (“EAR”) when exported to and re-exported from international jurisdictions, in addition to the local jurisdiction’s export regulations applicable to individual shipments. Licenses or proper license exceptions may lose revenue opportunities entirely, or experience delays in revenue recognition associated with a product or service. In addition, we may incur higher operating expenses duringbe required for the period required to correct the problem.

Our lengthy and variable sales cycle may make it difficult to predict our financial results.

The marketing, sale and manufactureshipment of our products to certain customers or countries. Obtaining an export license or determining whether an export license exception exists often requires considerable effort by us and cooperation from the customer, which can add time to the order fulfillment process. We may be unable to obtain required export licenses or qualify for export license exceptions and, as a lengthy sales cycle ranging from several months to over one year before we can complete production and delivery. The lengthy sales cycle makes forecasting the volume and timing of sales difficult, and raises additional risks that customers may cancel or decide not to enter into contracts. The length of the sales cycle depends on the size and complexity of the project, the customer’s in-depth evaluation of our products, and, in some cases, the protracted nature of a bidding process. Because a significant portion of our operating expenses are fixed,result, we may incur substantial expense before we earn associated revenue. If customer cancellations occur, theybe unable to export products to our customers and/or meet their servicing needs. Non-compliance with the EAR or other applicable export regulations could result in a wide range of penalties including the lossdenial of anticipated sales without allowing us sufficient time to reduce our operating expenses.

We anticipate continued growth in our revenuesexport privileges, fines, criminal penalties, and operations during the next few years.seizure of commodities. If we fail to manage our growth effectively, we may experience difficulty in filling customer orders, declining product quality, increased costs or other operating challenges.

We anticipatean export regulatory body determines that continued growthany of our operations willshipments violate applicable export regulations, we could be required to satisfyfined significant sums and our projected increase in demand for our products and to avail ourselves of new market opportunities. The expanding scope of our business and the growth in the number of our employees, customers and productsexport capabilities could be restricted, which could have placed and will continue to place a significant strainmaterial adverse impact on our management, information technology systems, manufacturing facilities and other resources. To properly manage our growth, we may need to hire additional employees, upgrade our existing financial and reporting systems and improve our business processes and controls. We may also be required to expand our manufacturing facilities or add new manufacturing facilities. Failure to effectively manage our growth could make it difficult to manufacture our products and fill orders, as well as lead to declines in product quality or increased costs; any of these would adversely impact our business and results of operations.business.

22

Historically, we have only manufactured in unit or small batch quantities. If we receive orders for a large number of our systems, we may not have the internal manufacturing capacity to fill these orders on a timely basis, if at all, and may be forced to subcontract or outsource some of the fabrication of these systems to third parties. We cannot assure you that we will be able to successfully subcontract or outsource the fabrication of our systems at a reasonable cost to us, or that such third parties will adhere to our quality control standards.


Our business might be adversely affected by our dependence on foreign business.

During the year ended December 31, 2016, 11.9% of our revenues came from foreign exports as compared with 9.0% for the year ended December 31, 2015.

Because a significant amount of our revenues are derived from international customers, our operating results could be negatively affected by a decline in the economies of any of the countries or regions in which we do business.  Each region in the global semiconductor and electronics equipment market exhibits unique characteristics, which can cause capital equipment investment patterns to vary significantly from period to period.  Periodic local or international economic downturns, trade balance issues and political instability, as well as fluctuations in interest and currency exchange rates, could negatively affect our business and results of operations.

All of our sales to date have been priced in U.S. dollars. While our business has not been materially affected in the past by currency fluctuations, there is a risk that it may be materially adversely affected in the future.  Such risks include possible losses due to both currency exchange rate fluctuations and from possible social and political instability. 

Failure to comply with the United States Foreign Corrupt Practices Act could subject us to penalties and other adverse consequences.

 

We are subject to the United States Foreign Corrupt Practices Act, which generally prohibits United States companies from engaging in bribery or other prohibited payments to foreign officials for the purpose of obtaining or retaining business. We have agreements with third parties and make sales in countries known to experience corruption, extortion, bribery, pay-offs, theft, and other fraudulent practices. We can make no assurance, however, that our employees or other agents will not engage in such conduct for which we might be held responsible. If our employees or other agents are found to have engaged in such practices, we could suffer severe penalties and other consequences that may have a material adverse effect on our business, financial condition, and results of operations.

If our critical suppliers fail to deliver sufficient quantities of quality materials and components in a timely and cost-effective manner, it could negatively affect our business.

We do not manufacture many components used in the production of our products, and consequently, we use numerous unrelated suppliers of materials and components.  We generally do not have guaranteed supply arrangements with our suppliers.  Because of the variability and uniqueness of our customer’s orders, we try to avoid maintaining an extensive inventory of materials and components for manufacturing. While we are not dependent on any principal or major supplier for most of our material and component needs, switching over to an alternative supplier may take significant amounts of time and added expense, which could result in a disruption of our operations and adversely affect our business.


It is not always practical or even possible to ensure that component parts are available from multiple suppliers; accordingly, we procure some key parts from a single supplier or a limited group of suppliers.  At certain times, increases in demand for capital equipment can result in longer lead-times for many important system components, which may cause delays in meeting shipments to our customers.  The delay in the shipment of even a few systems could cause significant variations in our quarterly revenue, operating results and the market value of our common stock. 

We cannot assure you that our financial position and results of operations will not be materially and adversely affected if, in the future, we do not receive in a timely and cost-effective manner a sufficient quantity of quality component parts and materials to meet our production requirements.

We might require additional financing to expand our operations.

We may require additional financing to further implement our growth plans.  We cannot assure you any additional financing will be available if and when required, or, even if available, that it would not materially dilute the ownership percentage of the then existing shareholders.

Cost of compliance with Section 404 of the Sarbanes-Oxley Act could adversely affect future operating results, the trading price of our common stock and failure to comply could result in loss of our stock market listing, civil penalties and other liabilities.

Section 404 of the Sarbanes-Oxley Act requires management to certify that it has tested and found the company’s internal controls to be effective.  It also requires, for accelerated filers, that a company’s independent auditors attest that such management representations are reasonably founded.  The adequacy of internal controls generally takes into consideration that the anticipated benefits of a control should outweigh the cost of that control.  Auditing standards related to the internal control requirements of Section 404 of the Sarbanes Oxley Act will significantly increase the cost and time needed to comply with the requirements of Section 404.  Complying with these requirements is very complex, costly and time consuming and, if we are required to comply under the existing regulations, will have a material impact on our operating results.  Failure to comply could result in civil penalties, loss of our listing on NASDAQ, and the imposition of possible litigation. 

Changes in accounting pronouncements or taxation rules or practices may adversely affect our financial results.

Changes in accounting pronouncements or taxation rules or practices can have a significant effect on our reported results. New accounting pronouncements or taxation rules and varying interpretations of accounting pronouncements or taxation practices have occurred and may occur in the future. New rules, changes to existing rules, or the questioning of our current or past practices may adversely affect our reported financial results.


We may be required to take additional impairment charges on assets.

We are required to assess goodwill and indefinite-lived intangible assets annually for impairment, or on an interim basis, whenever certain events occur or circumstances change, such as an adverse change in business climate or a decline in the overall industry, that would more likely than not reduce the fair value below its carrying amount. We are also required to test our long-lived assets, including acquired intangible assets and property, plant and equipment, for recoverability and impairment whenever there are indicators or impairment, such as an adverse change in business climate.

As part of our long-term strategy, we may pursue future acquisitions of other companies or assets which could potentially increase our assets. Adverse changes in business conditions could materially impact our estimates of future operations and result in impairment charges to these assets. If our assets were impaired, our financial condition and results of operations could be materially and adversely affected.

The price of our common shares is volatile and could decline significantly.

The stock market in general and the market for technology stocks in particular has experienced volatility. If those industry-based market fluctuations continue, the trading price of our common shares could decline significantly independent of the overall market, and shareholders could lose all or a substantial part of their investment. The market price of our common shares could fluctuate significantly in response to several factors, including, among others:

difficult macroeconomic conditions, unfavorable geopolitical events, and general stock market uncertainties, such as those occasioned by a global liquidity crises and a failure of large financial institutions;

receipt of large orders or cancellations of orders for our products;

issues associated with the performance and reliability of our products;

actual or anticipated variations in our results of operations;

announcements of financial developments or technological innovations;

changes in recommendations and/or financial estimates by investment research analysis;

strategic transactions, such as acquisitions, divestitures, or spin-offs; and

the occurrence of major catastrophic events

Significant price and value fluctuations have occurred with respect to our publicly traded securities and technology companies generally. The price of our common shares is likely to be volatile in the future. In the past, securities class action litigation often has been brought against a company following periods of volatility in the market price of its securities. If similar litigation were pursued against us, it could result in substantial costs and a diversion of management’s attention and resources, which could materially and adversely affect our financial condition, results of operations, and liquidity.

We face the risk of product liability claims.

The manufacture and sale of our products, which in operation may involve the use of toxic materials and extreme temperatures, involve the risk of product liability claims. For example, our rapid thermal processing systems are used to heat semiconductor materials to temperatures in excess of 1000º Celsius. In addition, a failure of one of our products at a customer site could interrupt the business operations of our customer. Our existing insurance coverage limits may not be adequate to protect us from all liabilities that we might incur in connection with the manufacture and sale of our products if a successful product liability claim or series of product liability claims were brought against us.


We are subject to environmental regulations, and our inability or failure to comply with these regulations could adversely affect our business.

We are subject to environmental regulations in connection with our business operations, including regulations related to the development and manufacture of our products and our customers’ use of our products. Our failure or inability to comply with existing or future environmental regulations could result in significant remediation liabilities, the imposition of fines or the suspension or termination of development, manufacturing, or use of certain of our products, or affect the operation of our facilities, use or value of our real property, each of which could damage our financial position and results of operations.

If we are subject to cyber-attacks we could incur substantial costs and, if such attacks are successful, we could incur significant liabilities, reputational harm, and disruption to our operations.

We manage, store and transmit proprietary information and sensitive data relating to our operations. We may be subject to breaches of the information technology systems we use for these purposes. Experienced computer programmers and hackers may be able to penetrate our network security and misappropriate and/or compromise our confidential information (and or third party confidential information), create system disruptions, or cause shutdowns. Computer programmers and hackers also may be able to develop and deploy viruses, worms, and other malicious software programs that attack our systems or our products, or that otherwise exploit any security vulnerabilities.

The costs to address the foregoing security problems and security vulnerabilities before or after a cyber-incident could be significant. Our remediation efforts may not be successful and could result in interruptions, delays, or cessation of service, and loss of existing or potential customers, impeding our sales, manufacturing, distribution, or other critical functions. In addition, breaches of our security measures and the unapproved dissemination of proprietary information or sensitive data about us, our customer, or other third parties, could expose us, our customers, or other third parties to a risk of loss or misuse of this information, result in litigation and potential liability for us, damage our reputation, or otherwise harm our business.

Regulations related to conflict minerals will force us to incur additional expenses, may make our supply chains more complex, and may result in damage to our relationships with customers.


Under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, or the Dodd-Frank Act, the SEC adopted requirements for companies that manufacture products that contain certain minerals and metals known as conflict minerals.“conflict minerals”. These rules require public companies to perform diligence and to report annually to the SEC whether such minerals originate from the Democratic Republic of Congo and adjoining countries. The implementation of these requirements could adversely affect the sourcing, availability, and pricing of minerals we use in the manufacture of our products. In addition, we have incurred and will continue to incur additional costs to comply with the disclosure requirements, including costs related to determining the source of any of the relevant minerals used in our products. Given the complexity of our supply chain, we may not be able to ascertain the origins of these minerals used in our products through the due diligence procedures that we implement, which may harm our reputation. We may also face difficulties in satisfying customers who may require that our products be certified as conflict mineral free, which could harm our relationships with these customers and lead to a loss of revenue. These requirements could limit the pool of suppliers that can provide conflict-free minerals, and we may be unable to obtain conflict-free minerals at competitive prices, which could increase our costs and adversely affect our manufacturing operations and our profitability.

23

Risks related to financial and accounting matters

Cyclical demand for our products may make it difficult for us to accurately budget our expense levels, which are based in part on our projections of future revenues.

Historically, demand for our equipment and related consumable products have been volatile because of changes in supply and demand, and other factors in the manufacturing process. Our orders tend to be more volatile than our revenue, as any change in demand is reflected immediately in orders booked, which are net of cancellations, while revenue, tends to be recognized over multiple quarters because of procurement and production lead times, and the deferral of certain revenue under our revenue recognition policies. The fiscal period in which we can recognize revenue is also at times subject to the length of time that our customers require to evaluate the performance of our equipment. This could cause our quarterly operating results to fluctuate.

When cyclical fluctuations result in lower-than-expected revenue levels, operating results have been and may continue to be materially adversely affected and cost reduction measures have been and may continue to be necessary for us to remain competitive and financially sound. During a down cycle, we must be able to make timely adjustments to our cost and expense structure to correspond to the prevailing market conditions. In addition, during periods of rapid growth, we must be able to increase manufacturing capacity and the number of our personnel to meet customer demand, which may require additional liquidity. We can provide no assurance, that these objectives can be met in a timely manner in response to changes within the industry cycles in which we operate. If we fail to respond to these cyclical changes, our business could be seriously harmed.

We do not have long-term volume production contracts with our customers, and we do not control the timing or volume of orders placed by our customers. Whether and to what extent our customers place orders for any specific products, and the mix and quantities of products included in those orders are factors beyond our control. Insufficient orders would result in under-utilization of our manufacturing facilities and infrastructure and will negatively affect our financial position and results of operations.

We might require additional financing.

Our continuing operating losses may make it difficult for us to obtain financing on commercially reasonable terms, if at all. If adequate financing is not available when required on commercially reasonable terms, if at all, our business and operations may be materially and adversely affected. In addition, we could issue additional common stock, to fund our growth initiatives and operations which could materially dilute the ownership interests of the then existing shareholders.

We may, in the future, identify deficiencies in controls over financial reporting.

While we have concluded that, as of December 31, 2023, our disclosure and reporting controls were effective as included in Part II, Item 9A, there can be no assurance that material weaknesses will not be identified in the future. If we do identify material weaknesses in our internal controls over financial reporting in the future, our ability to analyze, record and report financial information free of material misstatements, and to prepare our financial statements within the time periods specified by the rules and forms of the SEC, may likely be adversely affected.

24

We have and may continue to be required to take impairment charges on assets.

We are required to assess our long-lived assets, including acquired intangible assets and property, plant and equipment, for recoverability and impairment whenever there are indicators or impairment, such as an adverse change in business climate.

As part of our long-term strategy, we have pursued acquisitions of other companies or assets, and may pursue future acquisitions of other companies or assets which could potentially increase our assets. Adverse changes in business conditions could materially impact our estimates of future operations and result in impairment charges to these assets. If our assets were impaired, our financial condition and results of operations could be materially and adversely affected.

Acquisitions can result in an increase in our operating costs, divert management’s attention away from other operational matters and expose us to other associated risks.

We evaluate potential acquisitions of businesses and technologies, and we consider targeted acquisitions that expand our core competencies to be an important part of our future growth strategy. In the past, we have made acquisitions of other businesses with synergistic products, services and technologies, and plan to continue to do so in the future.

Acquisitions involve numerous risks, which include but are not limited to:

difficulties and increased costs in connection with the integration of the personnel, operations, technologies, services and products of the acquired companies into our existing facilities and operations;
diversion of management’s attention from other operational matters;
failure to commercialize the acquired technology;
the potential loss of key employees of the acquired companies;
lack of synergy, or inability to realize expected synergies, resulting from the acquisitions;
the risk that the issuance of our common stock, if any, in an acquisition or merger could be dilutive to our shareholders;
the inability to obtain and protect intellectual property rights in key technologies; and
the acquired assets becoming impaired as a result of technological advancements or worse-than-expected performance of the acquired assets.

Risks related to product liability

We face the risk of product liability claims.

The manufacture and sale of our products, which in operation sometimes involve the use of toxic materials and extreme temperatures and could result in product liability claims. For example, our rapid thermal processing systems used to heat semiconductor materials to temperatures more than 1000º Celsius have certain inherent risks. A failure of our products at a customer site could also result in losses due to interruption of the business operations of our customer. While we regularly evaluate the nature and limits of our insurance coverages, there can be no assurance that our existing policies of insurance will be adequate to protect us from all liabilities that we might incur in connection with the manufacture and sale of our products in the event of a successful product liability claim or series of successful claims against us.

25

The health and environmental effects of nanotechnology are unknown, and this uncertainty could adversely affect the expansion of our business.

The health and environmental effects of nanotechnology are unknown. There is no scientific agreement on the health effects of nanomaterials in general and carbon nanotubes but some scientists believe that in some cases, nanomaterials may be hazardous to an individual’s health or to the environment.

The science of nanotechnology is based on arranging atoms in such a way as to modify or build materials not made in nature; therefore, the effects are unknown. Future research into the effects of nanomaterials in general, and carbon nanotubes, on health and environmental issues, may have an adverse effect on products incorporating nanotechnology. Since part of our growth strategy is based on sales of research equipment to produce carbon nanotubes and the sale of such materials, the determination that these materials are harmful could adversely affect the expansion of our business.

Risk related to our stock

The price of our common shares is volatile and could decline significantly.

The stock market in general and the market for technology stocks has experienced volatility. If those industry-based market fluctuations continue, the trading price of our common shares could decline significantly independent of the overall market, and shareholders could lose all or a substantial part of their investment. The market price of our common shares could fluctuate significantly in response to several factors, including, among others:

difficult macroeconomic conditions, unfavorable geopolitical events, and general stock market uncertainties, such as those occasioned by a global liquidity crisis and a failure of large financial institutions;
an offering of our common shares to raise capital;
receipt of large orders or cancellations of orders for our products;
issues associated with the performance and reliability of our products;
actual or anticipated variations in our results of operations;
announcements of financial developments or technological innovations;
changes in recommendations and/or financial estimates by investment research analysis;
strategic transactions, such as acquisitions, divestitures, or spin-offs;
offerings of our securities;
the occurrence of major catastrophic events; and
volatile trading volumes.

26

Significant price and value fluctuations have occurred with respect to our publicly traded securities and those of technology companies generally. The price of our common shares is likely to be volatile in the future. In the past, securities class action litigation often has been brought against a company following periods of volatility in the market price of its securities. If similar litigation were pursued against us, it could result in substantial costs and a diversion of management’s attention and resources, which could materially and adversely affect our financial condition, results of operations, and liquidity.

General risks

Our success is highly dependent on the technical, sales, marketing and managerial contributions of key individuals, including our Chief Executive Officer and President, and we may be unable to retain these individuals or recruit others.

We depend on our senior executives including our Chief Executive Officer and President, and certain key managers as well as, engineering, research and development, sales, marketing and manufacturing personnel, who are critical to our business. Except for our Chief Executive Officer and President, we do not have employment agreements with our key employees. Furthermore, the current labor market remains very competitive and challenging for the acquisition and retention of key employees. Larger competitors may be able to offer more generous compensation packages to our executives and key employees, and therefore we risk losing key personnel to those competitors. If we were to lose the services of any of our key personnel, our engineering, product development, manufacturing and sales efforts could be slowed. We may also incur increased operating expenses and be required to divert the attention of our senior executives to search for their replacements. The integration of any new personnel could disrupt our ongoing operations.

We may not be able to hire or retain the number of qualified personnel, particularly engineering personnel, required for our business, which would harm the development and sales of our products and limit our ability to grow.

Competition in our industry for senior management, technical, sales, marketing and other key personnel is intense and has been made even more challenging in the current labor market. If we are unable to retain our existing personnel, or attract and train additional qualified personnel, our growth may be limited due to a lack of capacity to develop and market our products.

We have, from time to time, had trouble in hiring and retaining skilled engineers with appropriate qualifications to support our growth strategy. Our success depends on our ability to identify, hire, train and retain qualified engineering personnel with experience in equipment design. Specifically, we need to continue to attract and retain mechanical, electrical, software and field service engineers to work with our direct sales force to technically qualify and perform on new sales opportunities and orders, and to demonstrate our products.

27

Item 1B.Unresolved Staff Comments

Item 1B.     Unresolved Staff CommentsNone.

None.

Item 2.          Description of Property.

OwnedLocations

Item 1C.
Cybersecurity

We have implemented a risk-based approach to identify and assess the cybersecurity threats that could affect our business and information systems. We use recognized commercially reasonable measures, tools, and methodologies to manage cybersecurity risk, which are tested regularly. We also monitor and evaluate our cybersecurity posture on an ongoing basis through regular malware scans, penetration tests, and third-party reviews. Specific controls that are used to some extent include endpoint threat detection, identity and access management (IAM), privileged access management (PAM), logging and monitoring, multi-factor authentication (MFA), firewalls and intrusion detection and prevention, and vulnerability and patch management.

To manage our material risks from cybersecurity threats and to protect against, detect, and prepare to respond to cybersecurity incidents, we undertake the below listed activities:

Size (sf)

Division

Mortgage/Loan

Principal use

Monitor emerging data protection laws and implement changes to our compliance processes;
Conduct annual cybersecurity assessments for employees who use our system to evaluate training needs;
Conduct onboarding and cyber security training for all employees on an ongoing basis;
Conduct regular phishing email simulations for all employees; and
Carry cybersecurity risk insurance that protects against the potential losses from a cybersecurity incident.

Our incident response plan coordinates the activities that we and our third-party cybersecurity provider take to prepare to respond to and recover from cybersecurity incidents. These include processes to triage, assess severity, investigate, escalate, contain, and remediate an incident, as well as to comply with potentially applicable legal obligations and mitigate brand and reputational damage. We have an IT continuity plan that we continuously review and update in line with our evolving applications architecture.

Our Board of Directors and Audit Committee oversee our cybersecurity efforts to ensure effective governance in managing risks associated with cybersecurity threats. Our Director of Information Technology provides periodic updates to the Board of Directors and Audit Committee regarding our cybersecurity program, including status updates on various projects to enhance our overall cybersecurity posture.

We describe whether and how risks from cybersecurity threats have or are reasonably likely to affect our financial position, results of operations, and cash flows under the heading “Risk related to cybersecurity, intellectual property and regulatory compliance,” which is included as part of Item 1A. Risk Factors of this Annual Report on Form 10-K, which disclosures are incorporated by reference herein.

Item 2.Properties

Our corporate headquarters, research and development, manufacturing and process coating facilities as of December 31, 2023 are as follows:

Owned LocationsSize (sf)SegmentMortgage/LoanPrincipal use
Central Islip, NY

130,000

128,000

CVD/First Nano

Yes

CVD Equipment / CVD Materials

Corporate:No

Corporate headquarters; R&D; Mfg.

Manufacturing
Saugerties, NY22,000SDCNoManufacturing; Administration

Item 3.Legal Proceedings.

Not applicable.

Item 4.Mine Safety Disclosures.

Not applicable.

28
 

Saugerties, NY

22,000

SDC

Yes

Admin; Mfg.

Leased Locations

Size (sf)

Subsidiary

Lease term

Principal use

Nordborgvej,

Denmark

7,793

Tantaline AsP

5 Years

Process coatings; admin

 

Item 3.          Legal Proceedings.

None

Item 4.Mine Safety Disclosures.

Not applicable.


PART II

Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Item 5.          Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Our common stock is listed on the NASDAQ Capital Market under the symbol “CVV.” The following table sets forth, for the periods indicated, the high and low closing prices of our common stock on the NASDAQ Capital Market.

  

High

  

Low

 

Year Ended December 31, 2016:

        

1st Quarter

 $9.95  $7.79 

2nd Quarter

  8.74   6.27 

3rd Quarter

  9.27   8.33 

4th Quarter

  8.83   7.70 

  

High

  

Low

 

Year Ended December 31, 2015:

        

1st Quarter

 $16.48  $13.05 

2nd Quarter

  13.62   10.52 

3rd Quarter

  12.94   9.80 

4th Quarter

  13.18   9.70 

As of March 22, 201725, 2024, there were approximately 8355 holders of record and approximately 1,2263,544 beneficial owners of our common stock, and the closing sales price of our common stock as reported on the NASDAQ Capital Market was $10.17$4.93.

Dividend Policy

We have never paid dividends on our common stock and we do not anticipate paying dividends on common stock at the present time. We currently intend to retain earnings, if any, for use in our business. There can be no assurance that we will ever pay dividends on our common stock. Our dividend policy with respect to our common stock is within the discretion of the Board of Directors and its policy with respect to dividends in the future will depend on numerous factors, including earnings, financial requirements, and general business conditions. We are also prohibited from paying dividends under the terms of our Revolving Line of Credit Agreement with HSBC Bank, USA, N.A.


Equity Compensation Plan Information Table

The following table provides information about shares of our common stock that may be issued upon the exercise of options under all of our existing compensation plans as of December 31, 2016.

  

Number of

securities to be 

issued upon exercise 

of outstanding 

options, warrants 

and rights(1)

  

Weighted-average

exercise price of

outstanding options,

warrants and rights(2)

  

Number of 

securities remaining

available for future

issuance

 

Plan Category

            

Equity compensation plans approved by security holders

  284,730  $8.40   237,200 

Equity compensation

plans not approved by security holders

  --   N/A   -- 
             

Total

  284,730  $8.40   237,200 

(1)

Reflects aggregate options and restricted stock awards outstanding under our 1989 Key Employee Stock Option Plan, 2001 Stock Option Plan and 2007 Share Incentive Plan.

(2)

Calculation is exclusive of the value of any unvested restricted stock awards.

Recent Sales of Unregistered Securities

None.

Issuer Purchasesof of Equity Securities

None.

Item 6.Reserved.

29

 Selected Financial Data.

Not applicable.


Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Except for historical informationYou should read the following discussion and analysis in conjunction with our consolidated financial statements and related notes contained herein,elsewhere in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations”report. This discussion contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, as amended. These statementsthat involve known and unknown risks, uncertainties and other factors which may cause theassumptions. Our actual results performance, or achievementsmay differ materially from those anticipated in these forward-looking statements as a result of a variety of factors discussed in this report and those discussed in other documents we file with the CompanySEC. In light of these risks, uncertainties and assumptions, readers are cautioned not to be materially different from any future results, performance, or achievements expressed or implied byplace undue reliance on such forward-looking statements. These forward-looking statements were based on various factorsrepresent beliefs and were derived utilizing numerous important assumptions and other important factors that could cause actual results to differ materially from those in the forward-looking statements. Important assumptions and other factors that could cause actual results to differ materially from those in the forward-looking statements, include but are not limited to: competition in the Company’s existing and potential future product lines of business; the Company’s ability to obtain financing on acceptable terms if and when needed; uncertainty as to the Company’s future profitability, uncertainty as to the future profitability of acquired businesses or product lines, uncertainty as to any future expansion of the Company. Other factors and assumptions not identified above were also involved in the derivation of these forward-looking statements and the failure of such assumptions to be realized as well as other factors may also cause actual results to differ materially from those projected. The Company assumes no obligation to update these forward looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking statements. Past results are no guaranty future performance. You should not place undue reliance on any forward-looking statements, which speak only as of the dates they are made. When useddate of this report. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change. Past performance does not guarantee future results.

Executive Summary

We have served the advanced materials markets with this Report, the words “believes,” “anticipates,” ”expects,” “estimates,” “plans,” “intends,” “will”chemical vapor and similar expressions are intended to identify forward-looking statements.

We designthermal process equipment for over 40 years. CVD designs, develops, and manufacturemanufactures a broad range of chemical vapor deposition, gas control, and other state-of-the-art equipment and process solutions used to develop and manufacture materials and coatings for researchindustrial applications and research. To learn more about CVD’s systems and offerings, visit www.cvdequipement.com.

During 2023:

Revenue declined by $1.7 million or 6.6% as the prior year benefited from a large number of PVT150 orders.
Gross margin declined by $1.6 million or 23.5% due to cost overruns experienced on one large contract.
Total bookings for 2023 were approximately $25.8 million, a decrease of $7.3 million or 22.1% as compared to 2022. Bookings for 2022 included orders for PVT equipment as compared to none in 2023.
Received $8.7 million in orders from a major aerospace company for the production of CVI systems. The systems will be used by our customer to manufacture CMCs for their gas turbine jet engines.
Increased our backlog from $17.8 million to $18.4 million.
Cash balance at December 31, 2023 was $14.0 million.

30

Business Update

Our core strategy is to focus on growth market applications in end-user markets related to the “electrification of everything,” aerospace and industrial applicationsapplications. The phrase “electrification of everything” refers to the shift from fossil fuels to the use of electricity to power devices, buildings, electric vehicles or EVs, and many other applications. With respect to aerospace, our systems are being used by our customers to produce ceramic matrix composite materials or CMCs that will be used in next generation jet engines with the focus onenabling tomorrow’s technologiesTM. These coatings are used in numerous fields including but not limitedobjective of reducing jet fuel consumption and contributing to aerospace, medical, solar, nano and advanced electronic components. We offer a broad rangethe decarbonization of chemical vapor deposition, gas control and other equipmentthat industry.

During 2021, we received the first six (6) orders for our PVT150 system that is used by our customerscustomer to research, designgrow silicon carbide crystals and manufacture these materials or coatings for turbine blades, implants, semiconductors, solar cells, smart glass, carbon nanotubes, nanowires, LEDs, MEMSreceived an additional 24 orders from the same customer in 2022. The crystals would be further processed into 150 mm silicon carbide wafers and later processed into integrated circuits and other applications. Throughdevices. Devices based on silicon carbide have been shown to reduce energy consumption in EVs and reduce the need for additional cooling elements. While we did not receive any additional orders from this customer, we remain in continuing discussions regarding potential additional orders.

We launched our Application Laboratory,marketing campaign for the PVT150 in the latter part of 2022 as we provide process development support, startup assistanceseek orders from other potential customers. We also developed and focus on developing higher efficiency material manufacturinglaunched our new PVT200 system used to grow silicon carbide crystals for the manufacture of 200 mm wafers in 2023.

In February 2024, we received our first order for a wide variety of growth markets. We lookPVT200. This is our second customer for PVT equipment. This customer plans to accelerate the introduction of nano materials into a range of products and applications to help create a demand forevaluate our equipment or whichwith the objective to select a vendor for potential additional purchases of PVT equipment.

During 2022, we can market through our wholly owned subsidiary, CVD Materials Corporation. Our proprietary technology products are generally customized to meetcompleted the particular specificationsproduction of individuala system for a customer that deposits coatings onto powders used in silicon-graphite anodes that has the objective of increasing EV battery performance while lowering cost. We received two additional orders from this customer in 2023 that were completed during the year.

During 2023, we also received a total $10.6 million of aerospace orders from multiple customers, and to acceleratereflecting continuing strong interest in the commercializationapplication of their proprietary intellectual property. We also offer standard productsCMCs in gas turbine jet engines.

In February 2024, we received a multisystem order for approximately $10 million that are basedwill be used for depositing a silicon carbide protective coating on the expertise and know-how we have developed in designing and manufacturing our customized products.OEM components.

31

Based on more than 34 years of experience, we use our engineering, manufacturing and process development to transform new applications into leading-edge manufacturing solutions. This enables university, research and industrial scientists at the cutting edge of technology to develop next generation chemical vapor deposited products for use in solar, nano materials, LEDs, semiconductors and other applications. We also develop and manufacture research and production equipment based on our proprietary designs. We have built a significant library of design expertise, know-how and innovative solutions to assist our customers in developing these intricate processes and to accelerate their commercialization of chemically deposited materials. This library of solutions, along with our vertically integrated manufacturing facilities, allows us to provide superior design, process and manufacturing solutions to our customers on a cost effective basis.


Results of Operations

Twelve Months

Years Ended December 31, 2016 vs Twelve Months Ended2023 and 2022

The following table presents revenue and expense line items reported in our Consolidated Statements of Operations for the years ended December 31, 20152023 and 2022 and the period-over-period dollar and percentage changes for those line items (in thousands, except percentages).

 

 

 

 

Twelve Months Ended

         
  

December 31

         
  

2016

  

2015

  

Change

  

% Change

 

Revenue

                

CVD (net of eliminations)

 $18,560  $35,461  $(16,901)  (47.7)

SDC (net of eliminations)

  2,395   3,504   (1,109)  (31.6)

Total Revenue

  20,955   38,965   (18,010)  (46.2)
                 

Cost of Goods Sold

  13,851   23,820   (9,969)  (41.9)
                 

Gross Profit

  7,104   15,145   (8,041)  (53.1)

Gross Margin

  33.9%  38.9%      (5.0)
                 

Research & Development

  434   605   (171)  (28.3)

Selling and Shipping

  1,098   1,208   (110)  (9.1)

General & Administrative

  6,926   7,745   (819)  (10.6)
   8,458   9,558   (1,100)  (11.5)

Litigation settlement

  ---   995   (995)    

Gain on settlement

  (629)  ---   (629)    

Total Operating expenses

  7,829   10,553   (2,724)  (25.8)
                 

Operating (loss)/income

  (724)  4,592   5,316   115.8 
                 

Other income/(expense)

  71   (67)  138   206.0 
                 

(Loss)/income before taxes

  (653)  4,525   (5,178)  114.4 
                 

Income tax (benefit)/expense

  (504)  1,320   (1,824    
                 

Net (loss)/income

  (149)  3,205   (3,354)  104.6 
                 

Net (loss)/income per share

                

Basic

  (0.02)  0.52         

Diluted

  (0.02)  0.51         
  December 31, 2023  December 31, 2022  

 

Change

  

 

Percent

 
             
Revenue $24,109  $25,813  $(1,704)  (7%)
                 
Cost of revenue  19,038   19,186   (148)  (1%)
                 
Gross profit  5,071   6,627   (1,556)  (24%)
                 
Operating expenses                
Research and development  2,596   1,906   690   36%
Selling  1,632   1,216   416   34%
General and administrative  5,451   5,328   123   2%
Loss on disposition of Tantaline  162   -   162   * 
Impairment charge  111   -   111   * 
                 
Total operating expenses  9,952   8,450   1,502   18%
                 
Operating loss  (4,881)  (1,823)  (3,058)  (168%)
                 
Other income (expense):                
Interest income  577   162   415   256%
Interest expense  (23)  (8)  (15)  188%
Employee retention credits  -   1,529   (1,529)  (100%)
Foreign exchange loss  42   (95)  137   * 
Other income  91   15   76   * 
Total other income, net  687   1,603   (916)  (57%)
                 
Loss before income tax  (4,194)  (220)  (3,974)  * 
                 
Income tax (benefit) expense  (14)  4   (18)  * 
                 
Net loss $(4,180) $(224) $(3,956)   * 

* Not meaningful

32

Revenue

  December 31, 2023  December 31, 2022  Change  Percent 
CVD Equipment $16,334  $16,674  $(340)  (2%)
SDC  7,139   6,541   598   9%
CVD Materials  1,184   3,171   (1,987)  (63%)
Intersegment sales elimination  (548)  (573)  25    * 
Total $24,109  $25,813  $(1,704)  (7%)

* Not meaningful

Our revenue for the year ended December 31, 20162023 was $21$24.1 million compared to $39$25.8 million for the year ended December 31, 2015, resulting in2022, a decrease of 46.2%$1.7 million or 7%. This

The decrease in revenue versus the prior year period was primarily attributable to decreased revenue of $0.3 million from the protracted negotiations withCVD Equipment segment related to lower equipment sales and spare parts, $2.0 million decrease from our CVD Materials segment due to the disposition of Tantaline and wind down of MesoScribe’s operations, offset by a $0.6 million increase in revenue from our SDC segment due to higher demand.

Revenue from one aerospace customer a major aviation component supplier, which caused a delay in receiving a large anticipated follow-on order. 2023 represented 13.5% of our total revenues and 20.1% of CVD Equipment segment revenues. Sales of PVT150 systems made to one customer in 2023 and 2022 represented 14.3% and 29.2%, respectively, of our total revenues and 21.2% and 45.2%, respectively, of CVD Equipment segment revenues.

The revenue contributed by the CVD Equipment segment for the year ended December 31, 2016,2023 represented 67% of overall revenue as compared to 65% of overall revenue for the year ended December 31, 2022. The decrease in revenues of $0.3 million or 2% resulted from lower PVT150 revenues offset by an increase in aerospace revenue.

The revenue contributed by the CVD/First Nano division,SDC segment for the year ended December 31, 2023 represented 28% of $18.6overall revenue as compared to 25% of overall revenue for the year ended December 31, 2022. Revenue for our SDC segment increased $0.6 million which totaled 88.6%or 9% due to increased orders and demand for the SDC’s products during 2023 as compared to the prior year.

The revenue contributed by the CVD Materials segment for the year ended December 31, 2023 represented 5% of our overall revenue was 47.7% or $16.9 million less than the division’s $35.5 million contribution made in the prior year, which totaled 91%as compared to 12% of our overall revenue.

Annual revenue for the SDC division decreased to $2.4 million in 2016 compared to $3.5 million in 2015. This was a result of a general slowdown in the industry. However, we are beginning to see an increase in activity, as some of the expected orders from earlier are now being received. The SDC division represented 11.4% and 9% of our total revenue during the yearsyear ended December 31, 20162022 The decrease of $2.0 million was principally due to the disposition of Tantaline in May 2023 and the wind down of MesoScribe’s operations.

Our order backlog at December 31, 2015 respectively.2023 was approximately $18.4 million as compared to December 31, 2022 of $17.8 million. Our order backlog at December 31, 2023 consists of approximately $16.3 million related to remaining performance obligations of contracts in progress and the balance of approximately $2.1 million represents other orders received from customers. One aerospace customer represented 49.2% of our backlog as of December 31, 2023. Historically, our revenues and orders have fluctuated based on changes in order rate as well as other factors in our manufacturing process that impacts the timing of revenue recognition. Accordingly, orders received from customers and revenue recognized may fluctuate from quarter to quarter.

33

Gross Profit

Gross profit for the year ended December 31, 20162023 amounted to $7.1$5.1 million, with a gross profit margin of 33.9%21%, compared to a gross profit of $15.1$6.6 million and a gross profit margin of 38.9%26% for the year ended December 31, 2015.2022. The reduceddecrease in gross profit of $1.6 million was primarily due to significant cost overruns on one contract and gross marginlower PVT150 and CVD Materials revenues as compared to 2022.

Research and Development

For the year ended December 31, 2023, research and development expenses were $2.6 million, or 10.8% of revenue as compared to $1.9 million, or 7.4% for the year ended December 31, 2022. The increase in 2023 was the result of the lower revenueincreased personnel and theemployee-related costs associated with maintaining production staff in anticipation of the large follow-on order from our largest customer.to develop new products for key growth markets.

ResearchGeneral engineering support and Development, Selling and General and Administrative Expenses

Dueexpenses related to the technical development required on our custom orders, ourof more standard products and value-added development of existing products are reflected as part of research and development teamexpense. General engineering support and their expenses are charged to costs of goods sold when they are workingwork is performed directly on a customer project. When they are not working on a customer project they work in our Application Laboratory and their costs are charged to research and development. In 2016, we incurred $0.4 million of internal research and development costs compared to $0.6 million of internal research and product development expenses incurred in 2015. The Company had temporarily curtailed independent research and development activities during the first six months of 2016, however, it has begun to expand those activities during the last half of the year.order.

Selling and shipping

Selling expenses were $1.1$1.6 million or 5.2%6.8% of the revenue for the year ended December 31, 20162023 as compared to $1.2 million or 3.1%4.7% for the year ended December 31, 2015.2022. The decreaseincrease in actual expenses2023 was aprimarily the result of reducedincreased personnel and shippingemployee-related costs in the current period. The increase as a percentage of revenue was dueduring to the reduced revenues for the current year.support increased marketing efforts.

General and Administrative

General and administrative expenses for the year ended December 31, 20162023 were $6.9$5.5 million or 22.6% of revenue compared to $7.7$5.3 million duringor 20.6% of revenue for the year ended December 31, 2015, a decrease2022, an increase of $0.8$0.1 million. In 2016, we incurred general legalThe increase in expenses was principally due to increases in stock-based compensation of $0.2 million, higher professional fees of $75,000 compared$0.3 million, and increase in 401(k) match of $0.2 million, offset by lower bonus expense of $0.4 million and lower expenses for CVD Materials of $0.1 million due to $619,000 in legal fees related to litigation that was settled in 2015.the disposition of Tantaline.


Litigation SettlementLoss on Disposition of Tantaline

Pursuant to a settlement agreement, in September 2015,This expense represents the Company paid the sum of $995,000 to Development Specialists, Inc. an Illinois corporation, solely in its capacity as assignee for the benefit of creditors of CM Manufacturing, Inc., f/k/a Stion Corporation, a Delaware corporation in full settlement and satisfaction of all claims asserted in a previously disclosed proceeding. Each party released all claims of any nature which it had against the other.

Gain on Settlement

The Company has included the results of a negotiated reduction to legal fees and expenses

in connection with the settlement of the previously disclosed Taiwan Glass litigation. The final negotiated sum was $1.1 million, resulting in a reduction of the amount that was previously billed and accrued and a gainnet loss on the statementsale of operationsour Tantaline subsidiary including professional fees.

34

Impairment Charge

This expense represents the loss on the impairment of $629,000 duringcertain assets of MesoScribe based on the period.decision to wind down its operations.

Operating (Loss)/Other Income, Net

As a result of the decreased revenues, we incurred a loss from operations ofOther income, net was $0.7 million for the year ended December 31, 20162023 as compared to operatingother income, net of $4.5$1.6 million for the year ended December 31, 2015.2022.

Other Income/(Expenses)

The increase in interest income of $0.4 million was due to higher interest rates and increased amounts invested in U.S. treasury bills. During 2022, we conducted an analysis to determine if we were entitled to an employee retention credit (“ERC”) under the Coronavirus Aid, Relief, and Economic Security Act as amended by the Taxpayer Certainty and Disaster Tax Relief Act of 2020 and the American Plan Act of 2021. Based on our analysis, we determined that we were entitled to an ERC of approximately $1.5 million related to payroll paid in the first and third quarters of 2021 under the applicable Internal Revenue Service regulations and . we recognized other income of this amount during the year ended December 31, 2016, we received a payment from our insurance company on a property damage claim that exceeded2022. This amount was collected in July 2023.

Income Taxes

Income tax (benefit) expense for the repair costs by $119,000.

Income Taxes

For the twelve monthsyears ended December 31, 2016,2023 and 2022, was ($14,000) and $4,000, respectively. We continue to evaluate for potential utilization of our deferred tax asset, which has been fully reserved for, on a quarterly basis, by reviewing our economic models, including projections of future operating results.

Inflation and Supply Chain Matters

We experienced increased costs on certain materials and components as well as delays in supply chain delivery, which may also impact our ability to recognize revenue and reduce our gross profit margins, as well as extend our manufacturing lead times and reduce our manufacturing efficiencies. We have commenced placing orders with more lead time to help mitigate the manufacturing delays, as well as assessing other suppliers or components to attempt to mitigate the potential cost impacts. In addition, we recorded an income tax benefit of approximately $504,000. This is primarilyare utilizing our in-house flexible manufacturing to attempt to further mitigate both potential schedule delivery delays and material cost increase. While we have initiated actions to mitigate the result of available researchpotential negative impacts to our revenue and development and other tax credits to a pre-tax loss of $654 as compared to an income tax expense of $1.3 million on pre-tax income of $4.5 million for the twelve months ended December 31, 2015.

Net (Loss)/Income

As a resultprofitability, there can be no assurance of the foregoingultimate impact and the length of time that the supply chain factors for the year ended December 31, 2016, we incurred a net loss of $149,000 or $(0.02) per diluted share compared to net income of $3.2 million or $0.51 per diluted share for the year ended December 31, 2015.may impact our revenues and profitability.

Inflation

Inflation has not materially impactedalso had an impact on salaries and compensation. To remain competitive in the acquisition and retention of our operations.employees, we have reviewed and adjusted salaries and implemented bonus incentives to mitigate the potential negative impacts of inflation on our employees.

35

Liquidity and Capital Resources

As of December 31, 2016,2023, we had aggregate working capital of $20.5$14.3 million compared to aggregate working capital of $19.9$15.5 million at December 31, 2015 and had available cash and cash equivalents of $21.7 million, compared to $13.1 million, in2022. Our cash and cash equivalents at December 31, 2015.2023 and 2022 were $14.0 million and $14.4 million, respectively.

Net cash used in operating activities during 2023 was $0.2 million and was principally due to the net loss of $4.2 million, decrease in contract assets of $0.6 million, increase in inventories of $1.9 million, decrease in accrued expenses of $0.7 million (primarily due to payment of 2022 bonus) offset by a decrease in accounts receivable of $1.8 million, collection of employee retention credit receivable of $1.5 million, an increase in contract liabilities of $0.9 million and non-cash items of $2.0 million. The increase in working capitalinventory was related to the production of $0.6 million is primarily attributablePVT150 systems in anticipation of potential future orders and increases related to an increase in cash that was partially offset by a reduction in costs and estimated earnings in excess of billings on contracts in progress as well as an increase in billings in excess of costs and estimated earnings on contracts in progress. Net cash increased by $8.6 million as a result of cash provided by operating activities of $8.8 million which was primarily attributed to an increase in billings in excess of costs and estimated earnings on contracts in progress. new system orders.

Net cash used in investing activities during 2023 was $0.1 million. Capital expenditures of $0.4 million.million related to purchases of manufacturing equipment and building improvements. The disposition of Tantaline resulted in a cash outflow of $0.3 million based on the terms of the agreement. We received $0.6 million of deposits from the purchaser of certain MesoScribe equipment as described below.



Cash flows from financing activities during 2023 was not significant and included $0.1 million of proceeds from the exercise of employee stock options and $0.1 million of repayment of an equipment loan.

Accounts receivable, net

On August 4, 2023, we entered into a Purchase and License Agreement with a third-party. Pursuant to the Purchase and License Agreement, we will sell certain proprietary assets relating to its plasma spray technology and material deposition system and grant a non-exclusive license to use certain of allowanceour related intellectual property as more fully described in the Purchase and License Agreement, for doubtful accounts, decreased by $2.5 million or 80.6% atan aggregate purchase price of $0.9 million. The purchase price is payable in several installments and contingent upon certain performance metrics and other milestones.

During the year ended December 31, 2016 to2023, we received payments under the Purchase and License Agreement in the amount of $0.6 million compared to $3.1 million at December 31, 2015. This decreasewhich is principally due toreflected as deposits from purchaser in the timing of shipments and customer payments.

Inventoriesaccompanying consolidated balance sheet as of December 31, 2016 were approximately $3.3 million representing an increase2023. We expect the transaction to be completed during 2024.

We expect to continue to fulfill remaining customer orders for MesoScribe products through the end of approximately $0.2 million or 6.5% compared2024 at which time it plans to cease the balanceremaining operations of approximately $3.1 million asMesoScribe and dispose of December 31, 2015any remaining equipment.

We maintain a revolving credit facility with HSBC Bank, USA, N.A. (“HSBC”) providing up to $7 million, although we have never utilized this facility. This credit facility remains available until September 1, 2018. The credit facility also contains certain financial covenants, all of which we were in compliance with at December 31, 2016.

On August 1, 2016 we made the final payment on a $2.1 million term loan that was initially entered into in August 2011. The balance on that term loan at December 31, 2015 was $280,000.

The Company has a loan agreement with HSBC which is secured by a mortgage against our Central Islip facility. The loan is payable in 120 consecutive equal monthly installments of $25,000 in principal plus interest and a final balloon payment upon maturity in March 2022. The balances as of December 31, 2016 and December 31, 2015 were approximately $3.3 million and $3.6 million respectively. Interest accrues on the Loan, at our option, at the variable rate of LIBOR plus 1.75% which was 2.1765% and 1.9455% at December 31, 2016 and 2015 respectively.

On December 16, 2016, we purchased certain assets formerly owned by Tantaline A/S of Nordborg, Denmark through our wholly owned subsidiary, CVD Materials Corporation. Formed in 2007, as a spin off from The Danfoss Group, Tantaline A/S established itself as a leader in the commercialization of tantalum treated parts for corrosion resistance. We have now established in Nordborg a new and wholly owned CVD subsidiary operating under the name Tantaline CVD ApS (“Tantaline”).

We believe that our cash and cash equivalent positions and our projected cash flow from operations will be sufficient to meet our working capital and capital expenditure requirements for the next twelve months.months from the filing of this Form 10-K. We will continue to assess our operations and take actions anticipated to maintain our operating cash to support the working capital needs.

36

We may also raise additional funds in the event we determine in the future to effect one or more acquisitions of businesses, technologies or products. In addition, we may elect to raise additional funds even before we need them if the conditions for raising capital are favorable. Any equity or equity-linked financing could be dilutive to existing shareholders.


Critical Accounting Policies and Estimates

Use of Estimates

The preparationThis discussion and analysis of the Company’s financial condition and results of operations is based on the Company’s consolidated financial statements, which have been prepared in conformityaccordance with generally accepted accounting principles generally accepted in the United States of America, or U.S. GAAP. The preparation of these financial statements requires managementus to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenuesrevenue and expenses during the reporting period.reported periods. In accordance with U.S. GAAP, the Company bases its estimates on historical experience and on various other assumptions the Company believes are reasonable under the circumstances. Actual results couldmay differ from those estimates. Ourthese estimates under different assumptions or conditions.

We consider an accounting estimate to be critical if: (1) the accounting estimate requires us to make assumptions about matters that were highly uncertain at the time the accounting estimate was made, and (2) changes in the estimate that are reasonably likely to occur from period to period, or use of different estimates that we reasonably could have used in the current period, would have a material impact on our financial condition or results of operations.

We believe that of our significant accounting policies, which are described in the notes to the consolidated financial statements, the following accounting policies involve a greater degree of judgments, estimates include accounting for certain items such as revenues on long-term contracts recognizedand assumptions. Accordingly, these are the policies that we believe are the most critical to aid in fully understanding and evaluating our consolidated financial condition and results of operations. For information on the percentage-of-completion method; valuationCompany’s significant accounting policies and estimates refer to Note 2 “Summary of inventories atSignificant Accounting Policies” including the lower“Use of cost or market; allowance for doubtful accounts receivable; recognitionEstimates” section, in the consolidated financial statements.

Revenue Recognition

We design, manufacture, and sell custom chemical vapor deposition equipment through contractual agreements. These system sales require us to deliver functioning equipment that is generally completed within two to eighteen months from commencement of stock-based compensation; estimated lives and recoverable value of our long-lived assets; costs associated with product warranties; and certain components of the current and deferred income tax provisions which ae based on estimates of future taxable events.

Revenue Recognition

Product and service sales, including those based on time and materials type contracts, are recognized when persuasive evidence of an arrangement exists, product delivery has occurred or services have been rendered, pricing is fixed or determinable, and collection is reasonably assured. Service sales, principally representing repair, maintenance and engineering activities are recognized over the contractual period or as services are rendered.

order acceptance. We recognize revenues and incomerevenue over time by using the percentage-of-completionan input method for certain custom production-type contracts. Profits on these custom production-type contracts are recorded on the basis of our total estimated costs over the percentage of total costs incurred on individual contracts commencing when progress reaches a point where experience is sufficient to estimate final results with reasonable accuracy. Under this method, revenues are recognized based on costs incurred as it depicts our progress toward satisfaction of the performance obligation. Under this method, revenue arising from fixed price contracts is recognized as work is performed based on the ratio of costs incurred to date compared withto the total estimated costs.costs at completion of the performance obligations.

Stock-Based Compensation

We record stock-based compensationIncurred costs include all direct material and labor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs and depreciation costs. Contract material costs are included in accordance withincurred costs when the provisions set forthproject materials have been purchased or moved to work-in-process as required by the project’s engineering design. Cost based input methods of revenue recognition require us to make estimates of costs to complete the projects. In making such estimates, significant judgment is required to evaluate assumptions related to the costs to complete the projects, including materials, labor, and other system costs. If the estimated total costs on any contract are greater than the net contract revenues, we recognize the entire estimated loss in the Financial Accounting Standard Board (“FASB”) Accounting Standards Codification (“ASC”) 718, “Stock Compensation,” usingperiod the modified prospective method. ASC 718 requires companiesloss becomes known and can be reasonably estimated.

37

We have been engaged in the production and delivery of goods on a continual basis under contractual arrangements for many years. Historically, we have demonstrated an ability to recognizeaccurately estimate total revenues and total expenses relating to our long-term contracts. However, there exist many inherent risks and uncertainties in estimating revenues, expenses and progress toward completion, particularly on larger or longer-term contracts. If we do not estimate the costtotal sales, related costs, and progress toward completion on such contracts, the estimated gross margins may be significantly impacted, or losses may need to be recognized in future periods. Any such resulting changes in margins or contract losses could be material to our results of employee services received in exchange for awards of equity instruments based upon the grant date fair value of those awards.operations and financial condition.

Long-Lived Assets

Long-lived assets consist primarily of property, plant and equipment. Long-lived assets are reviewed for impairment whenever events or circumstances indicate their carrying value may not be recoverable. When such events or circumstances arise, an estimate of the future undiscounted cash flows produced by the asset, or the appropriate grouping of assets, is compared to the asset’s carrying value to determine if impairment exists pursuant to the requirements of ASC 360-10-35, “Impairment or Disposal of Long-Lived Assets.” If the asset is determined to be impaired, the impairment loss is measured on the excess of itsit carrying value over its fair value. Assets to be disposed of are reported at the lower of their carrying value or net realizable value. We had no recorded long-lived assetIt is not possible for us to predict the likelihood of any possible future impairments or, if such an impairment charges inwere to occur, the statementmagnitude of operations during each of the years ended December 31, 2016 and 2015.any impairment.


Off-Balance Sheet Arrangements

None.

Item 7A.Quantitative and Qualitative Disclosures About Market Risk.

Item 7A.     Quantitative and Qualitative Disclosures About Market Risk.

Not applicable.

Item 8.Financial Statements and Supplementary Data.

Item 8.          Financial Statements and Supplementary Data.

The consolidated financial statements and supplementary data required by this item are included in this annual reportAnnual Report on Form 10-K beginning on page F-1.

Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

Item 9.         Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.None.

None.

Item 9A.Controls and Procedures.

Item 9A.      Controls and Procedures.

Disclosure Controls and Procedures. We maintain a system of disclosure controls and procedures (as defined in Rule 13a-15(e) and 13d-15(e) under the Exchange Act)Act of 1934, as amended, (the “Exchange Act”)). As required by Rule 13a-15(b) under the Exchange Act, management of the Company, under the direction of our Chief Executive Officer and Chief Financial Officer, reviewed and performed an evaluation of the effectiveness of design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of December 31, 2016. 2023.

38

Based on that review and evaluation, theour Chief Executive Officer and Chief Financial Officer, along with theothers in our management, of the Company, have determined that as of December 31, 2016,the end of the period covered by this Report on Form 10-K, the disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and were effective to provide reasonable assurance that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer,officers, as appropriate to allow timely decisions regarding required disclosures.


Changes in Internal Controls

There were no changes in our internal controls over financial reporting as defined in Rule 13a-15(f) or Rule 15d-15(f) under the Exchange Act that occurred during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the internal controls over financial reporting.

Limitations on the Effectiveness of Controls

We believe that a control system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the control systems are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

Management’s Annual Report on Internal Control Over Financial Reporting. Our management is responsible for establishing and maintaining effective internal control over financial reporting (as defined in Rule 13a – 15(f) of the Exchange Act). There are inherent limitations to the effectiveness of any internal control, including the possibility of human error and the circumvention or overriding of controls. Accordingly, even effective internal controls can provide only reasonable assurance with respect to financial statement preparation. Further, because of changes in conditions, the effectiveness of internal control may vary over time. We have assessed the effectiveness of our internal controls over financial reporting (as defined in Rule 13a -15(f) of the Exchange Act) as of December 31, 2016.2023. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in “Internal Control – Integrated Framework (2013)”. Management concluded that, as of December 31, 2016,2023, our internal control over financial reporting was effective based on the criteria established by the COSO Internal Control Framework.

This annual reportAnnual Report on Form 10-K does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to the rules of the Securities and Exchange Commission that permit us to provide only management’s report in this annual report.Annual Report on Form 10-K.

Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting, identified in connection with the evaluation of such internal control that occurred during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Item 9B.      Other Information.

None.


PART III

Item 9B.

Other Information.

Not applicable.

Item 9C.Disclosure Regarding Foreign Jurisdictions That Prevent Inspections.

Not applicable.

39

PART III

Item 10.

Directors, Executive Officers, and Corporate GovernanceGovernance..

BackgroundBackground and Experience of Directors

When considering whether directors and nominees have the experience, qualifications, attributes or skills, taken as a whole, to enable the Board of Directors to satisfy its oversight responsibilities effectively in light of our business and structure, the Nominating, Governance and Compliance Committee focused primarily on each person’s background and experience as reflected in the information discussed in each of the directors’ individual biographies set forth immediately below. We believe that our directors provide an appropriate mix of experience and skills relevant to the size and nature of our business. As more specifically described in such person’s individual biographies set forth below, our directors possess relevant and industry-specific experience and knowledge in the engineering financial and business fields, as the case may be, which we believe enhances the Board’s ability to oversee, evaluate and direct our overall corporate strategy. The Nominating, Governance and Compliance Committee annually reviews and makes recommendations to the Board regarding the composition and size of the Board so that the Board consists of members with the proper expertise, skills, attributes, and personal and professional backgrounds needed by the Board, consistent with applicable regulatory requirements.

The Nominating, Governance and Compliance Committee believes that all directors, including nominees, should possess the highest personal and professional ethics, integrity, and values, and be committed to representing the long-term interests of our shareholders. The Nominating, Governance and Compliance Committee will consider criteria including the nominee’s current or recent experience as a senior executive officer, whether the nominee is independent, as that term is defined in existing independence requirements of the NASDAQ Capital Market and the Securities and Exchange Commission, the business, scientific or engineering experience currently desired on the Board, geography, the nominee’s industry experience, and the nominee’s general ability to enhance the overall composition of the Board.

The Nominating, Governance and Compliance Committee does not have a formal policy on diversity; however, in recommending directors, the Board and the Committee consider the specific background and experience of the Board members and other personal attributes in an effort to provide a diverse mix of capabilities, contributions and viewpoints which the Board believes enables it to function effectively as the Board of Directors of a company with our size and the nature of our business.

40

Director Service on other Boards

Lawrence J. Waldman has served as a director of Bovie Medical Corporation (“Bovie”) since 2011 and is currently the Chair of the Audit Committee and Lead Independent Director of Bovie’s Board. Mr. Waldman serves as a member of the Board of Directors of Northstar/RXR Metro Income Fund, a non-traded Real Estate Investment Trust, and has served as a member of its Audit Committee since 2014. Mr. Waldman also serves as a member of the Board of Directors of Comtech Telecommunications, Corp. since August of 2014, and has served as the Chairman of the Audit Committee since December 2015.

Raymond A. Nielsen has been a member of the Board of Directors of Bridgehampton National Bank and Bridge Bancorp Inc., its parent holding company since 2013. He currently serves on the Compensation Committee, Corporate Governance and Nominating Committee as well as on the ALCO and Loan Committees and the Compliance BSA & CRA Committee.


Legal Proceedings Involving Directors

None.

Board Leadership

Our Corporate Governance practices contain several features which we believe will ensure that the Board maintains effective and independent oversight of management, including the following:

Executive sessions without management and non-independent directors present are a standing Board agenda item. Executive sessions of the independent directors are held at any time requested by an independent director and, in any event, are held in connection with at least 100% of regularly scheduled Board meetings.
The Board regularly meets in executive session with the CEO without other members of management present.
All Board committee members are independent directors. The committee chairs have authority to hold executive sessions with management and non-independent directors present.

While our Board has no formal policy with respect to separation of the positions of Chairman and CEO or with respect to whether the Chairman should be a member of management or an independent director, we believe that the appointment of Mr. Waldman as Chairman properly facilitates better communication between the Independent Directors on the one hand and believes that these are matters that should be discussedthe non-Independent Director and determinedmembers of management on the other hand and leads to improved oversight and discussions by the Board from time to time. Currently, Leonard A. Rosenbaum serves as our Chairman, President and CEO. Givena whole. The Chief Executive Officer of the fact that Mr. Rosenbaum, in his capacity as our President and CEOCompany, Emmanuel Lakios, is tasked with the responsibility of implementing our corporate strategy, we believe he is best suited for leading discussions with input from the Chairman, at the Board level, regarding performance relative to our corporate strategy and these discussions accountthis discussion accounts for a significant portion of the time devoted at ourthe Board meetings.

Our Certificate of Incorporation and Bylaws provide for our Company to be managed by or under the direction of the Board of Directors. Under our Certificate of Incorporation and Bylaws, the number of directors is fixed from time to time by the Board of Directors. The Board of Directors currently consists of fivesix members. Directors are elected for a period of one year and thereafter serve, subject to the Bylaws, until the next annual meeting at which their successors are duly elected by the shareholders.

The following table sets forforth the names, ages and positions with the Company of each of our directors and executive officers, as of March 22, 2017.25, 2024.

Name

Age

Age

Position(s) with the Company

Leonard A. Rosenbaum

Emmanuel Lakios

71

62

Chief Executive Officer, President, Director
Lawrence J. Waldman77Chairman of the Board of Directors, Chief Executive Officer, President

Chairman-Audit Committee

Martin J. Teitelbaum

66

Director, General Counsel and Assistant Secretary

Conrad J. Gunther

70

Director, Chairperson-Audit Committee

Lawrence J. Waldman

70

Director, Chairperson-Compensation Committee

Raymond A. Nielsen

66

73

Director, Chairperson-Nominating,Chairman - Nominating, Governance and

Compliance Committee
Robert M. Brill

Compliance77

Director, Chairman - Strategic Planning Committee

Glen R. Charles

Debra Wasser

63

59

Director
Ashraf Lotfi63Director
Richard A. Catalano64Chief Financial Officer, Vice President, Secretary

and Treasurer

Steven Aragon

55

Chief Operating Officer

Karlheinz Strobl

57

Vice President of Business Development

William S. Linss

59

Vice President of Operations-CVD/First Nano Division

Kevin R. Collins

51

58

Vice President and General Manager-SDC Division

Manager of SDC

Emmanuel Lakios

Jeffrey A. Brogan

55

54

Vice President of Sales and Marketing

Maxim S. Shatalov53Vice President of Engineering and Technology
Warren D. Cheesman51Vice President of Manufacturing Operations

41

Leonard A. RosenbaumEmmanuel Lakios

Leonard A. Rosenbaum founded the Company in 1982Emmanuel Lakios was appointed to serve as President and has been our President, Chief Executive Officer and has served as Chairman of the Board of Directors since that time. From 1971 until 1982, Mr. RosenbaumCompany on January 22, 2021, and on July 15, 2021 was president, director and a principal stockholder of Nav-Tec Industries, a manufacturer of semiconductor processing equipment similar toelected by the type of equipment we manufacture. From 1966 to 1971, Mr. Rosenbaum was employed by a division of General Instrument, a manufacturer of semiconductor materials and equipment.

Martin J. Teitelbaum, Esq.

Martin J. Teitelbaum has served as a member of our Board of Directors and General Counsel since 1985 and as our in-house General Counsel since May 16, 2011. Mr. Teitelbaum is an attorney, who prior to May 16, 2011, conducted his own private practice, the Law Offices of Martin J. Teitelbaum. Prior to establishing his own firm in 1988, Mr. Teitelbaum was a partner at Guberman and Teitelbaum from 1977 to 1987. In addition, Mr. Teitelbaum currently acts as our Assistant Secretary. Mr. Teitelbaum earned a B.A. in Political Science from the State University of New York at Buffalo and a Juris Doctor from Brooklyn Law School. Mr. Teitelbaum has served as our outside General Counsel for many years and his legal expertise makes him an asset to the Company’s board of directors.

Conrad J. Gunther

Conrad J. Gunther has served as a member of our Board of Directors since 2000. Mr. Gunther has extensive experience in mergers and acquisitions and in raising capital through both public and private means. He has been an executive officer and director of several banks, both public and private, and has served on the boards of two other public companies. He most recently served on the board of GVC Venture Corp., a public company from June 2004 until it merged with the Halo Companies in September 2009. Since January 2008, Mr. Gunther has served as an Executive Vice President and Senior Loan Officer for Community National Bank, a Long Island, New York based commercial bank, where he is responsible for all commercial lending. Mr. Gunther qualifies to serve on our board of directors as a result of his experience and expertise in the financial community.


Lawrence J. Waldman

Lawrence J. Waldman was appointed a member of the Board of Directors on October 5, 2016. Mr. Waldman has over forty years of experience in public accounting. He joined First Long Island Investors LLC, an investment and wealth management firm, as a Managing Director in May 2016. Prior to that Mr. Waldman served as an advisor to the accounting firm of EisnerAmper LLP, where he was previously the Partner-in-Charge of Commercial Audit Practice Development for Long Island since September 2011. Prior to joining EisnerAmper LLP, Mr. Waldman was the Partner-in-Charge of Commercial Audit Practice Development for Holtz Rubenstein Reminick, LLP from July 2006 to August 2011. Mr. Waldman was the Managing Partner of the Long Island office of KPMG LLP from 1994 through 2006, the accounting firm where he began his career in 1972. Mr. Waldman has served as a director of Bovie Medical since 2011 and he is currently the Chair of the audit committee and Lead Independent Director of the Board. Mr. Waldman servesshareholders as a member of the Board of Directors of Northstar/RXR Metro Income Fund, a non-traded Real Estate Investment Trust, and has served as a member of its audit committee since 2014.Directors. Mr. Waldman was elected to the Board of Directors of Comtech Telecommunications Corp. in August of 2015, and since December 2015, serves as Chair of its Audit Committee. Mr. Waldman is also a member of Supervisory Committee of Bethpage Federal Credit Union. Mr. Waldman also serves as a member of the State University of New York's Board of Trustees and as chair of its audit committee. He previously served as the Chairman of the Board of Trustees of the Long Island Power Authority and as Chair and a member of the finance and audit committee of its Board of Trustees. Mr. Waldman is a Certified Public Accountant.

Raymond Nielsen

Raymond Nielsen was appointed a member of the Board of Directors on October 5, 2016. Mr. Nielsen is currently the Director of Finance for The Beechwood Organization and has been responsible for Project and Corporate Finance including Strategic Planning Initiatives since 2014. He has been a member of the Board of Directors of Bridgehampton National Bank and Bridge Bancorp Inc., its Parent holding company since 2013, serving on the Compensation Committee, Corporate Governance & Nominating Committee, ALCO, Loan, and the Compliance, BSA & CRA Committees. Mr. Nielsen is the former CEO of Reliance Federal Savings Bank and Herald National Bank, and a 45 year veteran of the banking industry. Mr. Nielsen also served as a Director of North Fork Bancorporation and its subsidiary North Fork Bank for 6 years where he chaired both the Compensation Committee and Audit Committee as well as having served as Lead Independent Director. Mr. Nielsen’s extensive public company, banking and real estate development experience will provide a valuable resource to the Board of Directors and Executive Management.

Glen R. Charles

Glen R. Charles has been the Chief Financial Officer and Secretary of the Company since January, 2004. From 2002 until heLakios joined the Company he was the Director of Financial Reporting for Jennifer Convertibles, Inc., the owner and licensor of the largest group of sofabed specialty retail stores in the United States. From 1994 to 2002, he was the Chief Financial Officer of Trans Global Services, Inc., a public company providing temporary technical services to the aerospace, aircraft, electronics and telecommunications markets. Mr. Charles has also had his own business in the private practice of accounting. Mr. Charles earned his B.S. in Accounting from the State University of New York at Buffalo.


Steven Aragon

Dr. Steven Aragon was appointed Chief Operating Officer by the Board of Directors on October 20, 2014. Dr. Aragon has over 25 years of thin-film process, materials, and system expertise applied to photovoltaic, optical, electronic, and magnetic device fabrication. He received his Ph.D. in Physical Chemistry from the University of California, Santa Cruz, in 1990 and his MBA from Santa Clara University in 1996. He is the holder of five process equipment design patents. Dr. Aragon was a co-founder of Optimus Energy Systems International Inc. and served as its Chief Technical Officer and Senior Vice-President – Engineering from November 2011 to October 2014. From June 2008 to October 2011, He has also served as Vice-President – Engineering at Stion Corp of San Jose, California, a maker of nanostructure-based CIGS (copper indium gallium sulphur-diselenide) thin-film photovoltaic panels and as the Vice President – Engineering at Day Star Technologies Inc. from June 2001 to June 2008.

Karlheinz Strobl

Dr. Karlheinz Strobl has been the Vice President of Business Development since October 2007. From 1997 to 2007, he was the founder and President of eele Laboratories, LLC, a technology and manufacturing solutions development company for a novel Light Engine for the video and data projection display market. Dr. Strobl holds over 14 patents and earned an MBA from Boston University, a PhD from the University of Innsbruck and an MS from both the University of Innsbruck and the University of Padova. He has also worked at the Max Plank Institute and at Los Alamos National Laboratory.

William S. Linss

William S. Linss is the Vice President, Operations for the CVD/First Nano Division of CVD. In addition to managing daily engineering and production operations, Bill is instrumental in expanding the company’s technology capabilities, developing new products and positioning CVD for growth. Prior to his promotion in 2013, Bill was the Division Manager for the CVD/First Nano Division since 2005. Bill has worked in semiconductor manufacturing and chemical vapor deposition for 25 years. From 1980 through 1988 Bill worked at Standard Microsystems Corp. in Hauppauge, NY, advancing to Equipment Engineering Manager with all capital equipment responsibilities for SMC’s MOS/VLSIC manufacturing. Bill was employed by CVD from 1988 through 1994, advancing through various positions as Electrical Systems Designer, Field Service Engineer and Production Manager. From 1994 through 2001 Bill served as a Software Quality Assurance (SQA) Manager with Otari Corporation, at their Long Island pro-audio R&D office; and later with AP Engines in Sacramento, CA, a Cable TV billing solutions start-up.  In 2001, Bill re-joined CVD to head the newly acquired Research International Division for SMT reflow oven manufacturing, which then resulted in CVD’s acquisition of the Conceptronic product line.

Kevin R. Collins

Prior to his appointment as Vice President Sales and General Manager-SDC Division, Mr. Collins served as the General Manager of CVD’s SDC Division since 1999. From 1990 to 1999 he was employed by Stainless Design Corp. as Manager of Field Operations and Product Development Advisor. Mr. Collins attended Columbia University School of Engineering and Applied Science. 


Emmanuel Lakios

Marketing in February 2017. Mr. Lakios has over thirty (30)30 years of experience serving the aerospace, semiconductor, data storage and optical device industries and is the holder of several patents in the field of process equipment and device structure. From January 2015 until earlier this year,through February 2017, Mr. Lakios was the President and Chief Executive Officer at Sensor Electronic Technology, Inc., overseeing that company’s transition from R&D to a leading global commercial UV LED supplier. From 2003 to 2011 he was the Executive Vice President of Field Operations and President and Chief Operating Officer at Imago Scientific, bringing it from pre-revenue to a commercial leadership position in the 3D atomic scale tomography field. Mr. Lakios was previously employed at Veeco Instruments Inc. from 1984 until 2003, where he held several positions, including President of the Process Equipment Group and Executive Vice President of Field Operations. He has been involved in several acquisitions and numerous product line launches. He received his BE in Mechanical Engineering with focus in Material Science from SUNY Stony Brook in 1984.

Lawrence J. Waldman

Lawrence J. Waldman was appointed a member of the Board of Directors on October 5, 2016 and currently serves as Chairman of the Board and Chairman of the Audit Committee. Mr. Waldman has over 40 years of experience in public accounting.

Mr. Waldman is a member of the board of directors of Comtech Telecommunications Corporation since August 2015 and Lead Independent Director since December 2021. He serves as the chairperson of Comtech’s Audit Committee. Mr. Waldman is a member of the board of directors and Lead Independent Director and Audit Committee Chairperson at APYX Medical Corporation, a Nasdaq-listed advanced energy medical technology company. Mr. Waldman serves as a Senior Advisor at First Long Island Investors, LLC since 2016 and was previously an Advisor to the accounting firm of EisnerAmper LLP following his role as Partner-in-Charge of Commercial Audit Practice Development for Long Island. Mr. Waldman served as the Managing Partner of the Long Island office of KPMG LLP from 1994 through 2006, the accounting firm where he began his career in 1972. During his tenure at KPMG, Mr. Waldman served as audit partner to a number of public and privately held technology companies.

42

Mr. Waldman is currently Chairman of the Board of Directors of the Long Island Association and a member of the boards of directors of the Long Island Angel Network and the Advanced Energy Research Center at Stony Brook University. Through October 21, 2018, Mr. Waldman was a member of the board of directors of Northstar/RXR Metro Income, Inc., an SEC registered non-traded real estate investment trust.

Mr. Waldman is the current Chairman of the Supervisory Committee of Bethpage Federal Credit Union and previously served as the Chairman of the Audit Committee of the State University of New York’s (“SUNY”) Board of Trustees, the largest state university system in the United States. Mr. Waldman previously served as Chairman of the Audit and Finance Committee Board of Trustees of the Long Island Power Authority (“LIPA”), the second largest government utility in the United States, and as the Chairman of the Board. Mr. Waldman also served as an adjunct professor at Hofstra University, teaching graduate courses in advanced accounting theory and advanced auditing. Mr. Waldman is a certified public accountant in New York State. He is a member of the American Institute of Certified Public Accountants and the New York State Society of CPAs. Mr. Waldman holds a Bachelor of Science and a Master of Business Administration from Hofstra University in Hempstead, New York.

Mr. Waldman qualifies to serve as a director, Audit Committee Chairman and Lead Independent Director because of his significant experience leading public company boards, his extensive relevant industry and financial and accounting expertise.

Ashraf Lotfi

Dr. Ashraf Lotfi is currently a venture partner with Deep Sciences Ventures and serves on the board of Lotus Microsystems, ApS, Xonia Ltd., HyperCIM Ltd. Dr. Lotfi previously served as Vice President and a Fellow at Intel Corporation. Prior to Intel, he was Power Chief Technology Officer for Altera Corporation serving its Enpirion Power Business as well as the broader Field Programmable Gate Array community. Altera was acquired by Intel in 2015. Prior to Altera, he served as President and Chief Executive Officer of Enpirion, Inc., which he founded in 2002.

From Enpirion’s inception, Dr. Lotfi led its strategic direction with a unique industry-first vision to create the ultimate power converter-on-chip creating ubiquitous DC-DC conversion at the silicon level. In 2013, he led Enpirion’s merger into Altera to realize his vision of highly integrated power management closely coupled to leading-edge digital silicon loads. Prior to founding Enpirion, he was Director of Advanced Power Research at Bell Laboratories.

Dr. Lotfi has a B.S. in Electrical Engineering from Cairo University and an M.S. and PhD. in Electrical Engineering from Virginia Tech.

Dr. Lotfi currently serves on the boards of Lotus Microsystems ApS, Xonai Ltd., HyperCIM Ltd. and his extensive experience in high power electronics provide a valuable resource to the Board of Directors and Executive Management.

43

Debra Wasser

Ms. Wasser currently serves as Vice President of Investor Relations and ESG Engagement for Etsy, Inc. (Nasdaq: ETSY), the global marketplace for unique and creative goods. She is responsible for Etsy’s external shareholder relationships, with a focus on corporate and financial reporting, driving increased analyst coverage and investor connectivity, effective corporate messaging, strategic investor targeting, and elevating the company’s ESG messaging with the financial community. Ms. Wasser has led investor and broad internal and external communications strategies on multiple financial transactions and offerings, and a host of product and technology launches and marketing initiatives.

Prior to joining Etsy in April 2018, Ms. Wasser led Edelman’s Investor Relations practice in the U.S., and advised boards of directors and senior managements of public companies on strategic communications including investor relations, financial and corporate public relations, transaction communications, crisis communications and leadership positioning.

Prior to joining Edelman in 2015, Ms. Wasser was Senior Vice President, Investor Relations & Corporate Communications for Veeco Instruments, Inc. (Nasdaq: VECO) for over 15 years. While at Veeco, Ms. Wasser created and implemented a global investor relations program to raise visibility and deepen ownership to reflect business trends. She led effective communications strategy through positive periods of growth, over a dozen merger and acquisition transactions, a highly successful secondary equity offering, and new market opportunities.

Prior to joining Veeco, Ms. Wasser was Vice President of Dewe Rogerson Inc. where she ran the firm’s U.S. investor relations client base, focused on healthcare/biotech, high-tech, consumer products, financial services, publishing, and general industry. During her tenure at the firm, Ms. Wasser serviced clients across the globe and helped grow the firm from four to 80 employees. Debra has a B.S. in Communications and Business from The State University of New York at Albany.

Ms. Wasser has provided business and communications advice to Boards of Directors of publicly traded and privately held companies for over three decades. She has served on the Board of Directors of NIRI, the Association of Investor Relations Professionals, including the maximum service of four years on the National Chapter Board, as well as earlier as a Board member of the organizations New York Chapter.

Raymond A. Nielsen

Raymond A. Nielsen was appointed a member of the Board of Directors on October 5, 2016. Mr. Nielsen was the Director of Finance for The Beechwood Organization until January 2019 and had been responsible for Project and Corporate Finance including Strategic Planning Initiatives since 2014. He has been a member of the Board of Directors of Dime Community Bank since its merger on February 1, 2021 with Bridge Bancorp Inc. In addition, he is Chairman of the Credit Risk Committee and a member of the Audit and Compliance Committees. Prior to the merger, he was a member of the Board of Directors of Bridgehampton National Bank and Bridge Bancorp Inc., its Parent holding company since 2013, and served on the Audit Committee, Compensation Committee, Corporate Governance & Nominating Committee, as well as on the ALCO and Loan Committees and the Compliance BSA & CRA Committee. Mr. Nielsen also served as a Director of North Fork Bancorporation and its subsidiary North Fork Bank from 2000 to 2006 where he chaired both the Compensation Committee and Audit Committee as well as having served as Lead Independent Director. Mr. Nielsen is the former CEO of Reliance Federal Savings Bank and Herald National Bank, and a 45-year veteran of the banking industry. Mr. Nielsen’s extensive public company, banking and real estate development experience provides a valuable resource to the Board of Directors and Executive Management.

44

Dr. Robert M. Brill

Dr. Brill was appointed a Director of the Company on March 5, 2021. Dr. Brill was co-founder and managing partner of Newlight Management from 1997 to 2019, which managed venture capital funds that focused on early-stage technology companies. Prior to co-founding Newlight, Dr. Brill was a general partner of Poly Ventures, a Long Island based venture capital fund. Dr. Brill is a member of the Board of Directors of the Long Island Angel Network and one private company. Dr. Brill has also previously served on the Board of Directors of multiple public and private companies. Dr. Brill has been the CEO of both public and private companies. Dr. Brill served as General Manager of Harris Corporation’s CMOS Semiconductor Division. He also held various technical and management positions at IBM’s semiconductor operation. Dr. Brill holds a Ph.D. in nuclear physics from Brown University and a B.A. and a B.S. in Engineering Physics from Lehigh University. Dr. Brill had previously served on the Company’s Board from April 2018 until October 2019.

Richard A. Catalano

Richard Catalano was appointed as the Company’s Vice President and Chief Financial Officer effective as of August 30, 2022. Mr. Catalano began his career at KPMG LLP and became an audit partner in 1993. Throughout his over 35 years as an audit professional at KPMG LLP, Mr. Catalano advised a diverse array of clients through private equity financed transactions, merger-related accounting, and filings with the U.S. Securities and Exchange Commission. Towards the later part of his tenure, Mr. Catalano served as the leader of KPMG LLP’s Metro New York Healthcare and Life Sciences Practice and then co-led KPMG’s Global Audit Methodology Group. Mr. Catalano is a Certified Public Accountant in New York State and received a Bachelor of Business Administration in accounting from Hofstra University.

Kevin R. Collins

Prior to his appointment as Vice President and General Manager of SDC, Mr. Collins served as the General Manager of SDC since 1999. From 1990 to 1999 he was employed by Stainless Design Corp. as Manager of Field Operations and Product Development Advisor. Mr. Collins attended Columbia University School of Engineering and Applied Science.

45

Jeffrey A. Brogan

Dr. Jeffrey Brogan was appointed as Vice President Sales and Marketing for the Company on March 23, 2021. Previously he was Director of Sales and Marketing for CVD Materials Corporation since November 2017 with General Management responsibilities of CVD MesoScribe Technologies Corporation. Dr. Brogan served as the President and CEO of MesoScribe Technologies, Inc., spearheading its sale to CVD in 2017. He has over 20 years of experience in strategic sales and marketing, technology management, and advanced research & development. Dr. Brogan has led the development of innovative sensor products, transitioning high performance products to manufacturing using the Company’s Direct Write MesoPlasma™ printing technology. He received his PhD in Materials Science and Engineering from Stony Brook University in 1996.

Maxim S. Shatalov

Dr. Shatalov was appointed Vice President of Engineering and Technology in April 2018. Prior to CVD, Mr. Shatalov was employed by Sensor Electronic Technology Inc. (SETi) a LED company where he held multiple technical and management positions from 2006 thru 2018. In 2017, Dr. Shatalov became Vice President of Technology responsible for UV LED technology and LED application development at SETi. Dr. Shatalov has over twenty years of experience in semiconductor research and devices and holds more than 12 U.S. patents.

Warren D. Cheesman

Warren Cheesman was appointed Vice President of Manufacturing Operations in October 2022. He has over 25 years of management experience in the semiconductor, medical device and defense equipment sectors. Mr. Cheesman has held roles of increasing responsibility in engineering, operations, quality and strategic sourcing, at equipment manufacturers including Veeco Instruments, Air Techniques, and Kongsberg Defense & Aerospace. Mr. Cheesman provides strategic leadership across all divisions related to manufacturing, quality, and continuous improvement initiatives, with emphasis on process improvement, lean manufacturing, risk management, and collaboration. He holds two master of science degrees from Stony Brook University in Technology Management and Materials Science & Engineering, and a Bachelor of Science degree in Mechanical Engineering from Virginia Tech. His academic and professional experience is also complemented by a Six Sigma Black Belt certification.

Code Ofof Ethics

We have adopted a Corporate Code of Conduct and Ethics that applies to our employees, senior management and Board of Directors, including the Chief Executive Officer and Chief Financial Officer. The Corporate Code of Conduct and Ethics is available on our website,http://www.cvdequipment.com, by clicking on “About Us” and then clicking on “Corporate Overview.“Governance.

46

Audit Committee

Our Board of Directors has an Audit Committee that currently consists of Lawrence J. Waldman, Chairman, Raymond A. Nielsen, Robert M. Brill, Debra Wasser (effective July 13, 2023), Ashraf Lotfi (effective August 18, 2023) and Conrad J. Gunther Lawrence J. Waldman and Raymond A. Nielsen.(until July 13, 2023). During the fiscal year ended December 31, 2016,2023, the Audit Committee held four meetings. Pursuant to the Audit Committee Charter, the Audit Committee is directly responsible for the appointment, compensation, retention and oversight of the work of any independent registered public accounting firm engaged for the purpose of preparing or issuing an audit report or performing other audit, review or attest services for us, and each such independent auditor shall report directly to the Committee. The Audit Committee also reviews with management and the independent auditors, our annual audited financial statements (including the disclosures under “Management’s Discussion and Analysis of Financial Condition and Results of Operations”), the scope and results of annual audits and the audit and non-audit fees of the independent registered public accounting firm. Furthermore, the Audit Committee reviews the adequacy of our internal control procedures, the structure of our financial organizationMessrs. Waldman, Gunther, Nielsen and the implementation of our financialBrill and accounting policies. Messrs. Gunther, Waldman and NielsenMs. Wasser are “independent” under the requirements of the NASDAQ Stock Market.

The Board of Directors has determined that each of Messrs. Gunther andMr. Waldman is an “audit committee financial expert” as that term is defined in the rules and regulations of the Securities and Exchange Commission.

Section 16(a) Beneficial Ownership Reporting Compliance

The rules of the Securities and Exchange Commission require us to disclose late filings of reports of stock ownership and changes in stock ownership by our directors, officers and ten percent shareholders. To our knowledge, based solely on our review of (a) the copies of such reports and amendments thereto furnished to us and (b) written representations that no other reports were required, during our fiscal year ended December 31, 2016,2023, all of the filings for our officers, directors and ten percent shareholders were made on a timely basis, with the following exceptions: Lawrence Firestone,exception of: (i) a former directordelinquent Form 4 disclosing a single transaction for each of the Company, filed two late Form4’s; Bruce Swan,Mr. Lakios, Mr. Catalano, Dr. Brogan, Dr. Shatalov, Mr. Collins, and Mr. Cheesman; and (ii) a former director of the Company, filed two latedelinquent Form 4’s; Conrad Gunther filed two late Form 4’s; Lawrence Waldman filed4 disclosing one late Form 3; and Raymond A. Nielsen file one late Form 3.transaction for Mr. Africk.


Item 11.Executive Compensation.

Item 11.     Executive Compensation.

Summary Compensation Table

The following table sets forth the compensation of our chief executive officer and chief financial officer, and our “named executive officers,” for the years ended December 31, 20162023 and 2015.2022.

Name and
principal position

Year

 

Salary ($)

  

Bonus ($)

  

Option

Awards ($)

  

Stock

Awards ($)

  

All Other Compensation

  

Total ($)

 
            (1)    (1)          
                          

Leonard A. Rosenbaum

2016

  302,742   20,000   -   37,949   -   360,691 

President and ChiefExecutive Officer

2015  302,742   -   -       -   302,742 
                          

Glen R. Charles

2016

  163,942   15,000   -   28,469       192,411 
Secretary and Chief Financial Officer2015  163,942   -   -   -       163,942 
                          

Steven Aragon

2016

  193,462   15,000       53,469       218,459 

Chief Operating Officer

2015

  193,462       -   24,997       218,459 
                          

Martin J. Teitelbaum

2016

  266,126   15,000   -   28,469       309,595 

General Counsel andAssistant Secretary

2015

  261,968   -   -   48,040       310,008 

Name and principal position 

Year

  

Salary ($)

  

 

Bonus ($) (1)

  Option Awards ($) (2)  Stock Awards ($) (2)  All Other Compensation ($) (3)  

 

Total ($)

 
Emmanuel Lakios                            
President and Chief Executive  2023   388,600   -   699,990   -   19,522   1,108,112 
Officer  2022   316,800   191,600   236,704   -   13,830   758,934 
                             
Richard Catalano (4)                            
Secretary, Chief Financial  2023   274,700   -   233,330   -   27,201   533,231 
Officer and Executive Vice President  2022   80,769   31,250   68,151   -   288   180,458 
                             
Thomas McNeill (5)                            
Secretary, Chief Financial Officer  2023   -   -   -   -   -     
and Executive Vice President  2022   187,425   29,988   -   -   137,689   355,102 
                             
Jeffrey A. Brogan Vice  2023   203,300   -   139,998   -   7,863   351,161 
President Sales & Marketing  2022   196,000   58,800   47,341   -   3,053   305,194 

47

(1)

Amounts shown do not reflect compensation actually received byReflects cash bonuses under the named executiveofficer. Instead,Company’s Management Bonus Plan. Bonuses listed for a particular year represents amounts earned with respect to such year even though all or part of such amounts have been paid during the amounts shown reflect the total remaining compensation on restricted stock and option awards granted, that have not previously been shown, as determined pursuant to ASC 718. The assumptions used to calculate the value of stock and option awards are set forth under Note 11 of the Notes to Consolidated Financial Statements. This column representsfollowing year.

(2)These columns represent the grant date fair value of the stock awards as calculated in accordance with FASB ASC 718 (Stock Compensation). Pursuant to SEC rule changes effective February 28, 2010, we are required to reflect the total grant date fair values of the option grantsThe stock options granted in the2022 and 2023 vest 25% per year of grant, rather than the portion of this amount that was recognized for financial statement reporting purposes inover four years and have a given fiscal year which was required under the prior SEC rules, resulting in a change to the amounts reported in prior Annual Reports, which was valued utilizing the grant date fair value in the year granted.

ten-year life.


(3)All other compensation consists of 1) 401(k) match in 2023 and 2022 of $9,900 and $8,895 for Emmanuel Lakios, $9,179 and $288 for Richard Catalano, $0 and $4,094 for Thomas McNeill and $7,863 and $3,053 for Jeffrey Brogan, respectively; 2) severance in 2022 of $104,125 and accrued and used vacation time in 2022 of $29,470 for Thomas McNeill; and 3) health insurance premiums in 2023 and 2022 of 9,622 and $8,895 for Emmanuel Lakios and $18,022 and $0 for Richard Catalano.

(4)Effective August 30, 2022, Richard Catalano was appointed Vice President and Chief Financial Officer.

(5)Effective August 30, 2022, Thomas McNeill resigned as Executive Vice President and Chief Financial Officer.

Employment Agreements and Potential Payments Upon Termination or Change in Control

ThereEmmanuel Lakios Employment Agreement

On June 1, 2021, the Company entered into an Employment Agreement with Emmanuel Lakios, the Company’s President and Chief Executive Officer (the “Lakios Agreement”). The term of Mr. Lakios’s employment under the Lakios Agreement commenced as of the effective date thereof and shall continue until terminated in accordance with the terms of the Lakios Agreement. Under the Lakios Agreement, Mr. Lakios will receive an initial annual base salary of $288,000, which shall be reviewed from time to time and may be increased, but not decreased, by the Compensation Committee of the Board of Directors (the “Committee”) in its sole and exclusive discretion. Mr. Lakios shall be entitled to participate in any bonus or incentive plan available to the Company’s senior executives generally, on such terms as the Committee may determine in its discretion.

In the event of the termination of the Lakios Agreement and Mr. Lakios’s employment thereunder, Mr. Lakios or his estate (in the event of his death) shall be entitled to (A) receive any unpaid base salary earned and accrued under the Lakios Agreement prior to the date of termination (and reimbursement for expenses incurred prior to the date of termination), (B) indemnification in accordance with any applicable indemnification plan, program, corporate governance document or other arrangement, and any vested rights pursuant to any insurance plan, benefit plan or retirement plan, and, except in the event of Mr. Lakios’s termination by the Company for Cause (as defined in the Lakios Agreement, (C) treatment of his stock option grants in accordance with the terms of the applicable plan and award agreement.

48

In the event Mr. Lakios’s employment is terminated as a result of death or disability, Mr. Lakios shall also be entitled to receive a pro rata bonus payment under the Company’s bonus Plan for the year of termination, if applicable.

In the event Mr. Lakios’s employment is terminated by the Company for Cause, Mr. Lakios’s stock option grants, whether vested or unvested, shall immediately terminate and be null and void.

In the event Mr. Lakios’s employment is terminated by the Company without Cause, or by Mr. Lakios for Good Reason (as defined in the Lakios Agreement), Mr. Lakios shall also be entitled to (A) a pro rata bonus for the year of termination, and (B) continued payment of his base salary and the Company’s portion of Mr. Lakios’s then existing medical benefits for the nine (9) month period following the date of termination.

The Lakios Agreement contains customary non-competition, non-solicitation, and confidentiality provisions in favor of the Company.

Other then as set forth above, there are no arrangements for compensation of directors or Named Executive Officers and there are no employment contracts between the companyCompany and its directors or any change in control arrangements.

Outstanding Equity Awards atDecember 31, 20162023

The following table sets forth the outstanding equity awards held by our named executive officers as of December 31, 2016.2023.

              

OPTION

AWARDS

  

STOCK AWARDS

 
  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

 

Name

 

 

Number of

Securities

Underlying

Options

Exercisable

(#)

  

 

Number of

Securities

Options

Unexercisable

(#)

  

Exercise

Price

($)

  

Option

Expiration

Date

  

Number of

shares or

units of stock

that have not

Vested

(#)

  

Market

Value of

shares or

units of stock

that have not

Vested

($)

  

Equity Incentive

Plan Awards:

Number of

unearned shares

or units that have

not vested

(#)

  

Equity Incentive

Plan Awards:

Market or payout

value of

unearned shares

or units

that have

not vested

($)

 
                                 

Leonard ARosenbaum

  24,000   -   3.65  

12/12/2017

   -   -   4,347 (1)   37,732 

 

                                
                                 

Steven Aragon

  100,000   100,000   11.17   Various (6)           3,261 (2)  28,305 
                                 

Glen R. Charles

  -   -   -   -   -   -   6,811 (3)  59,119 
                           3,261 (2)  28,305 
                                 

Karlheinz Strobl

  -   -   -   -   -   -   6,009 (4)  52,158 
                           2,826 (5)  24,530 
                                 

Martin J.Teitelbaum

  -   -   -  

12/12/2017

   4,000   40,320   3,261 (2)  28,305 

 

  5,310   -   4.25  

1/15/2020

   -   -   -   - 
   1,400   -   7.90  

1/15/2021

   -   -   -   - 

  OPTION AWARDS  STOCK AWARDS 
Name Number of Securities Underlying Options Exercisable  Number of Securities Options Unexercisable  Exercise Price  Option Expiration Date Number of shares or units of stock that have not vested  Market value of shares or units of stock that have not vested  Equity Incentive Plan Awards: Number of unearned shares or units that not vested  Equity Incentive Plan Awards: Market or payout value of unearned shares or units that have not vested 
Emmanuel Lakios  -   100,000  $14.11   3/23/2033  -   -   -  $- 
   18,750   56,250  $5.02  8/17/2032                
   50,000   50,000  $4.26  6/1/2023                
   100,000   -  $10.30   2/6/2027  -   -         
Richard Catalano  -   25,000  $14.11   3/23/2033  -   -   -  $- 
   5,000   15,000  $5.42  8/30/2032                
                               
Jeffrey A. Brogan  -   15,000  $14.11  3/23/2033  -   -   -  $- 
   3,750   11,250  $5.02  8/17/2032                
   10,000   10,000  $4.01  7/15/2021                
   20,000   -  $11.61  10/31/2027                

49

 

(1)

Restricted stock units vest as to 1,449 shares respectively each July 1, 2017 through 2019.

(2)

Restricted stock units vest as to 1,087 shares respectively each July 1, 2017 through 2019.

(3)

Restricted stock units vest as to 3,205 shares and 3,606 shares respectively each on November 15, 2017 and November 15, 2018.

(4)

Restricted stock units vest as to 2,804 shares and 3,205 shares respectively each on November 15, 2017 and November 15, 2018.

(5)

Restricted stock units vest as to 942 shares respectively each July1, 2017 through 2019.

(6)

Options vest as to 20,000 shares on October 20 each year consecutively through 2019 and expire 10 years from date of issuance.

20162023 Director Compensation

The following table sets forth a summary of the compensation we paid to our non-employee directors in 2016.2023.

Name

 

Fees Earned or

Paid in Cash

  

Option Awards (1)

  

Restricted Stock

Awards (1)

  

Total

  

Fees Earned or

Paid in Cash

  Option Awards Restricted Stock Awards  

 

Total

 

Conrad J. Gunther

  23,000   -   30,991   53,991 

Bruce T. Swan (2)

  15,000   -   22,728   37,728 

Kelly S. Walters (3)

  20,000   -   30,991   50,991 

Lawrence D. Firestone (4)

  15,000   -   22,728   37,728 
         

Lawrence J. Waldman

  5,000   -   7,227   12,227  $113,000   -  $40,000  $153,000 

Raymond A. Nielsen

  5,000   -   7,227   12,227   50,000   -   40,000   90,000 
Robert M. Brill  50,000   -   40,000   90,000 
Debra Wasser  18,696   -   40,000   38,696 
Ashraf Lotfi  14,783   -   14,783   29,566 
Conrad J. Gunther  26,766   -   20,000   46,766 

(1)

Amounts shown do not necessarily reflect compensation actually received by the named director. Instead, the amounts shown are the compensation costs recognized by CVD in fiscal 2016 for awards as determined pursuant to ASC 718. The assumptions used to calculate the value of option awards are set forth under Note 12 of the Notes to Consolidated Financial Statements.

(2)

On August 27, 2016, Bruce T. Swan notified the Board of Directors of his retirement effective September 30, 2016

(3)

On October 5, 2016, Kelly S. Walters notified the Board of Directors that would not run for re-election at the next Annual Meeting of Shareholders held on December 9, 2016.

(4)

Lawrence D. Firestone resigned as a director effective October 5, 2016.

At a meetingOn October 11, 2021, the Board of Directors, following the unanimous recommendation of the Stock Option andBoard’s Compensation Committee, on November 19, 2008,unanimously approved a director compensation plan, was adopted applicableeffective October 1, 2021 (the “Plan”). The Plan is based on the recommendations of an independent compensation consultant engaged by the Board’s Compensation Committee. Pursuant to all nonemployee directors, providing for annual compensationthe Plan, each director is entitled to Director Compensation, divided into the following pay components: (i) Annual Board Cash Compensation in the sumamount of approximately forty thousand dollars ($40,000)$40,000 and (ii) an Annual Equity Retainer in the amount of $40,000, to be payableautomatically granted on the date of the Company’s annual meeting of shareholders. Additionally, a director serving as a chairman for the Board’s Compensation Committee, Nominating & Governance Committee, or Strategic Planning Committee is entitled to eachChair Compensation in the amount of $10,000. The director serving as the chairman for the Board’s Audit Committee is entitled to Chair Compensation in a combinationthe amount of cash, restricted stock grant and stock options. In 2011,$25,000. Furthermore, the Committee amendeddirector serving as the annual compensationNon-Executive Chairman is entitled to Board Leadership Compensation in the amount of non-employee directors beginning in 2012 to include a combination of a cash and stock grant. On May 9, 2016, the Board of Directors adopted a Director Compensation Plan for all non-employee directors, which retroactively from January 1, 2016, provided for annual compensation of approximately fifty thousand dollars ($50,000) to each non-employee director in a combination of 40% cash and 60% stock grant.$48,000.


Item 12.

Security Ownership of Certain Beneficial Owners and Management andRelated StockStockholder Matters.holder Matters.

The following table sets forth, as of March 22, 2017,25, 2024, information regarding the beneficial ownership of our common stock by (a) each person who is known to us to be the owner of more than five percent (5%) of our common stock, (b) each of our directors, (c) each of the named executive officers, and (d) all directors and executive officers and executive employees as a group. For purposes of the table, a person or group of persons is deemed to have beneficial ownership of any shares that such person has the right to acquire within 60 days of March 22, 2017.25, 2024.

Name and Address of Beneficial Owner(1)

 

Amounts and Nature of

Beneficial Ownership (2)

  

Percent of

Class (%)

 
         

Leonard A. Rosenbaum

  821,870 (3)   13.3 

Martin J. Teitelbaum

  79,046 (4)   1.3 

Conrad J. Gunther

  59,963 (5)   * 

Lawrence J. Waldman

  1,675 (6)   * 

Raymond A. Nielsen

  1,675 (6)   * 

Glen R. Charles

  17,685 (7)   * 

Steven Aragon

  43,976 (8)   * 

Karlheinz Strobl

  117,233 (9)   1.9 

William S. Linss

  9,819 (10)   * 

Kevin R. Collins

  66,814 (11)   1.0 

All directors and executive officers and executive employees as a group (ten (10) persons)

  1,204,606   19.4 

Name and Address of Beneficial Owner (1) Amounts and Nature of Beneficial Ownership (2)  Percent of Class (%) 
       
Andrew Africk / ADA Partners LP
Leviticus Partners, L.P.
  

1,076,834

660,000

   

15.9

9.7

 
Emmanuel Lakios  200,108(3)  3.0 
Kevin R. Collins  92,437(3)  1.4 
Lawrence J. Waldman  70,288(4)  1.0 
Raymond A. Nielsen  61,588(4)  * 
Jeffrey A. Brogan  42,019(3)  * 
Robert M. Brill  23,073(4)  * 
Maxim Shatalov  17,500(3)  * 
Richard Catalano  11,250(3)  * 
Warren Cheesman  7,500(3)  * 
Ashraf Lotfi  4,514(4)  * 
Debra Wasser  4,373(4)  * 
 All directors and executive officers and executive employees as a group (nine persons)  534,650   7.9 

*Less than 1% of the outstanding common stock or less than 1% of the voting power

(1)

(1)

The address of Messrs. Rosenbaum, Teitelbaum, Gunther,Lakios, Waldman, Nielsen, Charles, Strobl, Linss, CollinsBrogan, Brill, Shatalov, Catalano, Cheesman. Lotfi and AragonMs. Wasser is c/o CVD Equipment Corporation, 355 South Technology Drive, Central Islip, New York 11722.

The address of Mr. Collins is c/o Stainless Design Concepts, 1117 Old Kings Highway, Saugerties, NY 12477. The address of Andrew Africk / ADA Partners is c/o Searay Capital, 111 West 67th Street, New York, NY 10023. The address of Leviticus Partners, L.P. is 200 Park Avenue, Suite 1700, New York, NY 10166.

50
 

(2)
(2)All of such shares are owned directly with sole voting and investment power, unless otherwise noted below.
(3)Includes options to purchase 24,000 shares of our common stock. Does not include 4,347 shares of unvested restricted stock units.

(3)

(4)

Includes 2,000 shares held by Mr. Teitelbaum’s wife as to which beneficial ownership thereof is disclaimed by Mr. Teitelbaum. Also includes options to purchase 6,710 shares of our common stock. Does not include 3,261 shares of unvested restricted common stock units.

(5)

Includes options to purchase 18,110 shares of our common stock. Does not include 2,325 shares of unvested restricted common stock.


(6)

 Does not include 2,325 shares of unvested restricted common stock.

(7)

 Does not include 10,072 shares of unvested restricted common stock units.

(8)

Does not include unvested options to purchase 60,000the following shares of our common stock. stock: Lakios – 181,250; Collins – 27,500; Brogan – 32,500; Shatalov – 32,500; Catalano – 33,750; and Cheesman – 22,500

(4)Does not include 3,261unvested restricted shares of our common stock: Waldman – 1,458; Nielsen – 1,458; Brill – 1,458; Lotfi – 1,822 and Wasser – 1,438

Does not include shares to be issued per Director compensation agreement related to the Annual Equity Retainer in the amount of $40,000, to be determined at the 2024 Annual Meeting of Shareholders.

Equity Compensation Plan Information Table

The following table provides information about shares of our common stock that may be issued upon the exercise of options under all of our existing compensation plans as of December 31, 2023.

  Number of securities to be issued upon exercise of outstanding options, warrants and rights (1)  Weighted-average exercise price of outstanding options, warrants and rights (2)  Number of securities remaining available for future issuance 

Plan Category

            
Equity compensation plans approved by security holders
  846,875  $8.20   335,375 
Equity compensation plans not approved by security holders     

N/A

    
             
Total  846,875  $8.20   335,375 

(1)Reflects aggregate options outstanding under our 2007 Share Incentive Plan, 2016 Equity Incentive Plan and 2022 Equity Incentive Plan.
(2)Calculation is exclusive of the value of any unvested restricted common stock units.

awards.

(9)

 Does not include 8,835 shares of unvested restricted common stock units.

(10)

 Does not include 16,150 shares of unvested restricted common stock units.

(11)

 Does not include 10,723 shares of unvested restricted common stock units.

See Item 5, Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities under the heading “Equity Compensation Plan Information” for information regarding our securities authorized for issuance under equity compensation plans.

Item 13.Certain Relationships and Related Transactions, and Director Independence.

Item 13.     Certain Relationships and Related Transactions, and Director Independence.

Transactions with related persons, promoters and certain control persons.

None.

Director Independence

The current members of our Board of Directors are Leonard A. Rosenbaum, Martin J. Teitelbaum, Conrad J. Gunther, Lawrence J. Waldman, andEmmanuel Lakios, Raymond A. Nielsen.Nielsen, Robert M. Brill, Debra Wasser and Ashraf Lotfi. Messrs. Gunther, Waldman, Nielsen, Brill and NielsenLotfi and Ms. Wasser have been determined to be “independent” as defined under Rule 4200 of the Nasdaq Stock Market.

51

Item 14.Principal Accountant Fees and Services.

Item 14.     Principal Accountant Fees and Services.

The following presents fees for professional audit services rendered by MSPC,Marcum, LLP, Certified Public Accountants, and Advisors, A Professional Corporation (“MSPC”), for the audit of our financial statementsCompany’s independent registered public accounting firm for the years ended December 31, 20162023 and December 31, 2015.2022.

  

Year Ended

  

Year Ended

 
  

December 31, 2016

  

December 31, 2015

 

Audit Fees

 $132,000  $132,000 

Audit-Related Fees (1)

  10,000   10,000 

Tax Fees

  --   -- 

All Other Fees

  --   -- 

Total Fees

 $142,000  $142,000 
  2023  2022 
       
Audit fees $198,275  $181,500 
Audit-related fees  55,002   20,500 
All other fees  -   - 
Total fees $253,277  $202,000 

Audit-RelatedAudit Fees

Audit-relatedAudit fees consisted of the review of the first three quarters and audit of the year-end.

Audit-related Fees

Consisted of the audit of the Company’s Defined Contribution Plandefined contribution 401(k) for the years 2016plan and 2015 by MSPC.fees associated with registration statements and comfort letter.

Tax Fees

Tax fees consisted of the preparation of the tax returns by Baker, Tilley, Virchow Krause, LLP. The aggregate fees billed in 2016 were $20,000. The aggregate fees billed in 2015 were $19,500.

All Other Fees

We did not incur any other fees in 2016. In 2015, the firm of Baker, Tilley, Virchow and Krause, LLP was retained to prepare a comprehensive appraisal report to determine the fair value of certain stock options granted to an officer of the corporation for a fee of $10,000.

Audit Committee Approval

The engagement of the Company’s independent registered public accounting firm is pre-approved by the Company’s Audit Committee. The Audit Committee pre-approves all fees billed and all services rendered by the Company’s independent registered public accounting firm.

52

PART IV

Item 15.Exhibits, Financial Statement Schedules

Item 15.     Exhibits, Financial Statement Schedules

3.1

Certificate of Incorporation dated October 12, 1982 of Certificate of Corporation incorporated(Incorporated herein by reference to Exhibit 3.1 to ourthe Company’s Form S-1 filed on July 3, 2007.

2007).

3.2

3.2Certificate of Amendment of Certificate of Corporation, dated April 25, 1985 of Certificate of Corporation incorporated(Incorporated herein by reference to Exhibit 3.1 to ourthe Company’s Form S-1 filed on July 3, 2007.

2007).

3.3

3.3Certificate of Amendment of Certificate of Corporation, dated August 12, 1985 of Certificate of Corporation incorporated(Incorporated herein by reference to Exhibit 3.1 to ourthe Company’s Form S-1 filed on July 3, 2007.

2007).

3.4

3.4Certificate of Amendment of the Certificate of Incorporation, dated December 9, 2016 incorporated(Incorporated herein by reference to Exhibit 3.1 on ourthe Company’s Current Report on Form 8-K filed on December 14, 2016.

2016).

3.5

Bylaws of CVD Equipment Corporation, incorporated herein by reference to Exhibit 3.2 to our Form S-1 filed on July 3, 2007.

3.6

3.5

Amended and restated By-laws of CVD Equipment Corporation, dated as of October 5, 2016 incorporated(Incorporated herein by reference to Exhibit 3.5 to ourthe Company’s Current Report on Form 8-K filed on October 11, 2016.

2016).

10.1

Form

4.1Description of Non-Qualified Stock Option Agreement with certain directors, officers and employees of CVD Equipment Corporation incorporatedthe Company’s Securities (Incorporated herein by reference to our Registration Statementthe Company’s Annual Report on Form S-8 No. 33-30501, filed August 15, 1989.*

10.2

Purchase Agreement relating to a 22,000 square foot facility from Kidco Realty incorporated herein by reference to our Form 8-K filed on December 31, 1998.

10.3

CVD Equipment Corporation 2001 Stock Option Plan incorporated herein by reference to Exhibit 3.1 to our Form S-1 filed on July 3, 2007.*

10.4

Form of Non-Qualified Stock Option Agreement incorporated herein by reference to Exhibit 3.1 to our Form 10-KSB10-K filed on March 26, 2007.*

30, 2020).

10.5

1989 Key Employee Stock Option Plan incorporated herein by reference to Amendment No. 1 to our Form S-1 filed on August 7, 2007.

10.6

10.1

CVD Equipment Corporation 2007 Share Incentive Plan incorporated herein by reference to our Schedule 14A filed November 5, 2007.

10.7

Lease Agreement, dated February 9, 2012, by and between FAE Holdings 411519R, LLC and the Company incorporated(Incorporated by reference from the Company’s Report on Form 10-Q filed with the Commission on May 15, 2012.

2012).

10.8

10.2Assignment Agreement, dated February 9, 2012, by and between FAE Holdings 411519R, LLC and the Company incorporated(Incorporated by reference from the Company’s Report on Form 10-Q filed with the Commission on May 15, 2012.

2012).


10.9

Qualified Exchange Accommodation Agreement, dated February 9, 2012, by and between FAE Holdings 411519R, LLC and the Company incorporated by reference from the Company’s Report on Form 10-Q filed with the Commission on May 15, 2012.

10.10

10.3

Joint and Several Hazardous Material Guaranty and Indemnification Agreement, dated March 15, 2012, by and between FAE Holdings 411519R, LLC and the Company incorporated(Incorporated by reference from the Company’s Report on Form 10-Q filed with the Commission on May 15, 2012.

2012).

10.11

Assignment

10.4Guaranty of Leases and Rents,Payment, dated March 15, 2012, by and among FAE Holdings 411519R, LLC, the Town of Islip Industrial Development Agency and HSBC Bank USA, National Association incorporatedCompany (Incorporated by reference from the Company’s Report on Form 10-Q filed with the Commission on May 15, 2012.

2012).

10.12

Amended

10.5Agreement to Purchase and Restated FeeSale, the building and Leasehold Mortgage,real estate property located at 555 N Research Place, Central Islip, NY, dated March 15, 2012,29, 2021, by and among FAE Holdings 411519R, LLC,between 555 N Research Corporation, a wholly-owned subsidiary of the Town of Islip Industrial Development AgencyCompany, and HSBC Bank USA, National Association incorporatedSteel K, LLC. (Incorporated by reference fromto the Company’s Quarterly Report on Form 10-Q filed with the Commission on May 15, 2012.

13, 2021).

10.13

Amended and Restated Note,

10.6Employment Agreement, dated March 15, 2012,June 1, 2021, by and among FAE Holdings 411519R, LLC,between Emmanuel Lakios, the Town of Islip Industrial Development AgencyCompany’s President and HSBC Bank USA, National Association incorporatedChief Executive Officer, and the Company. (Incorporated by reference fromto the Company’s Quarterly Report on Form 10-Q filed with the Commission on May 15, 2012.

August 16, 2021).

10.14

Note and Mortgage Assumption

10.7Employment Agreement, dated March 15, 2012,June 1, 2021, by and among FAE Holdings 411519R, LLC,between Thomas McNeill, the Town of Islip Industrial Development AgencyCompany’s Executive Vice President and HSBC Bank USA, National Association incorporatedChief Financial Officer, and the Company. (Incorporated by reference fromto the Company’s Quarterly Report on Form 10-Q filed with the Commission on May 15, 2012.

August 16, 2021).

53

10.15

10.8

Guaranty

Assignment, Assumption and Amendment Agreement dated as of Payment, dated March 15, 2012,July 26, 2021, by the Company incorporatedand between Town of Islip Industrial Development Agency, 555N Research Corporation and Steel 555 NRP, LLC. (Incorporated by reference fromto the Company’s Quarterly Report on Form 10-Q10-Q/A filed with the Commission on May 15, 2012.

March 1, 2022).

10.16

Credit

10.9Second Amended and Restated Lease and Project Agreement, dated August 5, 2011,as of July 1, 2021, by and between CVD Equipment CorporationTown of Islip Industrial Development Agency and HSBC Bank, USA, National Association incorporated by reference to our Report on form 10-Q filed on November 14, 2011.

10.17

Contract of Sale, dated May 31, 2012, between CVD Equipment Corporation and Glomel LLC incorporated by reference to our Report on Form 10-Q filed on August 14, 2012.

10.18

Amendment No. 3 and waiver to Credit Agreement dated September 4, 2015 incorporatedFAE HOLDINGS 411519R, LLC. (Incorporated by reference to the Company’s CurrentQuarterly Report on Form 8-K10-Q/A filed with the Commission on September 10, 2015.

March 1, 2022).

21.1

10.10Agency Compliance Agreement, dated as of July 1, 2021, by and between Town of Islip Industrial Development Agency, CVD Equipment Corporation and CVD Materials Corporation. (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q/A filed with the Commission on March 1, 2022).
10.11Amended and Restated Sublease Agreement, dated as of July 26, 2021, by and between FAE HOLDINGS 411519R, LLC, CVD Equipment Corporation and CVD Materials Corporation. (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q/A filed with the Commission on March 1, 2022).
21.1List of Subsidiaries.

Subsidiaries

23.1

23.1**Consent of MSPC, Certified Public Accountants and Advisors, A Professional Corporation (S-1).


23.2

Consent of MSPC,MARCUM, Certified Public Accountants and Advisors, A Professional Corporation (S-8).

23.3

Consent of MSPC, Certified Public Accountants and Advisors, A Professional Corporation (S-8).

23.4

31.1**

Consent of MSPC, Certified Public Accountants and Advisors, A Professional Corporation (S-3).

31.1

Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer.

31.2

31.2**Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.

32.1

32.1**Section 1350 Certification of Principal Executive Officer.

32.2

32.2**Section 1350 Certification of Principal Financial Officer.

97 **CVD Equipment Corporation Executive Compensation Clawback Policy
101.INS***XBRL Instance
101.SCH***XBRL Taxonomy Extension Schema
101.CAL***XBRL Taxonomy Extension Calculation
101.DEF***XBRL Taxonomy Extension Definition
101.LAB***XBRL Taxonomy Extension Labels
101.PRE***XBRL Taxonomy Extension Presentation

101.INS** XBRL Instance

101.SCH** XBRL Taxonomy Extension Schema

101.CAL** XBRL Taxonomy Extension Calculation

101.DEF** XBRL Taxonomy Extension Definition

101.LAB** XBRL Taxonomy Extension Labels

101.PRE** XBRL Taxonomy Extension Presentation


* Management contract or compensatory plan or arrangement required

** Filed herewith

*** XBRL information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, , as amended, and otherwise is not subject to liability under these sections.

54

SIGNATURES

SIGNATURES

In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

DATE:March 30, 201728, 2024

CVD EQUIPMENT CORPORATION

 

    By: /s/ Leonard A. Rosenbaum

Name: Leonard A. Rosenbaum

CVD EQUIPMENT CORPORATION

By:/s/ Emmanuel Lakios
Name:Emmanuel Lakios
Title:President and Chief Executive Officer

By:

/s/ Glen R. Charles

Richard Catalano

Name: Glen R. Charles

Richard Catalano

Title:

Vice President, Chief Financial Officer and Secretary

 Principal Financial and Accounting Officer

In accordance with the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated below.

NAMEPOSITIONDATE

/s/ Leonard A Rosenbaum

Emmanuel Lakios

President, Chief Executive Officer and Director

March 30, 2017

3/28/2024

Leonard A. Rosenbaum

Emmanuel Lakios

(Principal Executive Officer)

/s/ Lawrence J. WaldmanDirector, Chairman of the Board3/28/2024
Lawrence J. Waldman
/s/ Raymond A. NielsenDirector3/28/2024
Raymond A. Nielsen
/s/ Robert M. BrillDirector3/28/2024
Robert M. Brill

/s/Martin J. Teitelbaum Debra Wasser

Director General Counsel and Assistant Secretary

March 30, 2017

3/28/2024

Martin J. Teitelbaum

Debra Wasser

/s/Conrad J. Gunther Ashraf Lotfi

Director

March 30, 2017

3/28/2024

Conrad J. Gunther

Ashraf Lotfi

55

/s/Lawrence J. Waldman

Director

March 30, 2017

Lawrence J. Waldman

/s/Raymond A. Nielsen

Director

March 30, 2017

Raymond A. Nielsen

 


CVD EQUIPMENT CORPORATION AND SUBSSUBSIDIARiesIDIARies

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

Page No.

No.

Report of Independent Registered Public Accounting Firm

(PCAOB ID Number 688)

F-1

Financial Statements:

Consolidated Balance Sheets as of December 31, 20162023 and 2015

2022

F-2

Consolidated Statements of Operations for the years ended December 31, 20162023 and 2015

2022

F-3

Consolidated Statements of Changes in Stockholders’ Equity for the years ended December 31, 20162023 and 2015

2022

F-4

Consolidated Statements of Cash Flows for the years ended December 31, 20162023 and 2015

2022

F-5

Notes to Consolidated Financial Statements

F-6

56

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Directors and Stockholdersof

CVD Equipment Corporation and Subsidiaries

   Central Islip, New York

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of CVD Equipment Corporation and Subsidiaries (the “Company”) as of December 31, 20162023 and 2015, and2022, the related consolidated statements of operations, changes in stockholders'stockholders’ equity and cash flows for each of the two years in the two-year period ended December 31, 2016. 2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company'sCompany’s management. Our responsibility is to express an opinion on these consolidatedthe Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement.misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included considerationAs part of our audits we are required to obtain an understanding of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’sCompany’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence supportingregarding the amounts and disclosures in the consolidated financial statements, assessingstatements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statement presentation.statements. We believe that our audits provide a reasonable basis for our opinion.

InCritical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Revenue Recognition – Estimated Total Contract Costs

Description of the Matter

As discussed in Notes 2 and 3 to the consolidated financial statements, referredthe Company recognizes revenue from the sale of systems (“System Projects”) over time by using an input method based on costs incurred as it best depicts the Company’s progress toward satisfaction of the performance obligation. Under this method, revenue arising from such contracts is recognized as work is performed based on the ratio of costs incurred to above present fairly,date to the total estimated costs at completion of the performance obligations. The estimation of these costs requires judgment by the Company given the unique product specifications and requirements for contracts related to the design, development, and manufacture of the system. During the year ended December 31, 2023, the Company recognized approximately $18.2 million of revenue recognized over time.

Subjective judgment is required by management in all material respects,determining the consolidated financial positionassumptions in estimating the estimated costs to complete on contracts for which revenue is recognized over time using a cost-to-cost model. Complex auditor judgment was required in evaluating initial cost estimates and expected costs to complete.

How We Addressed the Matter in Our Audit

The primary procedures we performed to address this critical audit matter included the following:

Obtaining an understanding of management’s process in developing the cost estimates;
Obtain and review contracts to ensure that the recognition of revenue over time was appropriate;
Evaluating management’s ability to reasonably estimate costs by performing a comparison of the actual costs to prior period estimates, including evaluating the timely identification of circumstances that may warrant a modification to the estimated costs;
Evaluate management’s methodologies and the consistency of management’s methodologies over the life of the contracts;
Tested the original estimated costs and profit margins on System Projects by obtaining the original estimates, comparing the actual costs and profit margins to the original estimates and investigating significant changes; and
Tested the estimated costs to complete Systems Projects that were not completed during the year ended December 31, 2023 by comparing the estimated cost to complete at December 31, 2023 to actual cost incurred subsequent to December 31, 2023.

/s/ Marcum llp

Marcum LLP

We have served as the Company’s auditor since 2019.

Melville, NY
March 28, 2024

CVD Equipment Corporation and Subsidiaries asEQUIPMENT CORPORATION AND SUBSIDIARIES

Consolidated Balance Sheets

As of December 31, 20162023 and 2015, and the results of their operations and their cash flows for each of the years 2022

(in the two-year period ended December 31, 2016, in conformity with accounting principles generally accepted in the United States of America.thousands, except share amounts)

         
  2023  2022 
ASSETS        
Current assets:        
Cash and cash equivalents $14,025  $14,365 
Accounts receivable, net  1,906   3,788 
Contract assets  1,604   2,170 
Inventories, net  4,454   2,538 
Other current assets  852   797 
Total current assets  22,841   23,658 
         
Employee retention credit receivable  -   1,529 
Property, plant and equipment, net  12,166   12,596 
Intangible assets, net  9   119 
Other assets  9   10 
Total assets $35,025  $37,912 
         
LIABILITIES AND STOCKHOLDERS’ EQUITY        
Current liabilities:        
Accounts payable $1,203  $1,454 
Accrued expenses  1,765   2,591 
Current maturities of long-term debt  81   77 
Deposits from purchasers of MesoScribe assets – note 15  597   - 
Contract liabilities  4,908   4,042 
Total current liabilities  8,554   8,164 
         
Long-term debt, net of current portion  268   349 
         
Total liabilities  8,822   8,513 
         
Commitments and contingencies (see note 13)  -    -  
         
Stockholders’ equity:        
Common stock - $0.01 par value – 20,000,000 shares
authorized; issued and outstanding 6,824,511 at December 31,
2023 and 6,760,938 at December 31, 2022
  68   67 
Additional paid-in capital  28,695   27,712 
(Accumulated deficit) retained earnings  (2,560)  1,620 
Total stockholders’ equity  26,203   29,399 
         
Total liabilities and stockholders’ equity $35,025  $37,912 

/s/MSPC

Certified Public Accountants and Advisors, 

A Professional Corporation 

New York, New York

March 30, 2017

The accompanying notes are an integral part of the consolidated financial statements

F-2

CVD EQUIPMENT CORPORATION AND SUBSIDIARSUBSIDIARIESIES

Consolidated Balance SheetsStatements of Operations

As ofYears ended December 31, 2023 and 2022

  

2016

  

2015

 

ASSETS

        

Current Assets

        

Cash and cash equivalents

 $21,677,186  $13,073,331 

Accounts receivable, net

  607,522   3,091,251 

Costs and estimated earnings in excess of billings on contracts in progress

  2,596,518   4,635,018 

Inventories, net

  3,286,539   2,986,430 

Restricted cash

  --   200,000 

Deferred income taxes

  428,355   398,009 

Other current assets

  235,537   167,056 

Total Current Assets

  28,831,657   24,551,095 
         
         

Property, plant and equipment, net

  14,344,924   14,793,923 

Construction in progress

  94,058   33,306 
         

Deferred income taxes

  2,011,979   1,606,830 

Other assets

  68,450   86,215 

Intangible assets, net

  253,624   60,335 

Total Assets

 $45,604,692  $41,131,704 
         
         

LIABILITIES AND STOCKHOLDERS’ EQUITY

        

Current Liabilities

        

Accounts payable

 $743,132  $308,004 

Accrued expenses

  1,942,818   3,445,880 

Current maturities of long-term debt

  300,000   580,000 

Billings in excess of costs and estimatedearnings on contracts in progress

  5,262,339   --- 

Deferred revenue

  77,633   307,683 

Total Current Liabilities

  8,325,922   4,641,567 
         

Long-term debt, net of current portion

  2,965,508   3,265,508 

Total Liabilities

  11,291,430   7,907,075 
         

Commitments and Contingencies (Note 16)

  -   - 
         

Stockholders’ Equity:

        

Common stock - $0.01 par value – 20,000,000 shares authorized at December 31, 2016 and 10,000,000 authorized at December 31, 2015: issued and outstanding 6,346,590 at December 31, 2016 and 6,198,135 shares at December 31, 2015

  63,466   61,981 

Additional paid-in capital

  24,131,474   22,895,202 

Retained earnings

  10,118,322   10,267,446 

Total Stockholders’ Equity

  34,313,262   33,224,629 
         

Total Liabilities and Stockholders’ Equity

 $45,604,692  $41,131,704 

(in thousands, except per share amounts)

         
  2023  2022 
       
Revenue $24,109  $25,813 
Cost of revenue  19,038   19,186 
         
Gross profit  5,071   6,627 
         
Operating expenses:        
Research and development  2,596   1,906 
Selling  1,632   1,216 
General and administrative  5,451   5,328 
Loss on disposition of Tantaline  162   - 
Impairment charge  111   - 
         
Total operating expenses  9,952   8,450 
         
Operating loss  (4,881)  (1,823)
         
Other income (expense):        
Interest income  577   162 
Interest expenses  (23)  (8)
Employee retention credits  -   1,529 
Foreign exchange income (loss)  42   (95)
Other income  91   15 
Total other income, net  687   1,603 
         
Loss before income tax  (4,194)  (220)
         
Income tax (benefit) expense  (14)  4 
         
Net loss $(4,180) $(224)
         
Loss per common share:        
Basic $(0.62) $(0.03)
Diluted $(0.62) $(0.03)
         
Weighted average number of shares:        
Basic  6,788   6,734 
Diluted  6,788   6,734 

The accompanying notes are an integral part of the consolidated financial statements

F-3

CVD EQUIPMENT CORPORATION AND SUBSIDIARSUBSIDIARIESIES

Consolidated Statements of OperationsChanges in Stockholders’ Equity

Years ended December 31, 2023 and 2022

  

2016

  

2015

 
         

Revenue

 $20,955,347  $38,965,387 
         

Cost of revenue

  13,850,824   23,819,864 
         

Gross profit

  7,104,523   15,145,523 
         

Operating expenses

        

Research and development

  433,844   605,264 

Selling and shipping

  1,097,661   1,208,174 

General and administrative

  6,926,487   7,745,092 

Litigation settlement

  --   995,000 

Gain on settlement

  (628,905)  -- 
         

Total operating expenses

  7,829,087   10,553,530 
         

Operating (loss)/income

  (724,564)  4,591,993 
         

Other income (expense):

        

Interest income

  28,233   24,540 

Interest expense

  (79,861)  (92,101)

Other income/(expense)

  123,006   759 

Total other (expense)/income net

  71,378   (66,802)
         

(Loss)/income before income tax(benefit)/expense

  (653,186)  4,525,191 

Income tax (benefit)/expense

  (504,061)  1,320,195 
         

Net (loss)/income

 $(149,124) $3,204,996 
         
         

Basic (loss)/income per common share

 $(0.02) $0.52 

Diluted (loss)/income per common share

 $(0.02) $0.51 
         

Weighted average common shares

        

Outstanding-basic

  6,285,815   6,175,254 
         

Weighted average common shares

        

Outstanding-diluted

  6,285,815   6,283,307 

(in thousands, except share amounts)

                
  Common stock  Additional paid-in  (Accumulated Deficit) / Retained     
  Shares  Par Value  Capital  

Earnings

  Total 
                
Balance at January 1, 2022  6,723,438  $67  $27,277  $1,844  $29,188 
Net loss  -   -   -   (224)  (224)
Stock-based compensation  37,500   -   435   -   435 
Balance at December 31, 2022  6,760,938  $67  $27,712  $1,620  $29,399 
Balance  6,760,938  $67  $27,712  $1,620  $29,399 
                     
Net loss  -   -   -   (4,180)  (4,180)
Stock-based compensation  41,320   1   907   -   908 
Exercise of stock options and
issuance of shares
  22,253   -   76   -   76 
Balance at December 31, 2023  6,824,511  $68  $28,695  $(2,560) $26,203 
Balance  6,824,511  $68  $28,695  $(2,560) $26,203 

The accompanying notes are an integral part of the consolidated financial statements

F-4

CCVDVD EQUIPMENT CORPORATION AND SUBSIDIARSUBSIDIARIESIES

Consolidated Statements of Cash FlowsChanges inStockholders’ Equity

          

Additional

      

Total

 
  

Common Stock

  

Paid-In

  

Retained

  

Stockholders’

 
  

Shares

  

Amount

  

Capital

  

Earnings

  

Equity

 
                     

Balance – January 1, 2015

  6,162,027  $61,620  $22,144,805  $7,062,450  $29,268,875 
                     

Exercise of stock options

  ---   ---   ---       --- 
                     

Stock-based compensation

  36,108   361   750,397       750,758 
                     

Net income

              3,204,996   3,204,996 
                     

Balance – December 31, 2015

  6,198,135   61,981   22,895,202   10,267,446   33,224,629 
                     

Exercise of stock options

  100.000   1,000   461,000       462,000 
                     

Stock-based compensation

  48,455   485   775,272       775,757 
                     

Net (loss)

              (149,124)  (149,124)
                     

Balance – December 31, 2016

  6,346,590  $63,466  $24,131,474  $10,118,332  $34,313,262 

Years ended December 31, 2023 and 2022

(in thousands)

         
  2023  2022 
Cash flows from operating activities:        
Net loss $(4,180) $(224)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:        
Loss on disposition of Tantaline  162   - 
Impairment charge  111   - 
Stock-based compensation  908   435 
Depreciation and amortization  792   867 
Changes in operating assets and liabilities, net of effects of disposition of Tantaline:        
Accounts receivable  1,841   (2,342)
Contract assets  566   368 
Inventories  (1,921)  (1,313)
Income tax receivable  -   716 
Employee retention credit receivable  1,529   (1,529)
Other current assets  (47)  (301)
Accounts payable  (154)  293 
Accrued expenses  (679)  832 
Contract liabilities  866   2,392 
Net cash (used in) provided by operating activities  (206)  194 
         
Cash flows from investing activities:        
Net cash used in disposition of Tantaline  (312)  - 
Deposits from purchaser of MesoScribe assets  597   - 
Purchases of property and equipment  (418)  (665)
Capitalized patent costs  -   (53)
Net proceeds from sale of assets  -   10 
Net cash used in investing activities  (133)  (708)
         
Cash flows from financing activities:        
Proceeds from exercise of stock options  76   - 
Payments of long-term debt  (77)  (1,772)
Net cash used in financing activities  (1)  (1,772)
         
Net decrease in cash and cash equivalents  (340)  (2,286)
         
Cash and cash equivalents at beginning of year  14,365   16,651 
         
Cash and cash equivalents at end of year $14,025  $14,365 
         
Supplemental disclosure of cash flow information:        
Income taxes paid $8  $1 
Interest paid $24  $8 
         
Non-cash investing and financing activities:        
Loan obtained for new equipment
 $-  $432 

The accompanying notes are an integral part of the consolidated financial statements

F-5

CVD EQUIPMENT CORPORATION AND SUBSIDIARSUBSIDIARIESIES

Consolidated Statements ofCash Flows

Years ended December 31,

  

2016

  

2015

 

Cash flows from operating activities:

        

Net (loss)/income

 $(149,124) $3,204,996 

Adjustments to reconcile net (loss)/income to net cash used in operating activities

        

Stock-based compensation

  775,757   750,758 

Depreciation and amortization

  813,657   826,529 

Deferred income tax benefit

  (435,495)  1,633,254 

Provision for doubtful accounts

  (16,395)  (30,826)

Increase/(decrease) in operating assets

        

Accounts receivable

  2,500,124   3,402,625 

Cost in excess of billings on contracts in progress

  2,038,500   (2,136,356)

Inventories, net

  (290,109)  1,855,628 

Other current assets

  (68,473)  27,700 

Increase/(decrease) in operating liabilities

        

Accounts payable

  435,129   (1,374,835)

Accrued expenses

  (1,503,062)  148,856 

Current maturities of long-term debt

  (280,000)  (140,000)

Billings in excess of costs and estimated earnings on contracts in progress

  5,262,339   (1,328,508)

Accrued litigation settlement

  ---   (4,925,000)

Deferred revenue

  (230,050)  (181,008)

Total adjustments

  9,001,922   (1,471,183)

Net cash provided by operating activities

  8,852,798   1,733,813 
         
Cash flows from investing activities:        

Restricted cash

  200,000   200,000 

Capital expenditures

  (112,493)  (248,305)

Purchase of assets Tantaline A/S

  (500,000)  --- 

Deposits

  1,550   960 

Net cash (used in) investing activities

  (410,943)  (47,345)
         

Cash flows from financing activities

        

Net proceeds from stock options exercised

  462,000   --- 

Payments of long-term debt

  (300,000)  (580,000)

Net cash provided by/(used in) financing activities

  162,000   (580,000)
         

Net increase in cash and cash equivalents

  8,603,855   1,106,468 
         

Cash and cash equivalents at beginning of year

  13,073,331   11,966,863 
         

Cash and cash equivalents at end of year

 $21,677,186  $13,073,331 
         
Supplemental disclosure of cash flow information:          
Income taxes paid $101,352   427,078 
Interest paid $79,861   92,101 

The accompanying notes are an integral part of the consolidated financial statements


CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 20162023 and 20152022

Note 1 – Business Description

CVD Equipment Corporation and its subsidiaries (the “Company”), is a New York corporation, was organized and commenced operations in October 1982.corporation. Its principal business activities include thedesigning, developing, and manufacturing a broad range of chemical vapor deposition, equipment, customizedphysical vapor transport, gas control, systems, the manufacturing ofand other equipment and process equipment suitablesolutions used to develop and manufacture materials and coatings for the synthesis of a variety of one-dimensional nanostructuresindustrial applications and nanomaterials and a line of furnaces, all of whichresearch. Its products are used primarilyin production environments as well as research and development centers, both academic and corporate.

We conduct our business through three reportable operating segments: i) CVD Equipment that supplies chemical vapor deposition, physical vapor transport and thermal process equipment; ii) SDC that designs and manufactures ultra-high purity gas and chemical delivery control systems; and iii) CVD Materials that provide products related to produce semiconductorsadvanced materials and other electronic components. The Company engages in business throughout the United States and internationally.coatings.

Note 2 - Summary of Significant Accounting Policies

Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

Liquidity

At December 31, 2023, the Company had $14.0 million in cash and cash equivalents. The Company anticipates that the existing cash and cash equivalents balance together with potential future income from operations, collections of existing accounts receivable, revenue from its existing backlog of products as of this filing date, the sale of inventory on hand, deposits and down payments against significant orders will be adequate to meet its working capital and capital equipment requirements, and its anticipated cash needs over the next 12 months from the date of issuance of the accompanying Form 10-K.

Reclassifications

In addition, certain reclassifications have been made to the prior period consolidated financial statements to conform to the current period presentation. These reclassifications had no effect on net (loss).

Principles of Consolidation

The consolidated financial statements include the accounts of CVD Equipment Corporation and its wholly owned subsidiaries. In December 1998, a subsidiary, Stainless Design Concepts, Ltd., was formed as a New York Corporation. In April 1999, this subsidiary was merged into CVD Equipment Corporation. The Company has two wholly owned subsidiaries: CVD Materials Corporation, which provides marketing for our Application Laboratory and FAE Holdings 411519R, LLC, a real estate holding company whose sole asset is its interest in the real estate and building housing our corporate headquarters. All significant intercompany accounts and transactions have been eliminated in consolidation.

F-6

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2023 and 2022

Note 2 - Summary of Significant Accounting Policies (continued)

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

The Company’s significant estimates are the accounting for certain items such as revenues on long-term contracts recognized on the percentage-of-completioninput method, depreciation and amortization, valuation of inventories at the lower of cost or market;net realizable value; allowance for doubtful accounts receivable;credit losses; valuation allowances for deferred tax assets, estimated lives and impairment considerations of long-lived assets and valuation of stock-based compensation and costs associated with product warranties.compensation.

Revenue Recognition

ProductIn accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606 - Revenue from Contracts with Customers (“ASC 606), the Company records revenue in an amount that reflects the consideration to which the Company expects to be entitled in exchange for goods or services promised to its customers. Under ASC 606, the Company follows a five-step model to: (1) identify the contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price for the contract; (4) allocate the transaction price to the performance obligations; and service(5) recognize revenue using one of the following two methods:

Over time

The Company designs, manufactures and sells custom chemical vapor deposition, thermal process equipment and other equipment through contractual agreements. These system sales including thoserequire the Company to deliver functioning equipment that is generally completed within two to eighteen months from commencement of order acceptance. For systems sales that meet the criteria to recognize revenue over time, the Company recognizes revenue over time by using an input method based on costs incurred as it depicts the Company’s progress toward satisfaction of the performance obligation. For system sales that do not meet the criteria to recognize revenue over time and materials type contracts, are recognized when persuasive evidence of an arrangement exists, product delivery has occurred or services have been rendered, pricing is fixed or determinable, and collection is reasonablybased on the contract provisions, the Company recognizes revenue based on point in time.


CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2016 and 2015

Note 2 - Summary of Significant Accounting Policies (continued)

assured. Service sales, principally representing repair, maintenance and engineering activities are recognizedUnder the over the contractual period or as services are rendered.

Revenuestime method, revenue arising from fixed price contracts areis recognized as work is performed based on the percentageratio of costs incurred to date to the total estimated costs at completion method, measured onof the basis of incurred costs to estimated total costs for each contract. This “cost to cost” method is used because management considers it to be the best available measure of progress on these contracts.

Contractperformance obligations. Incurred costs include all direct material and labor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs and depreciation costs. Contract material costs are included in incurred costs when the project materials have been purchased or moved to work-in-process, and installed, as required by the project’s engineering design. Cost based input methods of revenue recognition require the Company to make estimates of costs to complete the projects. In making such estimates, significant judgment is required to

F-7

Provisions for

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2023 and 2022

Note 2 - Summary of Significant Accounting Policies (continued)

evaluate assumptions related to the costs to complete the projects, including materials, labor and other system costs. If the estimated lossestotal costs on uncompleted contractsany contract are madegreater than the net contract revenues, the Company recognizes the entire estimated loss in the period the loss becomes known and can be reasonably estimated. There were no material impairment losses recognized on contract assets during the year ended December 31, 2023 and 2022.

The timing of revenue recognition, billings and collections results in which such lossesaccounts receivables, unbilled receivables or contract assets and contract liabilities on our consolidated balance sheet. Under typical payment terms for our contracts accounted for over time, amounts are determined. Changesbilled as work progresses in job performance, job conditions, and estimated profitability, and final contract settlements may result in revisions to costs and income and are recognized in the period in which the revisions are determined.accordance with agreed-upon contractual terms, either at periodic intervals or upon achievement of contractual milestones.

The asset “Costs and estimated earningsUnder ASC 606, payments received from customers in excess of billingsrevenue recognized to-date results in a contract liability. These contract liabilities are not considered to represent a significant financing component of the contract because we believe these cash advances and deposits are generally used to meet working capital demands which can be higher in the earlier stages of a contract. Also, advanced payments and deposits provide us with some measure of assurance that the customer will perform on its obligations under the contract.

Contract assets include unbilled amounts typically resulting from system sales under contracts in progress”and represents gross revenuesrevenue recognized that exceeds the amount billed to the customer.

Contract liabilities include advance payments and billings in excess of amounts billed.revenue recognized. The Company typically receives down payments upon receipt of order and progress payments as the system is manufactured.

The liability “Billing in excess of costsContract assets and estimated earnings oncontract liabilities are classified as current as these contracts in progress” represents gross amounts billedprogress are expected to be substantially completed within the next twelve months.

Point in excesstime

For non-system sales of revenues recognized.products and services, revenue is recognized at the point in time when control of the promised products or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products or services (the transaction price). A performance obligation is a promise in a contract to transfer a distinct product or service to a customer and is the unit of account under ASC 606, “Revenue from Contracts with Customers.”

InventoriesFor any system equipment sales where the equipment would have an alternative use or where the contract provisions of the contract preclude the use of over time revenue recognition, revenue is recognized at the point in time when control of the equipment is transferred to the customer. For the year ended December 31, 2023 and 2022, all system equipment sales were recorded over time by using an input method.

F-8

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2023 and 2022

Note 2 - Summary of Significant Accounting Policies (continued)

Inventories

Inventories (raw materials, work-in-process and finished goods) are valued at the lower of cost (determined on the first-in, first-out method) or market.net realizable value. Work-in-process and finished goods inventory reflect all accumulated production costs, which are comprised of direct production costs and overhead, and is reduced by amounts recorded in cost of sales as the related revenue is recognized. Indirect costs relating to long-term contracts, which include expenses such as general and administrative, are charged to expense as incurred and are not included in our cost of sales or work-in-process and finished goods inventory.

Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. The Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for the Company’s products may require a write down of inventory, which would be reflected in cost of sales in the period the revision is made.

Product Warranty

The Company typically provides standard warranty coverage on its systems for one year from the date of final acceptance or fifteen months from the date of shipment by providing labor and parts necessary to repair the systems during the warranty period. The Company records the estimated warranty cost when revenue is recognized on the related system. Warranty cost is included in “Cost of revenue” in the consolidated statements of operations. The estimated warranty cost is based on the Company’s historical cost. The Company updates its warranty estimates based on actual costs incurred.

Income Taxes

Deferred tax assets and liabilities are determined based on the estimated future tax effects of temporary differences between the financial statements and tax bases of assets and liabilities, as measured by using the future enacted tax rates. Deferred tax expense (benefit) is the result of changes in the deferred tax assets and liabilities. The Company records a valuation allowance against deferred tax assets when it is more likely than not that future tax benefits will not be utilized based on a lack of sufficient positive evidence.

InvestmentThe Company records uncertain tax credits are accounted for by the flow-through method, reducing income taxes currently payable and the provision for income taxespositions in the period the assets giving rise to such credits are placed in service. To the extent such credits are not currently utilizedaccordance with ASC 740 on the


CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2016 and 2015

Note 2 - Summary basis of Significant Accounting Policies (continued)

Company’s tax return, deferred tax assets, subject to considerations about the need for a valuation allowance, are recognized for the carryforward amount.

The Company recognizes the tax benefit from an uncertain tax position only iftwo-step process in which (1) we determine whether it is more-likely-than-not thatmore likely than not the tax position will be sustained on examination by taxing authorities based on the technical merits of the position. The tax benefits recognized inposition and (2) for those positions that meet the financial statements from such

a position are measured based onmore-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that has a greateris more than 50% likelihood of beinglikely to be realized upon ultimate settlement. The accounting guidance on accounting for uncertainty in income taxes also addresses derecognition, classification, interest and penalties on income taxes, and accounting in interim periods. The Company does not believe it has any uncertainsettlement with the related tax positions through the year ending authority.

F-9

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2016 which would have2023 and 2022

Note 2 - Summary of Significant Accounting Policies (continued)

The Company’s policy for global intangible low taxed income (“GILTI”) is to treat such amounts as a material impact on the Company’s consolidated financial statements.period cost when incurred.

The CompanyImpairment of Long-Lived Assets and its subsidiaries file combined income tax returns in the U.S. Federal and New York State jurisdiction. In addition, the parent company files standalone tax returns in California, Michigan, Minnesota, New Hampshire and Wisconsin. The Company is no longer subject to U.S. federal and state income tax examinations for tax periods before 2013.Intangibles

The Company recognizes interest and penalties accrued related to unrecognized tax benefits, if any, in its income tax provision. The Company had no interest and penalties accrued at December 31, 2016 and 2015.

Long Lived Assets

Long-lived assets consist primarily of property, plant, and equipment. Intangibles consist of patents, copyrights and intellectual property, licensing agreements and certifications. Long-lived assets are reviewed for impairment whenever events or circumstances indicate their carrying value may not be recoverable. Whenrecoverable.When such events or circumstances arise, an estimate of the future undiscounted cash flows produced by the asset, or the appropriate grouping of assets, is compared to the asset’s carrying value to determine if impairment exists pursuant to the requirements of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 360-10-35, “Impairment or Disposal of Long-Lived Assets.” Ifexists.If the asset is determined to be impaired, the impairment loss is measured on the excess of its carrying value over its fair value. Assets to be disposed of are reported at the lower of their carrying value or net realizable value. The Company had no recorded impairment charges in the consolidated statement of operations during each of the years ended December 31, 2016

Property, Plant and 2015.Equipment


CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2016 and 2015

Note 2 - Summary of Significant Accounting Policies (continued)

Construction in Progress

Construction in progress consists of amounts expended for renovating the facility which was purchased on March 15, 2012,Property, plant and equipment thatare recorded at cost. Depreciation is built internallydetermined on a straight-line basis for company use. Expendituresbuildings and building improvements over 5 to 39 years and for maintenancemachinery and repairsequipment over 5 to 8 years. Depreciation and amortization of assets used in manufacturing are charged to operationsrecorded in cost of revenue. Depreciation and amortization of all other assets are recorded as incurred; additions, renewals and betterments are capitalized.operating expenses.

Computer Software

The Company follows ASC 350-40, “Internal Use Software.” This standard requires certain direct development costs associated with internal-use software to be capitalized including external direct costs of material and services and payroll costs for employees devoting time to the software projects. These costs totaled $2,000 and $21,000 for the years ended December 31, 2016 and 2015, respectively, and are included in Other Assets. All computer software is amortized using the straight-line method over its estimated useful life of three to five years. Amortization expense related to computer software totaled $18,000 and $16,000 for the years ended December 31, 2016 and 2015, respectively.

Intangible Assets

The cost of intangible assets is being amortized on a straight-line basis over their estimated initial useful lives which ranged from 5 to 20 years. Amortization expense recorded by the Company in 2016

Research and 2015 totaled $31,000 and $24,000, respectively.Development

Research & Development

Research and development costs are expensed as incurred. In 2012 we expanded our laboratory staff and began conducting research and development independent of customer orders. In 2016 we incurred approximately $2,448,000 of research and development expenses of which $434,000 were independent of external customer orders compared to 2015, when we incurred approximately $1,727,000 of research and development expenses of which approximately $605,000 were independent of external customer orders.

Accounts Receivable

Accounts receivable is presented net of an allowance for doubtful accounts of $2,000 and $19,000 as of December 31, 20165 and 2015, respectively. The allowance is based on historical experience and management’s evaluation of the collectability of accounts receivable. Management believes the allowance is adequate. However, future estimates may fluctuate based on changes in economic and customer conditions. The Company doesn’t require collateral from its customers.


CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2016 and 2015

Note 2 - Summary of Significant Accounting Policies (continued)

Product Warranty

The Company records warranty costs as incurred and does not provideinclude charges for possible future costs. Management estimates such costs are immaterial, based on historical experience. However, it is reasonably possible that this estimate may differ in future periods.the development of new technology and transition of existing technology into new products.

Earnings Per Share

Basic earnings per common share is computed by dividing the net income by the weighted average number of shares of common stock outstanding during each period. When applicable, diluted earnings per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be adjusted upon exercise of common stock options, unvested restricted shares, and warrants.

F-10

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2023 and 2022

Note 2 - Summary of Significant Accounting Policies (continued)

Potential common shares issued are calculated using the treasury stock method, which recognizes the use of proceeds that could be obtained upon the exercise of options and warrants in computing diluted earnings per share. It assumes that any proceeds would be used to purchase common stock at the average market price of the common stock during the period.

Cash and Cash Equivalents

The Company had cash and cash equivalents of $21.7$14.0 million and $13.7$14.4 million respectively at December 31, 20162023 and 2015.2022, respectively. The Company invests excess cash in treasury bills, certificates of deposit or deposit accounts, all with original maturities of less than three months. Cash equivalents were $12.1 million and $11.7 million at December 31, 2023 and 2022, respectively.

The Company places most of its temporary cash investments with financial institutions, which from time to time may exceed the Federal Deposit Insurance Corporation limit. The amount in excess of the limit at both December 31, 2023 and 2022 was $1.5 million. The Company’s cash in our Denmark subsidiary exceeded the government guarantee limit by approximately $0.5 million at December 31, 2022.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, and accounts receivable. The Company places its cash equivalents with high credit-quality financial institutions and invests its excess cash primarily in money market instruments.treasury bills, certificates of deposit or deposit accounts. The Company has established guidelines relative to credit ratings and maturities that seek to maintain stability and liquidity. The Company sells products and services to various companies across several industries in the ordinary course of business.

The Company routinely assesses the financial strength of its customers. In accordance with the “expected credit loss” model, the carrying amount of accounts receivable is reduced by a valuation allowance that reflects the best estimate of the amounts the Company does not expect to collect. In addition to reviewing delinquent accounts receivable, the Company consider many factors in estimating our reserve, including types of customers and maintains allowancestheir credit worthiness, experience and historical data adjusted for anticipatedcurrent conditions and reasonable supportable forecasts. The Company records an allowance for credit losses based upon historical experience.a specific review of all significant outstanding invoices. For those invoices not specifically reviewed, provisions are provided based upon the collection history, current economic trends and reasonable supportable forecasts.

The Company has accounts receivables from certain customers that exceed 10%. As of December 31, 2023, the accounts receivable balance includes amounts from three customers that represented 37.6%, 13.0% and 12.8% of total accounts receivable, and as of December 31, 2022, two customers that represented 35.7% and 30.3% of total accounts receivable.

F-11

CVD EQUIPMENT CORPORATION AND SUBSIDIARSUBSIDIARIESIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 20162023 and 20152022

Note 2 - Summary of Significant Accounting Policies (continued)

Accounts receivable is presented net of an allowance for credit losses of $36,000 as of both December 31, 2023 and 2022. The allowance is based on prior experience and management’s evaluation of future economic conditions. Measurement of credit losses requires consideration of historical loss experience, including the need to adjust for changing business conditions, and judgments about the probable effects of relevant observable data, including present economic conditions such as delinquency rates and the financial health of specific customers. Future changes to the estimated allowance for doubtful accounts could be material to our results of operations and financial condition.

Sales Concentrations

Revenue to a single customer in any one year can exceed 10% of our total sales. There were three customers in the year ended December 31, 2023 that represented 14.3%, 13.5% and 10.9% of our revenues, while there was one customer in the year ended December 31, 2022 that represented 29.2% of our revenues. The loss of a large customer could have a material adverse effect on the Company’s business and financial condition.

Export sales to customers represented approximately 17% of sales for both years ended December 31, 2023 and 2022. Export sales in both 2023 and 2022 were primarily to customers in Europe and Asia. All contracts except those entered into by the Company’s subsidiary in Denmark are denominated in U.S. dollars. The Company has not entered into any foreign exchange contracts.

Supplier Risk

The Company relies on suppliers to manufacture many of the components and subassemblies used in its products. Quality or performance failures of the Company’s products or changes in its manufacturers’ financial or business condition could disrupt the Company’s ability to supply quality products to its customers and thereby have a material and adverse effect on its business and operating results. Some of the components and technologies used in the Company’s products are purchased and licensed from a single source or a limited number of sources. The loss of any of these suppliers may cause the Company to incur additional transition costs, result in delays in the manufacturing and delivery of its products or cause it to carry excess or obsolete inventory and could cause it to redesign its products.

Fair valueValue of Financial Instruments

The carrying amounts of financial instruments including cash and cash equivalents, accounts receivable, net, accounts payable, contract assets and accrued expenses, deferred revenue and customer depositscontract liabilities approximate fair

Note 2 - Summary of Significant Accounting Policies (continued)

value due to the relatively short-term maturity of these instruments. The carrying value of long-term debt approximates fair value based on prevailing borrowing rates currently available for loans with similar terms and maturities.

F-12

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2023 and 2022

Note 2 - Summary of Significant Accounting Policies (continued)

Stock-Based Compensation

The Company records stock-based compensation in accordance with the provisions set forth in ASC 718, “Stock Compensation” using the modified prospective method.. ASC 718 requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant date fair value of those awards.awards over the vesting period. The Company uses the Black-Scholes option-pricing model to compute the estimated fair value of option awards and includes assumptions regarding expected volatility, expected option term, dividend yields and risk-free interest rates.

Shipping and Handling

It is the Company’s policy to include freight charges billed to customers in total revenue. The amount included in revenue was $28,000$55,000 and $57,000$87,000 for the years ended December 31, 2023 and 2022, respectively.

Recently Adopted Accounting Standards

In June 2016, the FASB issued Accounting Standard Update (“ASU”) 2016-13, Financial Instruments – Credit Losses (Topic 326), which require that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the increase or decreases of expected credit losses that have taken place during the period. The measurement of expected credit losses is based upon historical experience, current conditions, and 2015, respectively.reasonable and supportable forecasts that affect the collectability of the reported amount. The adoption of the ASU 2016-3 as of January 1, 2023 did not have a material impact on the Company’s financial position.

RecentlyAdopted Issued Accounting PronouncementStandards

In May 2014, TheDecember 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from ContractsASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which requires public business entities to disclose additional information in specified categories with Customers” (Topic 606),respect to the reconciliation of the effective tax rate to the statutory rate for federal, state, and foreign income taxes. It also requires greater detail about individual reconciling items in the rate reconciliation to the extent the impact of those items exceeds a specified threshold. In addition to new disclosures associated with the rate reconciliation, the ASU requires information pertaining to taxes paid (net of refunds received) to be disaggregated for federal, state, and foreign taxes and further disaggregated for specific jurisdictions to the extent the related amounts exceed a quantitative threshold. The ASU also describes items that need to be disaggregated based on their nature, which changesis determined by reference to the criteria for recognizing revenue. The standard requires an entity which recognizes revenue to depictitem’s fundamental or essential characteristics, such as the transfertransaction or event that triggered the establishment of promised goods or services to customers in an amount that reflects the consideration toreconciling item and the activity with which the entity expects to be entitled in exchange for those goods or services.reconciling item is associated. The standard requiresASU eliminates the historic requirement that entities disclose information concerning unrecognized tax benefits having a five-step process for recognizing revenues including identifying the contract with the customer, identifying the performance obligations in the contract, determining the transaction prices, allocating the transaction price to the performance obligations in the contract, and recognizing revenue when (or as) the entity satisfies a performance obligation. Publicly-traded companies were initially required to adopt the ASU for reporting periods beginning after December 15, 2016; however, the FASB, in August 2015, then issued Accounting Standards Update (“ASU”) No. 2015-14 to defer the effective datereasonable possibility of ASU 2014-09 for all entities by one year. Currently companies may choose among different transition alternatives. Management is currently evaluating the impact that ASU 2014-09 will have on the Company’s

F-13

CVD EQUIPMENT CORPORATION AND SUBSIDIARSUBSIDIARIESIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 20162023 and 20152022

Note 2 - Summary of Significant Accounting Policies (continued)

consolidated financial statements and have not yet determined which method of adoption will be selected.

In April 2015, the FASB issued ASU No. 2015-03, “Interest-imputation of interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs”, which requires that debt issuance costs be presentedsignificantly increasing or decreasing in the balance sheet as a direct deduction from12 months following the carrying amount of the related debt liability, rather than as a deferred charge asset.reporting date. This ASU No. 2015-03 is effective for the Company beginning January 1, 2016 and is to be applied retroactively. Management is currently evaluating the effect that this ASU will have on the Company’s consolidated financial statements and related disclosures.

In November 2015, the FASB issued ASU No. 2015-17, “Balance sheet Classification of Deferred Taxes”, which simplifies the presentation of deferred income taxes by requiring that deferred income tax liabilities and assets be classified as noncurrent in our consolidated balance sheet. ASU No. 2015-17 is effective for reportingannual periods beginning after December 15, 2016, with early2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. This ASU should be applied on a prospective basis; however, retrospective application is permitted. The CompanyWe are currently evaluating the impact that ASU 2023 – 09 will adopt this method beginning in 2017.have on our consolidated financial statements.

In March 2016,November 2023, the FASB issued ASU No. 2016-09, “Stock Compensation2023-07, “Segment Reporting (Topic 280): Improvements to Employee Share-Based Payment Accounting”Reportable Segments, which simplifies several aspectsaims to improve financial reporting by requiring disclosure of incremental segment information on an annual and interim basis for all public entities to enable investors to develop more decision-useful financial analyses. Currently, Topic280 requires that a public entity disclose certain information about its reportable segments. For example, a public entity is required to report a measure of segment profit or loss that the accounting for share-based payments.CODM uses to assess segment performance and make decisions about allocating resources. Topic 280 also requires other specified segment items and amounts, such as depreciation, amortization, and depletion expense, to be disclosed under certain circumstances. The amendments in this ASU 2016-09do not change or remove those disclosure requirements and do not change how a public entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. This ASU is effective for reporting periodsfiscal years beginning after December 15, 2016. Management2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the effectimpact that this ASU 2023 – 07 will have on the Company’sour consolidated financial statemetns and related disclosures.statements.

We believeThe Company believes there is no additional new accounting guidance adopted, but not yet effective that is relevant to the readers of our financial statements. However, there are numerous new proposals under development which, if and when enacted, may have a significant impact on our financial reporting.

F-14

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2023 and 2022

Note 3 – Revenue3

The following table represents a disaggregation of revenue from contracts by end markets for the years ended December 31, 2023 and 2022 (in thousands):

Schedule of Disaggregation of Revenue

  Over time  Point in time  Total 
  Year Ended December 31, 2023 
          
  Over time  Point in time  Total 
Energy $4,901  $189  $5,090 
Aerospace  3,427   1,469   4,896 
Industrial  6,123   2,821   8,944 
Research  3,700   1,479   5,179 
Total $18,151  $5,958  $24,109 

  Over time  Point in time  Total 
  Year Ended December 31, 2022 
          
  Over time  Point in time  Total 
Energy $9,094  $58  $9,152 
Aerospace  95   1,527   1,622 
Industrial  5,961   4,856   10,817 
Research  2,807   1,415   4,222 
Total $17,957  $7,856  $25,813 

 Contracts

The energy market includes customers involved in Progressthe manufacture of silicon carbide wafers and batteries. Aerospace market includes customers that manufacture aircraft engines. Industrial end market consists of various end customers in diverse industries. Research market principally represents customers that are universities and other research institutions.

CostsThe Company has unrecognized contract revenue of approximately $16.3 million at December 31, 2023, which it expects to recognize as revenue within the next twelve months.

Judgment is required to evaluate assumptions including the amount of net contract revenues and the total estimated earningscosts to determine our progress towards contract completion and to calculate the corresponding amount of revenue to recognize.

Changes in excessestimates for sales of billingssystems occur for a variety of reasons, including but not limited to (i) build accelerations or delays, (ii) product cost forecast changes, (iii) cost related change orders or add-ons, or (iv) changes in other information used to estimate costs. Changes in estimates may have a material effect on percentagethe Company’s consolidated financial position and results of completionoperations.

F-15

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2023 and 2022

Note 3 – Revenue (continued)

Contract assets and contract liabilities on input method type contracts in progress are summarized at December 31 as follows:

  

2016

  

2015

 

Costs incurred on contracts in progress

 $4,678,192  $7,695,281 

Estimated earnings

  10,733,826   7,635,114 
   15,412,018   15,330,395 

Billings to date

  (18,077,839)  (10,695,377)
  $(2,665,821) $4,635,018 

  

2016

  

2015

 

Included in accompanying balance sheets

        

Under the following captions:

        

Costs and estimated earnings in excess of billings on contracts in progress

 $2,596,518  $4,635,018 
         

Billings in excess of costs and estimated earnings on contracts in progress

 $(5,262,339) $--- 

follows (in thousands):

Schedule of Cost and Estimated Earnings in Excess of Billings

  2023  2022 
Costs incurred on contracts in progress $9,500  $14,390 
Estimated earnings  5,083   10,926 
Costs and estimated earnings on uncompleted contracts  14,583   25,316 
Billings to date  (17,553)  (26,925)
Net cost in excess of billings  (2,970)  (1,609)
Deferred revenue related to non-systems contracts  (334)  (263)
Contract liability in excess of contract assets $(3,304) $(1,872)

Included in accompanying consolidated balance sheets under the following captions (in thousands):

        
         
Contract assets $1,604  $2,170 
Contract liabilities $4,908  $4,042 

Of the contract liability balances at December 31, 2022 and December 31, 2021, $3.7 million and $1.7 million was recognized as revenue during the years ended December 31, 2023 and 2022, respectively. Contract assets at December 31, 2021 were $2.5 million.

Note 4 - Inventories

Inventories as of December 31 consist of (in thousands):

Schedule of Inventories, net

  2023  2022 
       
Raw materials $2,351  $2,165 
Work-in-process  1,248   373 
Finished goods  855   - 
Total $4,454  $2,538 

F-16

CVD EQUIPMENT CORPORATION AND SUBSIDIARSUBSIDIARIESIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 20162023 and 20152022

Note4 - Inventories

Inventories consist of:                          

  

2016

  

2015

 
         

Raw materials

 $3,062,830  $2,718,328 

Work-in-process

  159,482   174,698 

Finished goods

  64,227   93,404 

Totals

 $3,286,539  $2,986,430 


Note5Property, Plant and Equipment

Major classes of property, plant and equipment consist of the following:following as of December 31 (in thousands):

Schedule of Property, Plant and Equipment

  

2016

  

2015

 

Land

 $2,220,000  $2,220,000 

Buildings

  6,631,039   6,631,039 

Building improvements

  5,615,823   5,615,823 

Machinery and equipment

  2,671,333   2,381,964 

Furniture and fixtures

  547,144   721,919 

Computer equipment

  479,534   701,367 

Transportation equipment

  65,994   65,994 

Lab equipment

  1,975,533   1,972,838 

Totals at cost

  20,206,400   20,310,944 

Less: Accumulated depreciation and amortization

  (5,861,476)  (5,517,021)
Property, plant and equipment, net $14,344,924  $14,793,923 
         

Depreciation and amortization expense (1)

 $813,657  $826,529 
  2023  2022 
       
Land $2,220  $2,220 
Buildings and improvements  12,798   12,530 
Machinery and equipment  7,536   7,810 
Construction in progress  167   12 
Totals at cost  22,721   22,572 
         
Less: accumulated depreciation  (10,555)  (9,976)
Property, plant and equipment, net $12,166  $12,596 

Machinery and equipment also include furniture and fixtures and software.

Depreciation expense was $0.7 million and $0.8 million for the years ended December 31, 2023 and 2022, respectively.

The Company entered into an agreement with the Town of Islip Industrial Development Agency (Islip IDA) in July 2021 under which the Company was granted tax incentives whereby the Company agreed to make payments in lieu of all real estate taxes and assessments (PILOT payments). The agreement requires the Company to maintain certain employment levels at its Central Islip, New York facility. The agreement provides for the Islip IDA to recapture tax incentives provided to the Company in certain circumstances. Any recapture of such tax benefits could have a material adverse effect on the Company’s financial position and future results of operations and cash flows.

F-17
 

(1)

Includes amortization expense of $31,356 and $24,759 for the years ending December 31,2016 and 2015, respectively. Such amortization expense relates to other capitalized and intangible assets. 

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2023 and 2022

Note 6 – Intangible Assets

2016Intangible assets consisted of the following (in thousands):

  

Weighted Average

      

Accumulated

  

Carrying

 

Intangible Assets

 

Amortization Period

  

Cost

  

Amortization

  

Amount

 
                 

Patents, Copyrights and Intellectual Property

  18   396,757   143,133   253,624 

Licensing Agreement

  5   10,000   10,000   0 

Certifications

  3   58,722   58,722   0 

Other

  5   21,492   21,492   0 
                 

Totals

     $486,971  $233,347  $253,624 


Schedule of Finite Lived Intangible Assets

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 20162023

  Cost  Accumulated Amortization  Net 
Patents $87  $78  $9 

December 31, 2022

  Cost  Accumulated Amortization  Net 
Patents $565  $446  $119 

Amortization expense was $0.1 million and 2015$0.1 million in years ended December 31, 2023 and 2022, respectively, including costs of abandoned patent applications.

2015

  

Weighted Average

      

Accumulated

  

Carrying

 

Intangible Assets

 

Amortization Period

  

Cost

  

Amortization

  

Amount

 
                 

Patents, Copyrights and Intellectual Property

  16  $190,327  $129,992  $60,335 
                 

Licensing Agreement

  5   10,000   10,000   0 
                 

Certifications

  3   58,722   58,722   0 
                 

Other

  5   21,492   21,492   0 
                 
                 

Totals

     $280,451  $220,206  $60,335 

The estimated amortization expense related to intangible assets for each of the five succeeding fiscal years and thereafter as of December 31, 20162023 is approximately $1,000 per year.

Note 7 – Accrued Expenses

Accrued expenses consist of the following as follows:

Year Ended

    

2017

 $16,977 

2018

  15,311 

2019

  15,310 

2020

  15,311 

2021

  15,310 
Thereafter  175,405 
Total $253,624 

Note7 – Financing Arrangements

The Company has a revolving credit facility with HSBC Bank, USA, N.A. (“HSBC”) providing up to $7 million, although the Company has never utilized this facility. This credit facility remains available until September 1, 2018. The credit agreement also contains certain financial covenants, all of which the Company was in compliance with at December 31 2016.(in thousands):

Schedule of Accrued Expenses

  2023  2022 
       
Accrued wages and benefits $358  $995 
Accrued vacation  729   905 
Other  678   691 
Total accrued expenses $1,765  $2,591 

F-18

CVD EQUIPMENT CORPORATION AND SUBSIDIARSUBSIDIARIESIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 20162023 and 20152022

Note7 – Financing Arrangements (continued)

The Company has a loan agreement with HSBC which is secured by a mortgage against our Central Islip facility. The loan is payable in 120 consecutive equal monthly installments of $25,000 in principal plus interest and a final balloon payment upon maturity in March 2022. The balances as of December 31, 2016 and December 31, 2015 were approximately $3.3 million and $3.6 million respectively. Interest accrues on the Loan, at our option, at the variable rate of LIBOR plus 1.75% which was 2.1765% and 1.9455% at December 31, 2016 and 2015 respectively.

Note 8 – Long-term Debt

Long-term debt as of December 31 consistsconsist of the following:

  

2016

  

2015

 

HSBC

        

$2,100,000 5 year term loan payable in monthly installments of $35,000 plus interest on the unpaid principal balance which accrues at a fixed rate of 3.045%. This term loan was secured by $1 million, provided that, so long as no event of default occurred and is then continuing, HSBC would release $200,000 of the collateral on each anniversary of the closing date. As of December 31, 2016, this term loan had been paid in full.

 $---  $280,000 
         

HSBC

        

$6,000,000 Mortgage payable secured by real property

Buildings and improvements at 355 South Technology Drive, Central Islip, NY payable in monthly principle installments of $25,000 plus interest. Interest presently accrues at our option, at the variable rate of LIBOR plus 1.75% or HSBC’s prime rate minus 0.50% The loan matures on March 1, 2022.

  3,265,508   3,565,508 

Total long-term debt

  3,265,508   3,845,508 

Less: Current maturities

  300,000   580,000 

Long-term debt

 $2,965,508  $3,265,508 

following (in thousands, except percentages and amounts in notes):

Schedule of Long Term Debt

  2023  2022 
 Equipment loan payable in monthly repayments of $8 including interest at 6% per annum $349  $426 
Less: current maturities  81   77 
 Long-term debt, net of current maturities $268  $349 

In September 2022, the Company entered into a loan agreement to fund the acquisition of machinery equipment in the amount of $0.4 million.

Future maturities of long-term debt as of December 31, 20162023 are as follows:follows (in thousands):

Schedule of Maturities of Long Term Debt

2017

 $300,000 

2018

  300,000 

2019

  300,000 

2020

  300,000 

2021

  300,000 

Thereafter

  1,765,508 
Total long-term debt $3,265,508 
     
2024 $81 
2025  87 
2026  92 
2027  89 
     
Total $349 


CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2016 and 2015

Note9Earnings per Share

The calculation of basic and diluted weighted average common shares outstanding as of December 31 is as follows:follows (in thousands):

Schedule of Basic and Diluted Weighted Average Common Shares Outstanding

  

2016

  

2015

 

Weighted average common shares outstanding basic earnings per share

  6,285,815   6,175,254 
         

Effect of potential common share issuance:

        

Stock options

  ---   108,053 
         

Weighted average common shares outstanding

        

Diluted earnings per share

  6,285,815   6,283,307 
  2023  2022 
       
Basic weighted average shares outstanding  6,788   6,734 
Effect of potentially dilutive share-based awards  -   - 
         
Diluted weighted average shares outstanding  6,788   6,734 

StockAt December 31, 2023, stock options to purchase 284,730846,875 shares of common stock were outstanding and 124,730335,375 were exercisable at December 31, 2016.exercisable. At December 31, 2016 none2022, stock options to purchase 673,000 shares of thecommon stock were outstanding and 265,000 were exercisable.

At December 31, 2023 and 2022, 846,875 and 673,000 stock options, respectively, were not included in the computation of diluted earnings per share calculation asbecause their effect would have been anti-dilutive. At December 31, 2015 all outstanding options were included in the diluted earnings per share calculation because the average market price was higher than the exercise price.antidilutive.

F-19

Note 10 – Income Taxes

At December 31, 2016, the Company had approximately $27,000 in capital loss carryforwards, and $1,279,000 of federal research and development tax credits.

If not utilized, the investment tax credits expire from 2016 through 2030 and the research and development tax credits expire from 2031-2036. Based on the available objective evidence, including the Company’s history of taxable income and the character of that income, management believes it is more likely than not that these components of the Company’s deferred tax assets will be fully utilized. The Company has provided for a partial valuation allowance against its total net deferred tax assets at December 31, 2016 and December 31, 2015 of approximately $475,000 attributable to these components.


CVD EQUIPMENT CORPORATION AND SUBSIDIARSUBSIDIARIESIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 20162023 and 20152022

Note 1010Income Taxes (continued)

Loss before income taxes are as follows:

Schedule of Loss Before Income Taxes

  2023  2022 
       
Domestic $(4,073)  (596)
Foreign  (121)  376 
Total $(4,194) $(220)

The expense/(benefit) for income taxes for the years ended December 31 includes the following:following (in thousands):

Schedule of Components of Income Tax Expense (Benefit)

 

2016

  

2015

  2023 2022 

Current:

                

Federal

 $(71,070) $---  $(16) $1 

State

  2,504   3,070   2   3 

Total current tax provision

  (68,566)  3,070   (14)  4 

Deferred:

                

Federal

  (435,495)  1,317,125   -   - 

State

  -   ---   -   - 

Total deferred tax provision

  (435,495)  1,317,125   -   - 

Income tax (benefit)/expense

 $(504,061) $1,320,195 
Income tax (benefit) expense $(14) $4 

In March 2014, New York State eliminatedThe reconciliation of the statefederal statutory income tax rate to our effective tax rate for qualified manufacturing companies suchthe years ended December 31 is as CVD. follows (in thousands):

Schedule of Effective Income Tax Rate Reconciliation

  2023   2022 
Expected provision at federal statutory tax rate at 21% $(881) $(46)
Increase (decrease) in valuation allowance  688   (33)
State and local taxes  21   84 
Foreign tax rate differential  (1)  4 
US taxation of foreign operations  -   80 
Federal research and development credits  (75)  (55)
Change in tax rates  -   10 
Non-deductible expenses  37   62 
Disposition of Tantaline  193   - 
Other  4   (102)
Income tax (benefit) expense $(14) $4 

F-20

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2023 and 2022

Note 10 – Income Taxes (continued)

The tax effects of temporary differences giving rise to significant portions of the net deferred taxes as of December 31 are as follows:follows (in thousands):

Schedule of Deferred Tax Assets and Liabilities

  

2016

  

2015

 
         

Allowance for doubtful accounts

 $771  $6,345 

Inventory capitalization

  19,071   11,540 

Depreciation and amortization

  (211,014)  (228,610)

Investment tax credits

  475,000   475,000 

Research & development tax credits

  1,278,690   1,134,168 

Compensation costs

  1,000,073   730,909 

Vacation accrual

  333,396   323,860 

Accrued loss on legal settlement

  --   -- 

Net operating loss carryforward

  (7,280)  -- 

Capital loss carryforward

  26,627   26,627 

Gross deferred tax asset

  2,915,334   2,479,839 

Less valuation allowance

  (475,000)  (475,000)

Net deferred tax asset

 $2,440,334  $2,004,839 
         

Net current deferred tax asset

  428,355   398,009 

Net long-term deferred tax asset

  2,011,979   1,606,830 

Net deferred tax asset

 $2,440,334  $2,004,839 
  2023  2022 
Deferred income tax assets:        
Net operating loss carryforwards $849  $482 
R&D tax credit carryforwards  1,863   1,723 
Compensation costs  113   10 
Vacation accrual  153   174 
Intangible assets  38   27 
Capitalized research and development  759   356 
Other items  303   263 
Deferred income tax assets  4,078   3,035 
Less: valuation allowance  (3,646)  (2,957)
Deferred income tax assets, net of valuation allowance  432   78 
Deferred incomes tax liability:        
Property, plant and equipment  (365)  (11)
Prepaid expenses  (67)  (67)
Deferred income tax asset, net $-  $- 

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that the deferred tax assets will be realized. The ultimate realization of deferred tax assets is based on the assessment of available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit the utilization of existing deferred tax assets. The Company considered all positive and negative evidence when determining the amount of the net deferred tax assets that are more likely than not to be realized. This evidence includes, but is not limited to, historical earnings, scheduled reversal of taxable temporary differences, tax planning strategies and projected future taxable income A significant piece of objective negative evidence evaluated was the cumulative loss incurred over the prior three-year period ended December 31, 2023. Such objective evidence limits the ability to consider subjective evidence such as our projections for future growth. Based on this assessment, we maintained a full valuation allowance against our net deferred tax assets as of December 31, 2023, and 2022. If these estimates and assumptions change in the future, we may be required to reduce our existing valuation allowance resulting in less income tax expense.

For the year ended December 31, 2023, the valuation allowance increased by approximately $0.7 million from the prior year primarily from current year operating losses for which no tax benefit was provided.

F-21

CVD EQUIPMENT CORPORATION AND SUBSIDIARSUBSIDIARIESIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 20162023 and 20162022

Note 1010 – Income Taxes (continued)

At December 31, 2023, the Company had $4.0 million of U.S. federal net operating loss carryforwards. These net operating losses have an indefinite carryforward period but are only available to offset 80% of future taxable income. The reconciliationCompany also has $1.9 million of federal research and development tax credits which expire in varying amounts in tax years 2028 through 2042.

The Company applies the applicable authoritative guidance which prescribes a comprehensive model for the manner in which a company should recognize, measure, present and disclose in its financial statements all material uncertain tax positions that the Company has taken or expects to take on a tax return. As of December 31, 2023 and 2022, the Company had no uncertain tax positions. The Company does not expect that its unrecognized tax benefits will significantly increase or decrease within twelve months.

The Company files federal statutory income tax ratereturns and income tax returns in various state and local tax jurisdictions and in Denmark. The federal tax years open to our effectiveexamination are 2020 to 2023. The Company’s state and local tax rate is as follows:years that are open to tax examination are generally 2019 to 2023.

  

2016

  

2015

 
         

Expected provision at federal statutory tax rate (34%)

 $(222,083 $1,538,565 

State taxes, net of federal benefit

  2,504   3,070 

Stock-based compensation expense

  (269,163  (252,288)
         

Net operating loss carryforward

  (21,412)  954,581 

Federal research & development credit

  (144,522)  (437,303)

Other permanent differences

  150,615   (486,430)

Income tax (benefit)/expense

 $(504,061) $1,320,195 

The Inflation Reduction Act (“IRA”) and Chips and Science Act (“CHIPS Act”) were both enacted in August 2022. The IRA introduced new provisions including a 15% corporate alternative minimum tax for certain large corporations that have at least an average of $1 billion adjusted financial statement income over a consecutive three-tax-year period and a 1% excise tax surcharge on stock repurchases. The CHIPS Act provides a variety of incentives associated with investments in domestic semiconductor manufacturing and related activities. Both the IRA and CHIPS Act are applicable for tax years beginning after December 31, 2022 and had no impact to the Company’s consolidated financial statements for the years ended December 31, 2023 and 2022.

NOTE 11Note 11Stockholders’ equityEmployee Retention Credit

1989 Non-Qualified Stock Option Plan

On June 15, 1989,During 2022, the Company instituted a non-qualified stock option plan (the “Plan”). In connection therewith, 700,000 shares of the Company’s common stock were reserved for

issuance pursuantconducted an analysis as to options grantedwhether it was entitled to employee retention credits (“ERC”) under the CARES Act as amended by the Taxpayer Certainty and Disaster Tax Relief Act of 2020 and the American Plan through June 30, 2009. All options granted vested over a four-year period and expire between five to seven years afterAct of 2021. Based on the date of grant. This 1989 Non-Qualified Stock Option Plan expired in June 2009.

2001 Non-Qualified Stock Option Plan

In November 2006,analysis, the Company registered a non-qualified stock option plandetermined that it was entitled to an ERC of approximately $1.5 million related to payroll paid in the first and third quarters of 2021 under the applicable Internal Revenue Service regulations related to ERCs.

As ERCs are not within the scope of ASC 740, Income Taxes, the Company has chosen to account for the ERCs by analogizing to the International Standard IAS 20, Accounting for Government Grants and Disclosure of Government Assistance. In accordance with IAS 20, an entity recognizes government grants only when there is reasonable assurance that the shareholders had approvedentity will comply with the conditions attached to them and the grants will be received. Accordingly, the Company recognized a non-current receivable of $1.5 million as of December 31, 2022 and other income of $1.5 million for the year ended December 31, 2022. The Company received the ERC credit in July 2001, covering key employees, officers, directors and other persons that may be considered as service providers to the Company. Options were awarded by the Board of Directors or by a committee appointed by the Board. Under the plan, an aggregateof 300,000 shares of Company common stock, $.01 par value, were reserved for issuance or transfer upon the exercise of options which were granted. Unless otherwise provided in the option agreement, options granted under the plan would vest over a four year period commencing one year from the anniversary date of the grant. The stock option plan expired on July 22, 2011.2023.

F-22

CVD EQUIPMENTEQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 20162023 and 20152022

NOTE 11Note 12Stockholders’ equity (continued)Stock-Based Compensation

A summary of the Company’s Share Incentive Plans are as follows:

2007 Share Incentive Plan

On December 12, 2007, shareholders approved the Company’s 2007 Share Incentive Plan (“2017 Incentive Plan”), in connection therewith, 750,000 shares of the Company’s common stock are reserved for issuance pursuant to options or restricted stock that may be granted under the Share

2017 Incentive Plan through December 12, 2017. In The Plan expired in December 2017. As of December 31, 2023, there were 120,000 options outstanding under this plan.

2016 42,320 shares of stock were granted and issued to directors and key employees, additionally, options were granted to a key employee for 100,000Share Incentive Plan

On December 9, 2016, shareholders approved the Company’s 2016 Share Incentive Plan (“2016 Incentive Plan”), in connection therewith, 750,000 shares of the Company’s common stock. In 2015, 36,108stock are reserved for issuance pursuant to options or restricted stock that may be granted under the 2016 Incentive Plan through December 9, 2026. As of December 31, 2023, there were 442,125 options outstanding under this plan.

2022 Share Incentive Plan

On July 14, 2022, shareholders approved the Company’s 2022 Share Incentive Plan (“2022 Incentive Plan”), in connection therewith, 515,000 shares of the Company’s common stock are reserved for issuance pursuant to options or restricted stock that may be granted under the 2022 Incentive Plan through July 14, 2032. As of December 31, 2023, there were granted284,750 options outstanding under this plan.

Under the 2016 and issued to directors and key employees.

The2022 Share Incentive Plans, the purchase price of the common stock under each option plan shall be determined by the Committee, provided, however, that such purchase price shall not be less than the fair market

value of the shares on the date such option is granted. The stock options generally expire seven to ten years after the date of grant.

As of December 31, 2023, there were 26,948 shares available for grant under the 2016 Equity Incentive Plan and 188,930 shares available for grant under the 2022 Equity Incentive Plan.

F-23

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2023 and 2022

Note 12 – Stock-Based Compensation (continued)

The Company recorded stock-based compensation of $776,000$0.9 million and $751,000$0.4 million for the years ended December 31, 20162023 and 2015, respectively.2022, respectively, that were included in the following line items in our Consolidated Statements of Operations (in thousands):

Schedule of Stock Based Compensation

  2023  2022 
       
Cost of revenue $120  $34 
Research and development  159   57 
Selling  94   27 
General and administrative  535   317 
         
Total stock-based compensation expense $908  $435 

A summaryStock-based compensation expense in both years included approximately $0.2 million related to restricted stock awards pursuant to a Director Compensation plan discussed below. The Company recognizes forfeitures of stock awards as they occur.

For the year ended December 31, 2023, the Company granted 254,000 stock options, vesting 25% per year over four years, with a ten-year life. The Company determined the fair value of stock options granted during the year ended December 31, 2023 is based upon weighted average assumptions as provided below.

Schedule of Weighted Average Assumptions

Stock price $14.02 
Exercise price $14.02 
Dividend yield  0%
Expected volatility  72%
Risk-free interest rate  3.39%
Expected life (in years)  6.00 

The expected life is the number of years the Company estimates that the awards will be outstanding based on the simplified method that considers the vesting period and contractual period of the stock option activity related to the 1989 and 2001 Stock Option Plans and the 2007 Share Incentive Plan for the period from January 1, 2015 through December 31, 2016 is as follows:

1989 Non-Qualified Stock Option Plan

  

Beginning

  

Granted

  

Exercised

  

Canceled

  

Ending

     
  

Balance

  

During

  

During

  

During

  

Balance

     
  

Outstanding

  

Period

  

Period

  

Period

  

Outstanding

  

Exercisable

 
                         

Year ended December 31, 2015

                        

Number of shares

  35,250   -0-   -0-   0   35,250   35,250 

Weighted average exercise price

                        

Per share

 $4.62   -0-   -0-   -0-  $4.62  $4.62 

Year ended December 31, 2016

                        

Number of shares

  35,250   -0-   35,250   -0-   -0-   -0- 

Weighted average exercise price

                        

Per share

 $4.62   -0-  $4.62   -0-   -0-   -0- 


CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2016 and 2015

NOTE 11 – Stockholders’ equity (continued)

2001 Non-Qualified Stock Option Plan

  

Beginning

  

Granted

  

Exercised

  

Canceled

  

Ending

     
  

Balance

  

During

  

During

  

During

  

Balance

     
  

Outstanding

  

Period

  

Period

  

Period

  

Outstanding

  

Exercisable

 
                         

Year ended December 31, 2015

                        

Number of shares

  124,480   -0-   -0-   -0-   124,480   124,480 

Weighted average exercise price

                        

Per share

 $4.57   -0-   -0-   -0-  $4.57  $4.57 

Year ended December 31, 2016

                        

Number of shares

  124,480   -0-   64,750   -0-   59,730   59,730 

Weighted average exercise price

                        

Per share

 $4.57   -0-   4.62   -0-  $4.51  $4.51 

2007 Share Incentive Plan

  

Beginning

  

Granted

  

Exercised

  

Canceled

  

Ending

     
  

Balance

  

During

  

During

  

During

  

Balance

     
  

Outstanding

  

Period

  

Period

  

Period

  

Outstanding

  

Exercisable

 
                         

Year ended December 31, 2015

                        

Number of shares

  100,000   -0-   -0-   -0-   100,000   20,000 

Weighted average exercise price

                        

Per share

 $11.17   -0-   -0-   -0-  $11.17  $11.17 

Year ended December 31, 2016

                        

Number of shares

  100,000   125,000   -0-   -0-   225,000   65,000 

Weighted average exercise price

                        

Per share

 $11.17   8.04   -0-   -0-  $9.43  $9.97 

option. The Company has 284,730846,875 of outstanding stock options under the three plans at December 31, 2016.2023.

F-24

CVD EQUIPMENTEQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 20162023 and 20152022

NOTE 11Note 12Stockholders’ equityStock-Based Compensation (continued)

The following table summarizes stock options awards for the years ended December 31, 2023 and 2022:

Schedule of Stock Options Awards

  Awards
(in Shares)
  

Weighted
Average

Exercise Price

 
Outstanding at December 31, 2021  618,500  $11.26 
         
Granted  198,500   5.04 
Expired / cancelled  (144,000)  11.72 
Exercised  -   - 
Outstanding at December 31, 2022  673,000   5.70 
Granted  254,000   14.02 
Expired / cancelled  (44,500)  6.57 
Exercised  (35,625)  4.53 
Outstanding at December 31, 2023  846,875   8.20 

The following table summarizes information about the outstanding and exercisable options at December 31, 2016.2023:

Schedule of Outstanding and Exercisable Options Ranges of Exercise Prices

    

Options Outstanding

          

Options Exercisable

 
        

Weighted

  

Weighted

          

Weighted

     
        

Average

  

Average

          

Average

     

Exercise

 

Number

  

Remaining

  

Exercise

  

Intrinsic

  

Number

  

Exercise

  

Intrinsic

 

Price Range

 

Outstanding

  

Contractual

  

Price

  

Value

  

Exercisable

  

Price

  

Value

 
                               
$3.00-3.99   34,000   1.95  $3.65  $171,020   34,000  $3.65  $171,020 
$4.00-4.49   15,930   4.04  $4.25  $70,570   15,930  $4.25  $70,570 
$5.00-7.99   9,800   5.04  $7.90  $7,644   9,800  $7.90  $7,644 
$8.00-12.00   225,000   6.64  $9.43  $0   65,000  $9.43  $0 
  Options Outstanding  Options Exercisable 
     Weighted  Weighted        Weighted    
     Average  Average        Average    
Exercise Number  Remaining  Exercise  Intrinsic  Number  Exercise  Intrinsic 
Price Range Outstanding  Contractual  Price  Value  Exercisable  Price  Value 
$ 4.00-7.00  463,375   7.9  $4.55  $76,655   195,375  $4.47  $37,064 
$ 7.01-10.00  20,000   4.3  $8.07  $-   20,000  $8.07  $- 
$ 10.01-13.00  130,000   4.0  $11.51  $-   120,000  $10.52  $- 
$ 13.01-16.00  233,500   9.2  $14.11  $-   -  $-  $- 

The intrinsic valueAs of December 31, 2023, there was $2.4 million of unrecognized compensation costs related to stock options expected to be recognized over a weighted average period of 2.6 years.

Restricted Stock Awards

Pursuant to the Director Compensation plan approved on October 11, 2021, each of the 100,000 options exercised duringfive independent directors is entitled to compensation for an annual equity retainer in the year ended amount of $40,000 per director, to be automatically granted on the date of the Company’s annual meeting of shareholders.

F-25

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2016 was $203,000. There were no options exercised during the year ended December 31, 2015.2023 and 2022

Restricted Stock AwardsNote 12 – Stock-Based Compensation (continued)

The following table summarizes restricted stock awards for the years ended December 31, 20162023 and 2015:2022:

Schedule of Restricted Stock Awards

      

Weighted

 
  

Shares of

  

Average Grant

 
  

Restricted

  

Date Fair

 
  Stock  Value  

Unvested outstanding at January 1, 2015

  8,000  $10.97 
         

Granted

  9,211  $13.66 

Vested

  (13,211) $12.84 

Forfeited/Cancelled

  -     
         

Unvested outstanding at December 31, 2015

  4,000  $10.97 
         

Granted

  17,524  $8.45 

Vested

  (21,524) $12.84 

Forfeited/Cancelled

  -     
         

Unvested outstanding at December 31, 2016

  -0-     
     Weighted 
     Average Grant 
  Shares of  Date Fair 
  Restricted Stock  Value 
Unvested outstanding at January 1, 2022  -  $- 
Granted  32,000   5.02 
Vested  (32,000)  5.02 
Forfeited or cancelled  -   - 
Unvested outstanding at December 31, 2022  -   - 
         
Granted  41,320   6.65 
Vested  (24,187)  6.81 
Forfeited or cancelled  -   - 
Unvested outstanding at December 31, 2023  17,133  $6.53 

The total fair value of shares of restricted stock awards vested for the years ended December 31, 2016 and 2015 was approximately $276,000 and $170,000 respectively.


CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2016 and 2015

NOTE 11 – Stockholders’ equity (continued)

The fair value of the outstanding restricted stock awards will beis recorded as stockstock-based compensation expense over the one-yearvesting period. Asperiod and totaled $0.17 million $0.16 million for the years ending December 31, 2023 and 2022, respectively.

Restricted Stock Units

In prior years, the Company issued restricted stock units or RSUs. During the year ended December 31, 2022, 5,500 RSUs vested which had an intrinsic value of $22,745. No restricted stock units vested during the year ended December 31, 2023 and there were no RSUs outstanding as of December 31, 2015 there was $44,000 of unrecognized compensation costs related to restricted stock awards, which is to be recognized over a period of 0.35 years.2023 and 2022.

Restricted Stock Units

The following table summarizes restricted stock units for the years ended December 31, 2016 and December 31, 2015:

      

Weighted

 
  

Shares of

  

Average Grant

 
  

Restricted

  

Date Fair

 
  

Stock Units

  

Value

 

Unvested outstanding at January 1, 2015

  103,319  $11.71 
         

Granted

  24,210  $14.61 

Vested

  (24,892) $11.55 

Forfeited/Cancelled

  (8,057) $10.54 
         

Unvested outstanding at December 31, 2015

  94,580  $12.55 
         

Granted

  60,400  $8.56 

Vested

  (33,890) $12.43 

Forfeited/Cancelled

  (7,000) $11.68 
         

Unvested outstanding at December 31, 2016

  114,090  $10.47 

The total fair value of vested restricted stock units was $421,000 and $288,000 respectively for the years ended December 31, 2016 and 2015.

The fair value of the outstanding restricted stock units will be recorded as stock compensation expense over the vesting period. As of December 31, 2016, there was $1,194,000 of total unrecognized compensation costs related to restricted stock units, which is expected to be recognized over a weighted-average period of 1.18 years.

During the years ended December 31, 2016 and 2015, the Company recorded into selling and general administrative expense approximately $776,000 and $751,000 for the cost of employee and director services received in exchange for equity instruments based on the grant-date fair value of those instruments in accordance with the provisions of ASC 718.


CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2016 and 2015

NOTE 12Note 13Defined Contribution Plan

On August 1, 1998, theThe Company adoptedmaintains a 401(k) Plan for the benefit of all eligible employees. All employees as of the effective date of the 401(k) Plan became eligible. An employee is eligible to become a participant after three months of continuous service.

Participants may elect to contribute from their compensation any amount up to the maximum deferral allowed by the Internal Revenue Code. Employer contributions are optional. During

Effective July 1, 2022, the Company implemented a matching contribution of 50% of an employee’s contributions up to 6% of their compensation. The Company recorded compensation expense of $243,000 and $90,000 during the years ended December 31, 20162023 and 2015,2022, respectively, for matching contributions to the Company incurred administrative and audit fees totaling $14,636 and $13,080, respectively. 401(k) plan.

No discretionary employer contribution has been made for 20162023 and 2015.2022.

F-26

Note 13Significant Risks and Uncertainties

Cash and Cash Equivalents

The Company places most of its temporary cash investments with financial institutions, which from time to time may exceed the Federal Deposit Insurance Corporation limit. The amount at

risk at December 31, 2016 and at December 31, 2015 was $20,157,000 and $11,966,000respectively.

Sales Concentrations

Revenue to a single customer in any one year can exceed 10.0% of our total sales. One customer represented 45.3% and 49.6% respectively, of our annual revenues in fiscal years 2016 and 2015. Another customer represented 13.7% of our revenue in 2015. Previously, we have not been generally dependent on any single customer, and the loss of any customer would be replaced by others, however, the dynamic has changed and although, we believe that our relationship with our current largest customers will provide us with ongoing continuous sustainability for years to come, the loss of current key customers would have to be replaced by others, and our inability to do so may have a material adverse effect on our business and financial condition.

Export sales to unaffiliated customers represented approximately 11.9% and 9.0% of sales for the years ended December 31, 2016 and 2015, respectively. Export sales in both 2016 and 2015 were primarily to customers in Europe and Asia. All contracts are denominated in U.S. dollars. The Company does not enter into any foreign exchange contracts.


CVD EQUIPMENTEQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 20162023 and 20152022

Note 1414Segment Reporting

The Company adopted ASC 280, “Segment Reporting.” The Company operates through (2) segments,three segments: CVD Equipment, Stainless Design Concepts (“SDC”) and SDC.CVD Materials. The CVD division is utilized for silicon, silicon germanium, silicon carbideEquipment segment manufactures and gallium arsenide processes.sells chemical vapor deposition, physical vapor transport and similar equipment. SDC is the Company’smanufactures ultra-high purity manufacturing division in Saugerties, New York.gas control systems. The accounting policies of CVD Materials segment provides material coatings for aerospace, medical, electronic and SDC are the same as those described in the summary of significant accounting policies (see Note 2).other applications. The Company evaluates performance based on several factors, of which the primary financial measure is earningsincome (loss) before taxes.

The Company’s corporate administration activities are reported in the “Corporate” column. These activities primarily include expenses related to certain corporate officers and support staff, expenses related to the Company’s Board of Directors, stock option expense for shares granted to corporate administration employees, certain consulting expenses, investor and shareholder relations activities, and all of the Company’s legal, auditing and professional fees, and interest expense.

Elimination entries included in the “Eliminations” column represent intersegment revenues and cost of revenues that are eliminated in consolidation. Intersegment sales for the year ended December 31, 2023 and 2022 by the SDC segment to the CVD Equipment segment were $439,000 and $573,000, respectively. Intersegment sales by the CVD Equipment segment to the SDC segment for the year ended December 31, 2023 were $109,000. There were no intersegment sales by the CVD Equipment segment to the SDC segment during the year ended December 31, 2022.

The following table presents certain information regarding the Company’s segments as of December 31, 2016 and for the year then ended:years ended December 31, 2023 and December 31, 2022 (in thousands, including amount in notes):

  

CVD

  

SDC

  

Eliminations

  

Consolidated

 

Assets

 $44,783,126  $4,558,111  $(3,680,845) $45,660,392 
                 

Revenue

 $18,568,132  $2,934,831  $(547,616) $20,955,347 

Interest Expense

  78,322   1,539       79,861 

Depreciation andAmortization

  750,680   62,978       813,658 

Capital expenditures

      5,850         

Pretax earnings/(loss)

      (441,610)        

Schedule of Segments

2023

  CVD Equipment  SDC  CVD Materials  Corporate  Eliminations  Consolidated 
Assets $31,401  $3,468  $211  $-  $(55) $35,025 
                         
Revenue $16,334  $7,139  $1,184  $-  $(548) $24,109 
Operating (loss)
income(1)
  (2,129)  1,677   (193)  (4,118)  (118)  (4,881)
Pretax (loss) income (1)  (2,070)  1,677   (141)  (3,542)  (118)  (4,194)
Depreciation and amortization $620  $49  $123  $-  $-  $792 
Purchases of property,
plant & equipment
 $404  $14  $-  $-  $-  $418 

2022

  CVD Equipment  SDC  CVD Materials  Corporate  Eliminations  Consolidated 
Assets $31,622  $4,149  $2,099  $-  $42  $37,912 
                         
Revenue $16,674  $6,541  $3,171  $-  $(573) $25,813 
Operating (loss) income  (1,430)  1,546   1,050   (2,989)  -   (1,823)
Pretax (loss) income (2)  (156)  1,849   1,076   (2,989)  -   (220)
Depreciation and amortization $652  $49  $166  $-  $-  $867 
Purchases of property, plant & equipment (3) $653  $3  $3  $-  $-  $- 

(1)CVD Materials segment includes loss on sale of Tantaline of $0.2 million and an impairment charge related to MesoScribe fixed assets of $0.1 million.
(2)Includes other income related to ERCs of $1,103, $303 and $123 for the CVD, SDC and Materials segments, respectively.
(3)Include $0.4 million of purchased equipment financed with a loan

F-27

CVD EQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2023 and 2022

Note 15 – CVD Materials – Tantaline and MesoScribe Subsidiaries

Tantaline Subsidiary

On May 26, 2023, the Company sold its Tantaline subsidiary located in Nordborg, Denmark in exchange for a nominal amount at closing and an earn-out provision based on any net income that Tantaline may earn during the five-year period ending December 31, 2027. The following table presents certain information regardingCompany recorded a loss of $0.2 million upon the sale. Any earn-out amounts will be recognized when and if any such amounts become probable of receipt.

The decision to sell Tantaline was based on the Company’s ongoing strategy to focus on the equipment business consisting of the CVD Equipment and SDC segments and reduce its focus on the non-core CVD Materials business.

Including the loss on disposition of $0.2 million, the revenues and net income of Tantaline were $0.5 million and $0.1 million, respectively, for the year ended December 31, 2023. The total assets and total liabilities of the Tantaline subsidiary were $1.1 million and $0.4 million as of December 31, 20152022.

MesoScribe Subsidiary

On August 8, 2023, the Company entered into a Purchase and License Agreement (the “Agreement”) with a third-party. Pursuant to the Agreement, the Company will sell certain proprietary assets relating to its plasma spray technology and material deposition system and grant a non-exclusive license to use certain of the Company’s related intellectual property as more fully described in the Agreement, for an aggregate purchase price of $0.9 million. The purchase price is payable in several installments and contingent upon certain performance metrics and other milestones.

The Company will continue to fulfill remaining orders for MesoScribe products through the end of 2024 at which time it plans to cease the remaining operations of MesoScribe and dispose of any remaining equipment. During the year ended December 31, 2023, the Company recorded an impairment charge of $0.1 million for certain equipment of MesoScribe based on its decision to cease the operations of MesoScribe upon fulfillment of remaining orders. There were no impairment charges recorded in 2022.

The Company received payments under the Agreement in the amount of $0.6 million which has been reflected as “deposits from purchaser” in the accompanying consolidated balance sheet as of December 31, 2023. The Company expects the transaction to be completed in 2024 with the shipment of the equipment to the purchaser.

The revenues and net income of MesoScribe were $0.7 million and $33,000 for the year then ended:ended December 31, 2023, including the impairment charge of $0.1 million.

  

CVD

  

SDC

  

Eliminations

  

Consolidated

 

Assets

 $39,529,971  $3,619,304  $(2,017,571) $41,131,704 
                 

Revenue

 $35,473,057  $5,674,258  $(2,181,928) $38,965,387 

Interest Expense

  85,765   6,336       92,101 

Depreciation and Amortization

  764,467   62,062       826,529 

Capital expenditures

  212,140   36,165       248,305 

Pretax (loss)/earnings

  3,616,280   1,046,911       4,663,191 

The total assets and total liabilities of the MesoScribe subsidiary were $0.2 million and $0.7 million, respectively, as of December 31, 2023 and $0.9 million and $0.1 million, respectively, as of December 31, 2022.

F-28

CVD EQUIPMENTEQUIPMENT CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 20162023 and 20152022

Note 15 Purchase16 – Risks and Uncertainties

The Company currently operates in a challenging economic environment as the global economy continues to confront the remaining impacts from the pandemic, geopolitical conflicts, inflationary pressures, and adverse supply chain disruptions. The specific impacts on the Company have included:

Significant geopolitical developments across Europe and Asia (including the war in Ukraine) have and may continue to restrict the Company’s ability to procure raw materials and components such as nickel and integrated circuits, as well as impact the Company’s ability to sell its products into China, Russia and other Eastern European and Asian regions.
Supply chain disruptions have led to much longer lead times to acquire raw materials for production and has led to inflationary pressures in both materials and labor. These supply chain disruptions have impacted the Company’s ability to recognize revenue timelier as it delays the Company’s manufacturing processes.

While management has initiated actions to mitigate the potential negative impacts to its revenue and profitability, the Company is unable to predict the impact that the above uncertainties may have on its future results of assetsoperations and cash flows.

On December 16, 2016, we purchased certain assets formerly owned by Tantaline A/S of Nordborg, Denmark through our wholly owned subsidiary, CVD Materials Corporation. Formed in 2007, as a spin off from The Danfoss Group, Tantaline A/S established itself as a leader in the commercialization of tantalum treated parts for corrosion resistance. We have now established in Nordborg a new and wholly owned CVD subsidiary operating under the name Tantaline CVD Aps (“Tantaline”).

F-29

F-26